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Forebrain development is controlled by a set of transcription factors which are 
expressed in dynamic spatiotemporal patterns in the embryonic forebrain and are 
known to regulate complex gene networks. Pax6 is a transcription factor that 
regulates corticogenesis and mutations affecting Pax6 protein levels cause 
neurodevelopmental defects in the eyes and forebrain in both humans and mice. In 
previous studies, it was shown that the graded expression pattern of Pax6 protein, 
which is high rostro-laterally to low caudo-medially in the cerebral cortex, is critical 
for its control of cell cycle progression and proliferation of cortical progenitors. 
However the underlying mechanisms are still unclear.  
Based on a microarray analysis carried out in our laboratory, a number of cell cycle-
related candidate genes that may be affected by Pax6 have been identified. One such 
gene, Cell division cycle associated 7 (Cdca7) is expressed in a counter-gradient 
against that of Pax6. In my current study, I found that Cdca7 mRNA expression in 
the telencephalon is upregulated in Pax6 null (Small eye) mutants and downregulated 
in mice that overexpress PAX6 (PAX77) across developing time points from E12.5 to 
E15.5. There are several potential Pax6 binding motifs located in the genomic locus 
upstream of Cdca7. However, by chromatin immunoprecipitation, it is showed that 
none of the predicted binding sites are physically bound by Pax6. Promoter luciferase 
assays using fragments combining five suspected binding motifs show that Pax6 is 
functionally critical.  
Cdca7 is also identified as a Myc and E2F1 direct target and is upregulated in some 
tumours but its biological role is not fully understood. Current work using in utero 
 
xiv 
electroporation to overexpress Cdca7 around the lateral telencephalon, where Cdca7 
expression levels are normally low, tested the effects on the proliferation and 
differentiation of cortical progenitor cells in this region. In E12.5 mice embryos, 
overexpression of Cdca7 protein causes fewer intermediate progenitor cells and post-
mitotic neurons to be produced but these effects were not found in E14.5 embryos. 





Our brain is responsible for many functions such as sensory and motion control, 
consciousness and cognition. In order to execute those functions correctly, brain 
needs to develop correctly. This is achieved by the co-ordination of a set of protein 
called transcription factors. Transcription factors regulate the mRNA expression of 
their target genes, this regulation is tightly controlled both in time and space. Pax6 is 
one of these transcription factors, its functions have been found important in the 
development of forebrain, which consists of neocortex, hypothalamus, hippocampus 
and thalamus. Insufficient PAX6 protein in human causes aniridia, or absence of iris. 
Patients having this disease suffer from impaired or loss eyesight. Scientists adopt 
mice carrying the same mutation in human PAX6-insufficient patients as a disease 
model. In mouse cortex, the expression pattern of Pax6 protein is high rostro-
laterally and low caudo-medially. Previous study showed that Pax6 was able to affect 
progression of cell cycle in radial glia cells only from the region where Pax6 protein 
levels were high and moderate. However the underlying mechanisms remain elusive. 
Also in the cortex, a gene called Cell division cycle associated 7 (Cdca7) was 
identified as a potential downstream target of Pax6 regulation. In my current study, 
the expression of Cdca7 showed a counter-gradient against that of Pax6 at mouse 
embryonic stage E12.5 to E15.5. Furthermore the expression of Cdca7 was 
upregulated in mice lacking functional Pax6 protein, indicating that Pax6 may 
negatively control the expression of Cdca7. Mechanistically Pax6 as a transcription 
factor must be able to interact with the promoter or enhancer regions of its target 
genes. However in this study, no physical Pax6 binding sites were found near or 
 
xvi 
within the Cdca7 genomic regions, suggesting that Pax6 does not directly control the 
expression of Cdca7. 
The function of Cdca7 in cortical development has not been previously investigated.  
Using a technique called in utero electroporation, Cdca7 were overexpressed around 
the embryonic lateral cortex, where its expression levels are normally low, to 
investigate the effect of this protein on the proliferation and differentiation of cortical 
progenitor cells in this region. In E12.5 mice embryos, overexpression of Cdca7 
protein caused decreased production of intermediate progenitor cells, one of the two 
main progenitors in the cortex. In addition, production of neurons was also reduced 
by the overexpression of Cdca7 at E12.5. These effects were not observed in E14.5 
embryos. Taken together, Cdca7 may affect differentiation of radial glia cells into 
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Chapter 1  : General Introduction 
1.1 Early development of the brain in mammals 
1.1.1 Development of forebrain in mouse 
Mechanisms behind the formation of a complex brain which contains several 
compartments controlling movements, sensations and cognition has been one of the 
most intriguing topics in neuroscience field. During gastrulation, ectodermal cells 
default to neural fate, with fibroblast growth factors (FGFs) signalling playing a role 
in the induction of neural tissues. Bone morphogenetic proteins (BMPs) act against 
FGFs, and are expressed in the ectodermal tissues surrounding the future 
neuroectoderm to trigger epidermal fate (Beccari et al., 2013; Kudoh et al., 2004; 
Muñoz-Sanjuán and Brivanlou, 2002; Wilson and Edlund, 2001). Neural induction 
starts from a group of ectodermal cells transforming into neuroepithelial cells, which 
proceeds to form a flat sheet termed the neural plate. The neural plate elongates as 
development progresses and finally its edges fuse to become the neural tube (Colas 
and Schoenwolf, 2001; Schoenwolf and Smith, 1990; Smith, 1997; Vieira et al., 
2010). The most rostral part of neural plate called anterior neural plate, requires co-
ordination of several signalling molecules acting in a highly patterned and graded 
fashion to develop into different forebrain compartments, as well as to set up dorso-
ventral, antero-posterior, and proximo-distal axes which shape the structure of the 
growing organ. These signalling molecules include BMP, Wnts (wingless/ints), 
FGFs and retinoic acid (RA) (Wilson and Houart, 2004).  
The forebrain derives from the anterior vesicle of the neural tube, and resides in the 
most anterior part of the neural tube along the rostro-caudal axis followed by 
midbrain, hindbrain and spinal cord (Lumsden and Krumlauf, 1996; Wurst and 
Bally-Cuif, 2001). The telencephalon is located at the dorsal side of the forebrain. It 
consists of dorsal and ventral telencephalon, which later become the cerebral cortex 
and the basal ganglia, respectively, as well as the eyes. In addition to the 
telencephalon, the forebrain also contains the diencephalon, which is located 
caudally to the telencephalon. Diencephalon is further divided into prethalamus  
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 (pTh), thalamus (Th) and pretectum (PT) from rostral to caudal direction (Figure 






Schematic diagram showing the neural tube of an E10.5 mouse embryo. The 
telencephalon (Tel) is located at the dorsal side of the forebrain. The diencephalon (Di) 
shown in yellow colour is located caudally to the telencephalon and is further divided 
into ventral thalamus or prethalamus (vTh or pTh), thalamus (Th), and pretectum (PT) 
from rostral to caudal direction. Hypothalamus (Hy) is located ventrally to the 
diencephalon. Eth:epithalamus 
Drawings originate from (Lokmane andGarel, 2011; Martinez-Ferre andMartinez, 
2012) 
Figure 1.1 The forebrain compartments and the thalamocortical tracts. 
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FGFs are secreted by the gastrula organiser, or node in mammals, as well as 
endodermal cells beneath the future neuroectoderm. These molecules and are able to 
trigger neural fate by induction of pre-neural markers. Neural induction is further 
proceeded by release of BMP antagonist by the neural tissue, which progresses to 
separate from the epidermis (Kudoh et al., 2004; Muñoz-Sanjuán and Brivanlou, 
2002; Wilson and Edlund, 2001; Wilson and Houart, 2004). The function of Wnts is 
finely controlled temporally. Wnts at first cooperate with FGFs to induce neural fate 
but a later stage they promote non-neural ectoderm together with BMPs signals 
(Baker et al., 1999; Erter et al., 2001; Gaulden and Reiter, 2008; Heeg-Truesdell and 
LaBonne, 2006).  FGFs are also important in determining the antero-posterior axis in 
the neural tube. In the anterior end of the neural tube, FGFs are highly expressed 
together with Wnt antagonists such as Sfrp family members, which localise in a 
anteriorhigh to posteriorlow gradient, counteracting the Wnts gradient which exists in 
the opposite pattern (Beccari et al., 2013). Gain-of-function experiment found Fgf8-
soaked beads placed in the anterior neural plate can induce the production of Foxg1b, 
a transcription factor required for telencephalic and optic regionalisation (Shimamura 
and Rubenstein, 1997). Anterior overexpression of FGF8 in mice resulted in 
reduction of Wnt signalling in the cortical hem and hippocampus shrinkage 
(Shimogori et al., 2004).  
Fgf molecules also locate along the dorsa-ventral axis, where their gradients are high 
dorsally and low ventrally, opposite to the gradient of Sonic hedgehog (Shh) . 
Opposing gradients of the two genes act co-ordinately to develop telencephalon in 
the dorsal, and hypothalamus in the ventral region (Wilson and Maden, 2005)). High 
level of Shh signalling secreted from the ventral regions activates Gli1/2 and 
represses Gli3 function, which further induce several ventral markers such as Foxa2, 
Nkx2.2, Olig2 and Dbx1/2. Shh also inhibits Pax6 and Irx3 (Briscoe et al., 2000). 
Overexpression of Shh induced ventral interneuron and motor neurons while mice 
lacking Shh failed to develop floor plate and various types of ventral interneurons 
(Chiang et al., 1996; Echelard et al., 1993; Krauss et al., 1993; Roelink et al., 1994). 
Together, the gradient of Shh determines the localisation of various transcription 
factors, which patterns the dorso-ventral axis in the telencephalon.   
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Shh can also be secreted from a small group of cells in an organizer region called the 
zona limitans intrathalamica (Zli). The Zli locates between thalamus and prethalamus 
and separates the telencephalon from diencephalon. High level of Shh secreted from 
the Zli regionalises surrounding areas (Kiecker and Lumsden, 2004; Zeltser, 2005).  
The Zli region is flanked by an area expressing Lunatic fringe (Lfng). 
Overexpression of Lfng prevents the formation of Zli. In Pax6-/- mice, Zli regions 
expand along the dorso-ventral axis in the dienchphalon, possibly mediated by the 
transcription factor Barhl2. Together these data suggest formation of Zli is dependent 
on the combinatorial signalling between Shh, Pax6 and Lfng. (Caballero et al., 2014; 
Kiecker and Lumsden, 2004; Larsen et al., 2001; Parish et al., 2016).  
Wnts are secreted glycoproteins which function to establish posterior identity along 
the antero-posterior axis of the neural tube by antagonising FGF signalling (Wilson 
and Houart, 2004). Later in the development, Wnts are secreted from the dorsa-
medial border of cortex, named the cortical hem, where BMPs molecules are also 
produced (Furuta et al., 1997; Grove et al., 1998; Shimogori et al., 2004).  Signalling 
from the cortical hem is essential for the development of adjacent tissues such as 
hippocampus and choroid plexus. Choroid plexus was abnormally formed in Wnt-3a-
deficient mice. Hippocampus and dentate gyrus failed to form in this mutant mice. 
(Lee et al., 2000). In Gli3 mutant mice, the cortical hem was absent, causing 
significant reduction of cortical hem-derived Wnts and BMPs (Grove et al., 1998).  
The function of retinoic acid (RA) in forebrain development is less studied. RA is 
derived from vitamin A, it is synthesised by family members of retinaldehyde 
dehydrogenase and catabolized by the CYP26 class of P450 enzymes in the 
cytoplasm (Chithalen et al., 2002). The function of RA involves establishment of 
antero-posterior and dorso-ventral axis in a gradient-dependent manner (Maden, 
2007). Combined anterior expression of CYP26 in the forebrain and midbrain, and 
posterior expression of retinaldehyde dehydrogenase in the spinal cord specified the 
hindbrain compartments (Glover et al., 2006; Reijntjes et al., 2004). Defective 
expression of Fgf8 and Shh were seen in chick forebrain treated with RA receptors 
antagonist (Schneider et al., 2001). Moreover, retinaldehyde dehydrogenase 2-null 
mice also displayed downregulations of Fgf8 and Shh signalling, concurrent with 
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malformation of the telencephalon, optic vesicle and ventral diencephalon (Rhinn 
andDollé, 2012; Ribes et al., 2005).  
In the next section, gradients of signalling molecules in the cortex will be further 
discussed in details.   
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1.1.2 Gradients of signalling molecules in the cortex affect 
cerebral cortical development 
Multiple signalling pathways act in concord to regulate self-proliferation and 
differentiation of neural stem cells, as well as neuronal subtype specification and 
arealisation in the telencephalon. Signalling molecules and transcription factors are 
expressed in the signalling organisers or in restricted areas, and sometimes the 
expression occurs in a graded fashion to exert regional influences during cortical 
development (Figure 1.2A) (Montiel andAboitiz, 2015; Sansom andLivesey, 2009).  
Secreted molecules such as fibroblast growth factors (FGFs) are some of the best 
characterised morphogens involved in the forebrain development. Early expression 
of Fgf3, 8, 15, 17 and 18 are observed from E9.5 in mouse embryos in the rostral 
midline regions forming a secreting centre of Fgf molecules which function in a 
concentration-dependent manner (purple region, Figure 1.2A) (Bachler andNeubüser, 
2001; Maruoka et al., 1998; McWhirter et al., 1997). Fgf8 is expressed in a high 
rostrally to low caudally pattern in the forebrain (Figure 1.2B). Gain or loss-of 
function studies have demonstrated that Fgf8 is essential for rostral neocortex 
identity (Fukuchi-Shimogori andGrove, 2001; Okada et al., 2008; Sahara et al., 2007; 
Storm et al., 2006). Motor cortex, somatosensory cortex and primary visual cortex 
are located from rostral to caudal in the neocortex. Ectopically expressed Fgf8 by in 
utero electroporation in the rostral end of the neocortex results in an expansion and 
caudal shift of the motor cortex and shrinkage of somatosensory and primary visual 
areas (Fukuchi-Shimogori andGrove, 2001). In contrast, the rostral regions reduce 
when the area is injected with soluble Fgf receptor (sFgfr3) which competes with cell 
surface receptors for Fgf8, thereby inhibiting signals to the cells (Fukuchi-Shimogori 
andGrove, 2003, 2001). Moreover, ectopic introduction of Fgf8 in the caudal area of 
the cortex promotes the formation of an extra somatosensory cortex in the region 
(Fukuchi-Shimogori andGrove, 2001). The function of Fgf signalling was further 
demonstrated using a mouse model deficient in Fgf receptor (Fgfr)1 specifically in 
the forebrain. Fgfr1-deficient embryos possess normal rostro-caudal axis patterning 
indicated by the regional markers Pax6 and Emx2, but the olfactory bulb (OB), 
which is located at the rostral tip of the forebrain, fails to form (Hébert et al., 2003).  
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(A)There are four distinct signalling centres which account for the regional patterning in 
the forebrain. A rostral signalling centre or the anterior forebrain (AF, violet) secrets  
fibroblast growth factors (Fgfs) and the cortical hem (orange) on the caudodorsal side of 
the forebrain secrets Wnts (wingless/ints) and bone morphogenetic proteins (BMPs). A 
rostroventral centre close to commissural preoptic area (blue, POC) secrets sonic 
hedgehog (Shh) and the Antihem located at the interface of the cortex and the lateral 
ganglionic eminence (green, LGE) secrets retinoic acid (RA). (B) The graded expression 
of four transcription factors and one signalling molecule (Fgf8) in a mouse neocortex 
(ncx). The expression patterns of COUP-TF and Emx2 are caudalhigh to rostrallow while 
those of Sp8, Pax6 and Fgf8 are high rostrally and low caudally. OB: olfactory bulb; 
R:rostral; C: caudal; M:medial; L: lateral 
Diagrams originate from (Montiel andAboitiz, 2015; Sansom andLivesey, 2009) 
Figure 1.2 The signalling centres and gradients in the embryonic brain.  
The regulatory role of Pax6 on Cell Division Cycle Associated 7 and cortical progenitor cell proliferation 
Chapter 1: General Introduction 8 
Sp8 is a zinc finger transcription factor which is essential for rostral identity in 
neocortex (Figure 1.2B). Loss of Sp8 results in expansion of the caudal area in 
developing cortex (Zembrzycki et al., 2007). Moreover, conditional inactivation of 
Sp8 in embryonic ventral telencephalon causes downregulation of interneurons in the 
OB (Waclaw et al., 2006). Sp8 and Fgf8 mutually induce each other’s expression and 
Sp8 protein physically binds to Emx2 regulatory elements, repressing the expression 
of Fgf8, implying a sophisticated interactive regulatory network controlling region 
identity in developing cortex (Zembrzycki et al., 2007). 
Another transcription factor COUP-TF1 is expressed high caudomedially and low 
rostrolaterally in developing cortex (Figure 1.2B)(Liu et al., 2000; Zhou et al., 2001). 
This gradient is similar to that of Emx2 but is opposite to those of Fgfs, Sp8 and 
Pax6. COUP-TF1 has been shown to be responsible for the caudal identity of 
neocortex. Mice with cortex-specific deletion of COUP-TF1 exhibit phenotypes 
similar to those seen in the Fgf8 overexpression model in the rostral part of 
neocortex, with massive expansion of the rostral area or motor cortex at the expense 
of the caudal regions, and shrinkage of somatosensory and primary visual cortex 
(Armentano et al., 2007; Faedo et al., 2008). Being a transcriptional repressor, 
COUP-TF1 is also thought to inhibit rostral fate in the caudal area in a gradient-
dependent manner. Further studies have shown that the activity of Fgf signalling and 
COUP-TF1 are mutually repressive during area specification in the cortex (Borello et 
al., 2014). Upregulation of Fgfs expression in the rostral cortex results in contraction 
of the COUP-TF1 gradient, while downregulation of Fgfs leads to expansion 
(Fukuchi-Shimogori andGrove, 2003; Garel, 2003). Molecular studies have revealed 
that COUP-TF1 is repressed by Sp8, a downstream factor of Fgf8 signalling. 
Overexpression of Sp8 during early corticogenesis causes a reduction in COUP-TF1 
expression, while reduction in Sp8 expression leads to increased COUP-TF1. 
Additionally, COUP-TF1 overexpression results in downregulation of Sp8 (Borello 
et al., 2014). Taken together these two transcription factors, COUP-TF1 and Sp8 act 
in a mutually repressive manner. 
Studies using models with various expression levels of Emx2 have shown that caudal 
identity is determined by Emx2 dosage (Figure 1.2B) (Hamasaki et al., 2004). 
Elevated Emx2 expression under the control of the Nestin promoter results in an 
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expansion of the caudal area in neocortex, while in Emx2-null mutants, reduction in 
the caudomedial area and later the primary visual cortex have been observed (Bishop 
et al., 2002; Hamasaki et al., 2004; Muzio et al., 2002a, 2002b). The phenotypes of 
the Emx2-null mutant are similar to those of the COUP-TF1 mutant. However the 
expression level of COUP-TF1 is not altered in Emx2-null cortex, suggesting that 
COUP-TF1 may function upstream to Emx2 (Cecchi, 2002; Sansom andLivesey, 
2009; Zhou et al., 1999).  
 
1.1.3 Cell cycle control in mouse development 
Building a functioning cortex requires precise control of the number and type of 
neurons in the region, as well as correct formation of neural circuits. Neural 
progenitors undergo one to several rounds of cell cycles before committing to 
neurogenic division (Edlund andJessell, 1999; Galderisi et al., 2003). The rate of cell 
cycle progression and the balance between cell cycle re-entry and exit have been 
demonstrated to correlate with the number of neurons in individual layers of the 
cerebral cortex (Polleux et al., 1997). Modulation of cell cycle kinetics can also alter 
neuron production. Early mathematical models show that acceleration of 
proliferative division in progenitors results in an excess amount of neurons (Dehay 
andKennedy, 2007; Pilaz et al., 2009; Polleux et al., 1997). In contrast, acceleration 
of differentiative division in progenitors leads to a transient increase in neurons but 
eventually the number reduces due to exhaustion of the progenitor pool (Caviness et 
al., 2003; Polleux et al., 1997). Here, I will first focus on the general control of cell 
cycle progression and the outcomes of its misregulation during mouse cortical 
development.  
A complete cell cycle consists of four phases including G1, S, G2 and M (Figure 
1.3). During S phase DNA synthesis occurs and chromosomes are replicated, and in 
M phase (mitosis) the cell divides into two daughter cells. The two gap phases, G1 
and G2 both possess checkpoint roles which can halt the cell cycle to ensure that the 
cell is fully prepared for the coming DNA synthesis or cell division, respectively. 
There is an extra phase, known as G0, in post-mitotic and terminally differentiated 
cells which have become quiescent. Various protein complexes have been found to 
promote or restrict the progression of the cell cycle. Different combinations of 
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Cyclin-CDKs (cyclin-dependent kinases) tightly regulate cell cycle progression. 
During early G1 phase, Cyclin D/CDK4, 6 complex senses both intrinsic and 
environmental growth signals to promote cell cycle progression while in late G1 
phase, Cyclin E/CDK2 is required for transition to S phase. Expression of Cyclin 
A/CDK2, Cyclin A/CDK1, 2 and Cyclin B/CDK1 are required in S, G2 and M 
phases, respectively (Ciemerych andSicinski, 2005).  
The restriction point in G1 is the time when cells become committed to cell cycle 
progression even without extracellular growth factors. After passing this point, cells 
become growth factor-independent (Foster et al., 2010; Pardee, 1989). Various cell 
cycle inhibitors are produced by the cell to modulate passage through phases. The 
CIP/KIP inhibitor family contains p21, p27 and p57 and inhibits a broad range of 
cyclins and CDKs throughout the cell cycle, especially at the G1/S and G2/M 
checkpoints. The CIP/KIP family proteins act downstream of the tumour suppressor 
p53 which halts the progression of cell cycle in response to DNA damage, hypoxia 
stress and cell injury (Brugarolas et al., 1995; El-Deiry, 1993). The other inhibitor 
family INK4 consists of p15, p16, p18 and p19. INK4 family members modulate the 
G1/S checkpoints by competing with CDK4 and CDK6 in binding to Cyclin D, 
thereby interfering the formation of the Cyclin D/CDK4, 6 complex (Pavletich, 1999; 
Tvrdík et al., 2002). The cyclin D/CDK4, 6 complex can phosphorylate 
retinoblastoma protein (Rb) (Dyer andCepko, 2001; Massagué, 2004; Pavletich, 
1999). Rb when hypophosphorlated physically binds to E2f family transcription 
factors E2f1, 2, and 3. Phosphorylated Rb is released from this interaction, allowing 
E2fs to enter the nucleus and trigger the expression of their downstream target genes 
which include regulators of cell cycle progression (Blais andDynlacht, 2007; Helin et 
al., 1993; Lees et al., 1993). 
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A full cycle comprises four consecutive phases including S phase for DNA synthesis, M 
phase for cell division, and the two gap phases G1 and G2 for the cell to pause and become 
ready for the coming cellular events. There is an extra stage called G0. Cells in G0 phase exit 
the cell cycle and become quiescent or terminally differentiated. Protein complexes 
consisting of different combination of cyclins and CDKs tightly control cell cycle 
progression. The complexes are also monitored by groups of inhibitors including the INK 
family and CIP/KIP proteins. Adapted from (Dehay and Kennedy, 2007; 
www.pathophys.org) 
Figure 1.3 Structure, regulation and checkpoints of a cell cycle. 
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Previous studies have adopted loss-of-function approaches to reveal the importance 
of cyclin/CDK complexes as well as the inhibitory protein families. Some mutants 
display relatively normal and viable phenotypes while some are embryonic lethal 
(Berthet andKaldis, 2007; Sherr andRoberts, 2004). Mice lacking Cyclin D1, D2 and 
D3 (three members of the D-type cyclins) or Cyclin D2 and D3 die at E16.5 and 
E17.5-18.5, respectively, with megaloblastic anaemic phenotypes (Ciemerych et al., 
2002; Kozar et al., 2004). Cdk4-/- and Cdk6-/- double mutant mice also die 
embryonically between E14.5-E18.5 of severe anaemia and haematopoiesis-related 
deficits (Malumbres et al., 2004). Mice lacking individual INK family members are 
relatively normal during embryonic development but possess an increased risk of 
tumour occurrence in adulthood (Franklin et al., 2000, 1998; Latres et al., 2000; 
Serrano et al., 1996); however p27-/-;p57-/- double mutants are embryonic lethal at 
E12-E16.5 with abnormal proliferation in lens, limbs and intestine (Ciemerych 
andSicinski, 2005; Zhang et al., 1998).  
The developmental functions of the pRb-E2f pathway have also been elucidated.  
Mice deficient in individual E2f family members, E2f1-6, except E2f4, are viable but 
suffer from developmental defects in multiple organs (Swiss andCasaccia, 2010). 
Mice with combined null mutations in E2f2 and E2f3 or E2f1 and E2f3 are 
embryonic lethal (Wu et al., 2001). pRb knockout embryos die between E12-E15 
with severe defects in erythroid, neural and lens development (Clarke et al., 1992; 
Jacks et al., 1992; Lee et al., 1992; Swiss andCasaccia, 2010).  
Regulation of cell cycle progression is critical in mouse embryo development. In 
developing cortex, control of the progression rate both temporally and spatially 
determines the number of neurons and circuit connections in the region. In the next 
section I will summarise the decision making between proliferative or differentiative 
division in cortical progenitors, and the cell cycle kinetic mechanisms involved in 
this regulation.   
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1.1.4 Differentiation and proliferation of cortical progenitors   
In the dorsal telencephalon (dTel), a single layer of neuroepithelial cells which reside 
in the area closest to the ventricle become a type of neural progenitor cells called 
radial glia cells (RGCs). The shape of RGCs is elongated with their processes 
attached to the ventricle (inside) and the pial surface (outside), therefore RGCs are 
also called the apical progenitors (APs) (Barry et al., 2014; Kriegstein andGötz, 
2003; Malatesta et al., 2003). During neurogenesis, the nuclei of RGCs move within 
the ventricular zone (VZ) at different phases of the cell cycle. This movement is 
termed interkinetic nuclear migration (INM) (Hayes andNowakowski, 2000; Miyata 
et al., 2001; Noctor et al., 2001), and results in nuclei undergoing S-phase at the 
outer edge of the VZ and mitosis at the ventricular surface. RGCs are thought to give 
rise to most of the glutamatergic neurons via direct neurogenesis or indirectly via 
another type of progenitor cell called the intermediate progenitor cells (IPCs) (Figure 
1.4).  At the beginning of neurogenesis, around E11 to E12 in mouse, RGCs mainly 
undergo symmetrical divisions, doubling their population in order to expand the 
progenitor pool; a minority of RGCs divide asymmetrically, producing one RGC and 
one IPC or one neuron which exits the cell cycle and migrates to the preplate near the 
pial surface (Huttner andKosodo, 2005; Noctor et al., 2004). At later stages of 
neurogenesis, from E13, the proportion of RGCs undergoing asymmetric division 
increases, thereby accelerating the production of IPCs and neurons. IPCs reside in 
the subventricular zone (SVZ) and their cellular processes are not attached to the 
apical nor basal surfaces of the dTel. In mice they are committed to the neuronal 
lineage and divide symmetrically to generate two neurons which exit the cell cycle 
and migrate further outside to occupy the cortical plate (Haubensak et al., 2004; 
Noctor et al., 2004; Pontious et al., 2008). IPCs are the major type of transient-
amplifying progenitors, which in mouse only divide once to produce two daughter 
neurons, in contrast to these cells in human which are also capable of self-renewal 
(Hansen et al., 2010).   
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Figure 1.4 Interkinetic nuclear migration of radial glia cells and neurogenesis 
in developing mouse cortex. 
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Figure 1.4 Interkinetic nuclear migration of radial glia cells and 
neurogenesis in developing mouse cortex.  
(A) During early neurogenesis (E11-12), radial glia cells (RGCs) mainly undergo 
symmetrical division to generate two RGCs. Interkinetic nuclear migration (INM) is a 
specific feature of RGCs. The migration involves movement of the nucleus within the 
ventricular zone (VZ) during the cell cycle. The cell divides when the nucleus is at the 
ventricular surface, the nucleus then moves upward to the basal side of the VZ (bVZ) for 
DNA synthesis in S phase. During G2 phase, the nucleus moves apically for the next 
round of division. A small population of RGCs divide asymmetrically to either produce 
one RGC and one intermediate progenitor cells (IPCs, indirect neurogenesis) or one RGC 
and one post-mitotic neuron (direct neurogenesis). (B) During mid-neurogenesis, RGCs 
still undergo symmetrical and asymmetrical divisions, however the proportion of 
asymmetrical division increases. IPCs do not exhibit INM feature and they divide in the 
subventricular zone (SVZ). IPCs are the main source of post-mitotic neurons that migrate 
to the cortical plate (CP). PP: pre-plate; IZ: intermediate zone; MZ: marginal zone. 
Adapted from (Guillemot, 2005) 
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The mechanisms regulating the transition of RGCs from self-renewing to neurogenic 
or differentiative division are not fully understood. Two extracellular signalling 
pathways, retinoic acid (RA) and FGF signalling, have been found to be responsible 
for the transition, although the detailed biochemical events remain elusive (Diez del 
Corral andStorey, 2004; Kang et al., 2009). Meningeal derived retinoic acid may be 
the cause of the defects seen in Foxc1 mutants, which include a significant reduction 
of IPCs and neurons and abnormal meningeal development. In utero replacement of 
RA in Foxc1 mutants is able to rescue the deficit (Siegenthaler et al., 2009). Fgfr 1-3 
triple mutant mice show an early depletion of Pax6+ RGC cells which are committed 
to the IPC fate, causing reduced neuron production and ultimately a thinner cortex 
(Kang et al., 2009). Further evidence shows that transient expression of Fgf10 by the 
neuroepithelial cells (NCs) regulates the transition of NCs to RGCs. Loss of Fgf10 
signalling leads to delayed RGC production and fewer RGCs and IPCs in early 
neurogenesis, but eventually the production of progenitors and neurons becomes 
excessive, resulting in a larger cortex (Sahara andO’Leary, 2009).  
Notch signalling is known to maintain the proliferative capacity of RGCs. RGCs 
express Notch receptor while their daughter cells, both IPCs and post-mitotic 
neurons, and surrounding cells express Notch ligands such as Delta-like 1(Dll1). 
Engagement of Notch receptor with the ligand is required for RGCs to stay 
proliferative and prevents the cells from entering differentiation (Kageyama et al., 
2008; Shimojo et al., 2011, 2008). 
It has been hypothesised that unequal distribution of cell fate determinants promotes 
asymmetrical division of stem cells and highly polarised RGCs provide an ideal 
model to study these factors. The cleavage plane for RGC division is variable; in 
mouse cortical RGCs, which divide at the ventricular surface during M phase, the 
mitotic spindles align at certain angles (either parallel or perpendicular, or any angles 
in between) to the ventricular surface. The arrangement of mitotic spindles also 
determines the position of the cleavage plane. Based on previous studies as well as 
advanced time-lapse imaging techniques, it was found that the cleavage plane 
vertical or between 60-120 degrees to the ventricular surface leads to proliferative 
RGC (Figure 1.5A) while the cleavage plane parallel or between ± 30 degrees to the 
ventricular surface results in neurogenic division (Figure 1.5B). It is therefore 
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possible that the cleavage plane may control or be controlled by the distribution of 
cell fate determinants. Although there is no correlation between unequal inheritance 
of the apical membrane to the two daughter cells and fate decision (Shitamukai et al., 
2011), it is known that only one daughter cell will receive the basal process which 
attaches to the pial surface during neurogenic division of RGCs (Miyata et al., 2001; 
Noctor et al., 2001; Shitamukai et al., 2011).  
A number of studies have suggested several fate determinants which when unequally 
distributed will eventually influence the destiny of daughter cells. Numb and 
Mindbomb (Mb) are two candidates for such factors (Knoblich, 2008; LeBorgne 
andSchweisguth, 2003; Roegiers andJan, 2004; Shen et al., 2002). Numb and its 
homolog Numb-like are regulators of membrane trafficking involved in the 
internalisation of Notch receptor, causing down-regulation of Notch signalling and 
triggers differentiation (Bhalerao et al., 2005; McGill andMcGlade, 2003). Numb is 
also involved in the unequal distribution of Par3 which is associated with mitotic 
spindle alignment; cells that inherit more Par3 will stay in self-renewal mode with a 
reduction in Numb activity (Bultje et al., 2009). Asymmetrical inheritance of Mb in 
daughter cells also correlates with Notch signalling. A study has shown that cells 
receiving more Mb are associated with higher Delta activity, which eventually drives 
differentiation (Dong et al., 2012).  
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Figure 1.5 The link between the cleavage plane and the mode of division in 
radial glia cells. 
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Figure 1.5 The link between the cleavage plane and the mode of division in 
radial glia cells.  
The cleavage planes (solid black lines) are believed to associate with the mode of division. 
(A) In M phase, mitotic spindles are aligned in the middle of the cell. When the cleavage line 
is perpendicular to the ventricular surface or the angle is between 60-120 degrees, the RGC 
undergoes proliferative division, producing two RGCs. (B) Mitotic spindles tilt during 
asymmetrical division. When the cleavage plane is parallel or within ± 30 degrees to the 
ventricular surface, the RGC undergoes differentiative division, producing one RGC plus 
one IPC or one neuron. Correlation between the decision for IPC or neuron production and 
the cleavage plane is unclear. Adapted from (Guillemot, 2005) 
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It has been observed that during differentiation of stem cells to post-mitotic neurons, 
the duration of the cell cycle, especially the G1 phase, is extended (Roccio et al., 
2013). In addition, it is also hypothesised that two daughter cells which inherit 
unequal level of fate determinants will progress to different destinies, proliferation or 
differentiation, according to the length of their G1 phase (Figure 1.6). Cells that 
possess different amounts of determinants would act in the same manner under most 
circumstances. However upon reaching the threshold of G1 length, cells that possess 
more neurogenic-promoting molecules will be able to receive greater influences from 
both intrinsic and environmental stimuli to trigger differentiation. This theory is 
supported by studies manipulating the length of G1 by targeting CDKs and cyclins in 
cortical neural progenitors, which have shown that lengthened G1 triggers 
differentiation and inhibits proliferation (Calegari andHuttner, 2003; Glickstein et al., 
2009; Lange et al., 2009; Pilaz et al., 2009). However, whether prolonged G1 is the 
cause or the consequence of neural differentiation remains elusive. 
In summary, development of the dTel is tightly regulated both temporally and 
spatially by multiple signalling pathways and transcription factors. Later in this 
chapter I will discuss two key molecules, Pax6 and Cell division cycle associated 7 
(Cdca7) and how they may affect cortical development.  
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It is hypothesised that the duration of a cell cycle, especially the G1 phase is important for 
the progenitor cell to choose whether it should undergo proliferative or differentiative 
division. For instance, cell A and cell B contain unequal amounts of cell-fate determinants 
(40% and 60%, respectively). When the G1 phase is short (time unit = 1), both cell A and B 
undergo proliferative divisions to produce two daughter progenitors. When the G1 phase is 
long (time unit = 3), both cells perform differentiative division to generate two neurons. 
When the G1 phase is intermediate at the threshold (time unit = 2), intrinsic and 
environmental neurogenic signals cause cell B to exceed the neurogenesis threshold and 
enter asymmetrical division while leaving cell A in proliferative division. Adapted from 
(Calegari and Huttner, 2003; Dehay and Kennedy, 2007; Götz and Huttner, 2005) 
Figure 1.6 The link between G1 length and the mode of division in cortical 
progenitors. 
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1.2 Pax6 and its role in cortical development 
1.2.1 Discovery of PAX6/Pax6 and its related human disease   
Pax6 is an evolutionarily conserved paired-box family transcription factor (Glaser et 
al., 1992). PAX6/Pax6 contains two DNA binding domains, a paired domain (PD) 
and a homeodomain (HD), each of which can individually or co-operatively interact 
with DNA (Czerny et al., 1993; J. A.Epstein et al., 1994; Jun andDesplan, 1996). The 
expression of Pax6 can be observed from embryonic day 8 (E8) (Walther andGruss, 
1991) in the neural epithelium of forebrain, including the telencephalon, 
diencephalon, and hindbrain. Throughout the development of a mouse embryo, Pax6 
expression is maintained in the cortex and thalamus as well as in the olfactory bulb, 
developing eyes, spinal cord and pancreatic islet cells (Grindley et al., 1995; 
Stoykova andGruss, 1994; Walther andGruss, 1991). PAX6 mutations have been 
identified as the cause of the human disease Aniridia (Glaser et al., 1992; Jordan et 
al., 1992). Haploinsufficient PAX6 protein production leads to development of 
aniridia and patients carrying this disease suffer from iris hypoplasia, malformation 
of lens, cornea and retina and impaired vision (Guercio andMartyn, 2007). Small eye 
(Sey) mice carrying a mutation in Pax6 have become a great model for studying 
aniridia. Heterozygous mutant mice (Pax6Sey/+) suffer from similar symptoms as seen 
in human patients while Pax6Sey/Sey mice possess severe phenotypes including loss of 
eyes and nasal cavity, smaller brain size and die soon after birth (Hill et al., 1991; 
van derMeer-de Jong et al., 1990). 
 
1.2.2 Disruption of the pallial-subpallial boundary (PSPB) in Pax6 
mutants 
Pax6 protein is expressed in a gradient fashion in the dTel as well as in the 
diencephalon (Figure1.7) (Bishop et al., 2000; Georgala et al., 2011a; Mi et al., 
2013a; Sansom et al., 2009; Walther andGruss, 1991). The telencephalon is 
subdivided into dorsal and ventral telencephalon or pallium and subpallium, 
respectively. Establishment of the anatomical boundary between the dTel and vTel 
requires the presence of Pax6 (Stoykova et al., 2000; Stoykova andGruss, 1994; Yun 
et al., 2001).  
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Representative immunofluorescent images showing the gradient expression pattern of Pax6 
protein in the telencephalon. The gradient is rostrolateralhigh to caudomediallow at E12.5. (A) 
Sagittal section showing the expression of Pax6 which reaches the highest level at the rostral 
tip of the dorsal telencephalon (dTel) (B) Coronal section showing the expression of Pax6 
which reaches the highest level at the most lateral part of dTel. Both pictures demonstrate 
that the expression of Pax6 is fairly weak in the ventral telencephalon (vTel). Scale bar: 
100µm. Picture originally from (Mi et al., 2013a) 
 
Figure 1.7 The expression pattern of Pax6 at E12.5 in mice. 
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Pax6 is highly expressed in the VZ of dTel together with other proteins including 
Neurogenin 2 (Ngn2 or Neurog2) and Dbx (Fode et al., 2000; Lu et al., 1994, 1992). 
The expression of Pax6 in the subpallium is much reduced and instead Ascl1, Gsx2 
and Nkx2.1 are highly expressed (Georgala et al., 2011a; Toresson et al., 2000). 
Disruption of the PSPB can be observed in the Pax6Sey/Sey mutant and multiple 
mechanisms contribute to this defect. First, cells from the dorsal or the ventral side of 
PSPB express different cell adhesion molecules, such as R-cadherin (cdh4) in the 
dorsal and cadherin-6 (cad6) in the ventral region (Georgala et al., 2011a). Cells 
isolated from wild-type (WT) cortex and striatum tend to segregate in vitro while the 
segregation is defective in cells from the Pax6Sey/Sey mutant, indicating that the cell 
identities are regulated by Pax6 in a cell-autonomous manner (Tyas, 2003). Second, 
Pax6 is also involved in regulating the expression of some pallial and subpallial 
markers. As mentioned before, regional specific markers are expressed on either side 
of the PSPB from E9.5 in wild-type. A dorsal shift of ventral markers including 
Ascl1, Gsx2 and Oligo2 has been found to coincide with a down-regulation of dorsal 
markers such as Ngn2 and Tbr2 in Pax6-null embryos (Quinn et al., 2007; Stoykova 
et al., 1996; Toresson et al., 2000; Yun et al., 2001). In contrast, Gsx2-/- embryos 
possess opposite phenotypes to those seen in Pax6Sey/Sey embryos at E10.5, with 
ectopic expression of pallial markers Pax6, Ngn1, Ngn2 and Tbr2 in the subpallium 
and reduced expression of Ascl1 and Dlx1. However this mis-arealisation disappears 
later at E14.5 partially due to the upregulation and consequentially the compensation 
effects of Gsx1 (Toresson et al., 2000; Yun et al., 2001). 
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1.2.3 Cortical lamination and migration of post-mitotic neurons 
regulated by Pax6 
Neocortex consists of a six-layered structure with different cell types, cell density 
and inputs/outputs from/to other regions of mammalian brain and body, this area is 
responsible for sensory and motor control, as well as consciousness. (ref). Cortical 
neurons are classified into two groups: excitatory or glutamatergic neurons, and 
inhibitory or GABAergic interneurons. Excitatory neurons mainly originate from the 
VZ of the cortex, while inhibitory interneurons migrate from the vTel to the cortex 
after being produced in the medial and caudal ganglionic eminences. A small 
proportion of the inhibitory interneuron population is produced in the lateral 
ganglionic eminences and septal area (Nadarajah, 2003; Nadarajah andParnavelas, 
2002; Wonders andAnderson, 2006). Both types of neurons co-operatively form the 
layers of a mature cortex. Early in neurogenesis, around E12-13 in mouse, radial glia 
cells divide asymmetrically to produce excitatory neurons. Newborn neurons move 
out of the VZ via the radial glia cell scaffold, reaching cortical plate, or layer 6, at the 
end. As neurogenesis proceeds, more neurons are generated to populate deeper 
layers, layer 5 and 6. Neurons that are destined to upper layers (layer 2-4) are 
produced a later stage, and migrate through deeper layers. In summary, generation of 
cortical layers proceeds in an inside-first, outside-late fashion (Kwan et al., 2012).  
Excitatory neurons in different layers are responsible for processing information 
from/to different regions. Neurons in layer 1 and 2 send axons to other cortical 
layers. Layers 2/3, 4 and 5 neurons send axons across corpus collsum to cortex or 
striatum in the other hemisphere. Projection neurons located in layer 6 (and small 
numbers in layer 5) send projections to thalamus and to spinal cord (Thomson 
andBannister, 2003). Inputs from other regions are also specified, as thalamic signals 
are mainly transported to layer 4, and signals from other cortical areas are conducted 
in upper layers, layer 1-4 (Purves et al., 2001; Thomson andBannister, 2003).  
Production and migration of inhibitory interneurons is less known. It has been shown 
that inhibitory neurons generated in the vTel tangentially migrate into neocortex and 
further via radial movement to reach their destination in the cortical layers (Ang et 
al., 2003; Kwan et al., 2012; Nadarajah andParnavelas, 2002; Yokota et al., 2007). 
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Tangential migration of interneurons has been demonstrated to be regulated by some 
chemokine signalling involving C-X-C motif ligand 12 (CXCL12) and its receptors 
CXCR4 and CXCR7(Sánchez-Alcañiz et al., 2011; Sessa et al., 2010; Wang et al., 
2011).  
Many molecules have been found to affect cortical lamination. Transcription factor 
Sox5 is expressed in the deep-layer projection neurons, but not in the progenitors in 
the VZ and SVZ. Mice lacking Sox5 are defective in neural migration in the deep-
layer (Kwan et al., 2008; Lai et al., 2008). Tbr1 is mainly expressed in deep-layer 
neurons (layer 5 and 6) in the embryonic stage. Lamination defects was also found in 
Tbr1-deficient mice, with deep-layer neurons scattered in the cortical plate and 
upper-layer neurons failed to migrate across the subplate (Han et al., 2011; Hevner et 
al., 2001).  
Pax6 also controls the migration of neurons during corticogenesis (Chapouton et al., 
1999; Marín andRubenstein, 2003; Talamillo et al., 2003). During mid-late 
corticogenesis, the overall cortical thickness is decreased in Pax6Sey/Sey compared to 
WT embryos (Caric et al., 1997; Schmahl et al., 1993; Tuoc et al., 2009). This 
reduction may be due to a proliferation defect which will be discussed later in section 
1.2.5, although impairment in neuron migration may also contribute to the thinner 
cortex. Loss of Pax6 affects both radial migration of glutamatergic neurons in the 
cortex and tangential migration of interneurons from the vTel. At late stage of 
corticogenesis, accumulations of cells which have acquired neural identity, defined 
by the expression of markers such as Tuj1 and MAP2, can be observed in the border 
between SVZ and IZ in the Pax6-null mutant (Caric et al., 1997; Talamillo et al., 
2003). Further studies have also demonstrated that in Pax6Sey/Sey embryos, late-born 
neurons which form the cortical plate and superficial layers of cerebral cortex fail to 
migrate into their destined positions while early-born neurons which form the deeper 
layers of the cerebral cortex are not affected (Caric et al., 1997; Fukuda et al., 2000; 
Georgala et al., 2011b). Transplantation of cortical cells from Pax6Sey/Sey embryos 
into a WT context environment has proved that the migration defect is not cell-
autonomous and is caused by an abnormal morphology of RGCs in which late-born 
neurons are mainly utilised as scaffolds for migration (Caric et al., 1997; Götz et al., 
1998; Heins et al., 2002).  
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Pax6-null mice as a lamination model has limited practicality due to their perinatal 
death. Conditional knockout model allows Pax6 to be deleted at specific time and 
locations. A hGFAP-cre line was used by Tuoc et. al to delete Pax6 at E14-E16, with 
this approach it was found that the specification and number of neurons in superficial 
layers were not affected by Pax6 deletion. Cortex-specific deletion of Pax6 resulted 
in premature cell cycle exit of radial glia cells, leading to a significant reduction of 
upper-layer neurons. These data suggest that superficial layer defect in the cortex is 
likely to result from early exhaustion of progenitors for late-born neurons (Tuoc et 
al., 2009).  
Pax6-null mice possess an increased number of interneurons migrated from vTel in 
the subpial and paraventricular area of the cortex and this increase may due to a 
disruption of the PSPB (Chapouton et al., 1999; Kroll andO’Leary, 2005). This 
migration defect is not cell-autonomous since it can be rescued by transplanting 
Pax6-null cells into the WT environment (Gopal andGolden, 2008). A 
misspecification of guidance molecules such as SFRP-2, which are normally 
expressed in the PSPB region and provide inhibitory signals for cell migration, is lost 
in Pax6Sey/Sey (Kim et al., 2001; Roth et al., 2000). Disorganisation of thalamocortical 
and corticofugal axon tracts seen in Pax6Sey/Sey embryos (Hevner et al., 2002; Jones et 
al., 2002; Mastick et al., 1997; Pratt et al., 2002) may also contribute to the non-
autonomous defect since disassociated migrating interneurons and axon tracts were 
observed in the mutant (Gopal andGolden, 2008).  
 
1.2.4 Downstream targets of Pax6 involved in corticogenesis  
Pax6 as a transcription factor has been demonstrated to modulate the expression of 
numerous genes related to neural proliferation, differentiation, progression of cell 
cycle, cell-cell signalling, cell fate identity and lens and forebrain development (Mi 
et al., 2013a; Sansom andLivesey, 2009; Xie et al., 2013). Proneural transcription 
factor Ngn2 is a notable direct target of Pax6 and is transiently expressed in the 
cortical progenitors differentiated from Pax6+ to Tbr2+ cells (Englund et al., 2005; 
Hevner, 2006; Hodge et al., 2008). Previous research using the Pax6Sey/Sey rat has 
shown that loss of Pax6 results in absence of Ngn2 and Olig2 in the hindbrain 
(Mizuguchi et al., 2001). A later study further demonstrated that Pax6 is able to up-
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regulate Ngn2 expression by binding to its E1 enhancer element and this effect is 
dosage dependent in the lateral telencephalon, where Pax6 is most highly expressed 
(Scardigli et al., 2003). Activation of Ngn2 is known to supress the expression of 
several genes at G1 and S phase such as Ccnd1 and Ccne1/2, causing delays in cell 
cycle progression and promoting cell cycle exit (Lacomme et al., 2012).  
Kinesin Family Member 1B (Kif1b) is another identified direct target of Pax6 in 
developing forebrain and lens (Sansom andLivesey, 2009; Wolf et al., 2009; Xie et 
al., 2013). Kif1b interacts with the tumour suppressor DLC2 and co-operatively 
maintains spindle positioning and the plane of division during mitosis as well as cell 
junction integrity (Vitiello et al., 2014). Although little is known about the function 
of Kif1b in developing cortex, the general function of Kif1b in regulating division 
plane via control over microtubules and actin may also affect the division of cortical 
progenitor cells. 
Eomes/Tbr2, regarded as a marker of basal progenitors (BPs) or IPCs in the cortex 
(Englund et al., 2005; Hevner et al., 2006), is also positively regulated by Pax6. A 
chimera experiment in which cells from Pax6−/− host were grafted to Pax6+/+ tissues 
produced a reduced number of neurons and a population of immaturely derived IPCs 
which fails to express the Tbr2 marker (Quinn et al., 2007; Sansom andLivesey, 
2009). 
Other Pax6 target genes such as Cux1, Tle1, Sox4 and Btg2 are effective during 
neurogenesis (Sansom andLivesey, 2009; Tuoc et al., 2013). Cux1 is a homeobox 
transcription factor which is expressed in the VZ and SVZ of the vTel and 
interneurons in the upper layers of cerebral cortex (Nieto et al., 2004; Zimmer et al., 
2004). The number of Cux1+ neurons in Pax6−/− mutant embryos is greatly reduced, 
resulting in a much thinner cortical plate and a defect in late-born neuron 
specification as previously mentioned (Caric et al., 1997; Nieto et al., 2004).  
Another large set of Pax6 targets involve in the cell cycle progression and progenitor 
fate decision, these are discussed in the next section.   
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1.2.5 The regulatory role of Pax6 in the cell cycle progression and 
cell fate decision 
As discussed before, the duration of a cell cycle extends from 8.1 hours at E11 to 
18.4 hours at E16 in mouse embryos (Estivill-Torrus et al., 2002; Takahashi et al., 
1995, 1993) mainly due to G1 phase elongation. Loss of Pax6 results in shortened 
cell cycle as well as an increased proliferation rate and asymmetrical division of 
RGCs (Estivill-Torrus et al., 2002; Mi et al., 2013a; Warren, 1999; Warren andPrice, 
1997) at E12.5 but a decreased production of neurons and elongated cell cycling time 
compared to WT and overall reduced size of cortex during mid-corticogenesis at 
E15.5 (Estivill-Torrus et al., 2002). Furthermore, elevated levels of Pax6 in vivo also 
trigger expression of neural and basal progenitor genes such as Ngn2 and Tbr2 at 
E12.5, indicating premature neuron production as well as early depletion of the 
progenitor pool (Sansom andLivesey, 2009). A transgenic mouse model PAX77, in 
which human PAX6 protein is expressed at twice the physiological level in the 
region that resembles its physiological location, has been used for gain-of-function 
experiments (Manuel et al., 2007). Previous studies found that overexpression of 
PAX6/Pax6 protein affects the late-born or superficial layer neurons especially in the 
region where the highest level of Pax6 is present (Georgala et al., 2011b; Manuel et 
al., 2007). These results indicate that regulation of neurogenesis by Pax6 is both 
dosage and location dependent.  
In the dTel, the gradient of Pax6 expression is rostrolateralhigh to caudomediallow 
(Figure1.7) (Bishop et al., 2000; Georgala et al., 2011a; Sansom andLivesey, 2009; 
Walther andGruss, 1991). This gradient has been proven important for its regional 
specific role in modulating cell cycle progression in RGCs (Mi et al., 2013a; 
Talamillo et al., 2003).  
The graded expression of Pax6 in the dTel has been found to affect the cell cycle 
progression of neural progenitors. Acceleration of cell cycle in Pax6Sey/Sey mutant at 
E12.5 is only observed in the region where Pax6 expression is either strong or 
moderate in wild-type. Further research into the mechanism shows that Pax6 
negatively regulates its downstream target, Cdk6 to modulate the checkpoint control 
during G1/S transition. The phosphorylation of Rb protein is elevated in the 
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Pax6Sey/Sey mutant, concomitant with enhanced checkpoint transition and shorter cell 
cycle progression time in this model (Mi et al., 2013a).  
During the preneurogenic to neurogenic transition in chick retinal progenitors, the 
level of Pax6 is dynamic, implying a regulatory role during retinogenesis (Hsieh 
andYang, 2009). During retinogenesis, the expression level of Pax6 is down-
regulated from G1 to S phase of the proliferation cycle and is either up-regulated or 
down-regulated during G2/M phase. Up-regulated Pax6 expression favours the 
production retinal ganglion cells or amacrine interneurons while downregulation of 
Pax6 promotes the production of cone photoreceptors. This finding indicates that 
Pax6 protein level is essential for fate determination, and specific levels of the 
protein give rise to specific cell types during neurogenesis in retina (Hsieh andYang, 
2009).  
Previous studies show that a novel Myc and E2F1 target, Cdca7, is up-regulated in 
Pax6-null embryos and in cortex-specific conditional Pax6 knockout mice (Mi et al., 
2013; Martine Manuel unpublished), suggesting that Cdca7 may be a direct target, 
and may function downstream of Pax6 to modulate forebrain development through 
mechanisms that are poorly understood. In the next section I will briefly introduce 
our current understanding of the gene. 
 
1.3 Current understanding of the novel protein Cdca7 
Cell division cycle associated 7 (CDCA7) or JPO1 was first discovered as a c-MYC-
responsive gene (Lewis et al., 1997) and was further identified as a c-Myc direct 
target (Haggerty et al., 2003; Prescott et al., 2001). CDCA7/Cdca7 is a nuclear 
protein which contains 371 amino acid in human and 382 amino acids in mouse. 
Figure 1.8 shows the schematic structure of CDCA7/Cdca7, which contains a zinc-
finger domain of monoamine-oxidase A repressor R1 (zf-4CXXC_R1) in the C-
terminus in both human and mouse. Extra motifs have been identified in human 
CDCA7, including a leucine zipper region, a c-Myc/14-3-3 interaction domain and a 
cysteine-rich region. Both the leucine zipper and cysteine-rich regions are suggested 
to be important for protein-protein and protein-DNA interaction (Branschädel et al., 
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2010; Landschulz et al., 1988; Lüscher andLarsson, 1999; Voutsina et al., 2001). The 
expression of CDCA7 mRNA is detected in the thymus, small intestine, and colon 
and is relatively low in the foetal and adult brain.  
Multi-species alignment of protein sequence was performed, the pairwise multiple 
alignment scores are shown in Table 1.1.  The alignment was carried out using the 
HomoloGene function on NCBI website (Edgar, 2004) 
(https://www.ncbi.nlm.nih.gov/homologene) The result shows that the mouse Cdca7 
gene is 79.5% identical to the human homolog, and the Cdca7 protein in mouse is 
81.1% identical to human CDCA7. The alignment also shows that both protein and 
DNA sequences are highly similar between mouse (M.musculus) and rat 
(R.norvegicus) and much less similar between mouse and zebrafish (D.rerio), in 
agreement with the evolution distance between these species. 
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Schematic showing the polypeptides of human and mouse CDCA7/Cdca7 and the positions 
of major motifs. (A) Human CDCA7 (accession number: NP_665809) consists of 371 amino 
acids. It contains a zf-4CXXC_R1 domain which is important for DNA binding, and a motif 
specific for interaction with c-MYC and 14-3-3. It also contains a cysteine-rich region in its 
C-terminus, which is thought to be important for protein-protein and protein-DNA 
interaction. (B) Mouse Cdca7 (accession number: NP_080142) consists of 382 amino acids. 
The detailed structure has not been fully elucidated. There is a zf-4CXXC_R DNA-binding 
domain in its C-terminus. Figures adapted from (Edgar, 2004; Goto et al., 2006; Thijssen et 
al., 2015). 
 
Figure 1.8 Schematic representation of human and mouse CDCA7/Cdca7. 
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Table 1.1 Evolutionary conservation of CDCA7 protein 
Pink bar marked in the protein structure is the Zinc-finger domain of monoamine-oxidase A 
repressor R1 (zf-4CXXC_R1). 
 
A conserved DNA binding domain zf-4CXXC_R1 is present in Cdca7 protein 
sequences across the species (Chen et al., 2005) (Table 1.1). This DNA binding 
domain is also present in the transcription repressor R1 that inhibits the expression of 
monoamine oxidase A. The domain structure contains four-CXXC zinc finger motifs 
located at the C-terminal end of R1(Chen et al., 2005).  The zf-4CXXC_R1 domain 
is also located at the C-terminal of CDCA7 protein in all species analysed here.  
CDCA7 is overexpressed in some human solid tumours such as colon, ovary and 
lung cancers. CDCA7 is also frequently upregulated in patients during the blast crisis 
phase of chronic myelogenous leukaemia (CML), in which overexpression of Myc is 
also observed (Osthus et al., 2005). Induction of c-MYC expression in vitro leads to 
upregulation of CDCA7 (Prescott et al., 2001). Previous study focusing on the 
tumourigenicity of CDCA7 has demonstrated that it promotes anchorage-
independent growth and enhances the transforming ability of MYC in vitro (Prescott 
et al., 2001). An increased incidence of tumours including various lymphomas as 
    Identity (%) Protein structure 




vs. H.sapiens CDCA7 81.1 79.5 
 
vs. P.troglodytes CDCA7 81.6 79 
 
vs. M.mulatta CDCA7 82.1 79.9 
 
vs. C.lupus CDCA7 81.4 77.6 
 
vs. B.taurus CDCA7 84.5 81.1 
 
vs. R.norvegicus Cdca7 94.2 91.8 
 
vs. G.gallus CDCA7 63.2 65 
 
vs. X.tropicalis cdca7 64.9 63.5 
 
vs. D.rerio cdca7a 58.3 58.8 
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well as intestinal adenocarcinoma and carcinoma has also been observed in a 
CDCA7-transgenic mouse model (Osthus et al., 2005). 
 
How CDCA7 facilitates MYC-dependent apoptosis and transformation has been 
elucidated (Gill et al., 2013). The MYC and 14-3-3 binding motifs of CDCA7 
overlap and this region contains a threonine residue (T163) which is a target of 
phosphorylation by AKT. Phosphorylation of T163 triggers the relocation of CDCA7 
from nucleus to cytoplasm, promotes the interaction with 14-3-3 and reduces its 
binding affinity with MYC. CDCA7 also sensitises the cell to MYC-induced 
apoptosis upon serum withdrawal/starvation in the culture system. Moreover, 
interaction of CDCA7 with MYC largely promotes MYC-mediated transformation, 
as overexpression or knockdown of CDCA7 can affect the transformation ability of 
MYC (Gill et al., 2013). 
CDCA7 was also found to be a direct target of E2F1. E2F is a family of transcription 
factors involving in cell cycle progression, DNA replication as well as DNA damage 
response (Biswas andJohnson, 2012). Inactive E2F forms a complex with 
hypophosphorylated RB and becomes active following phosphorylation of RB. 
Hyperphosphorylated RB disassociates from E2F, allowing E2F to translocate into 
nucleus and subsequently activates its downstream targets which promote G1 to S 
phase progression (Blais andDynlacht, 2007; Helin et al., 1993; Lees et al., 1993). 
Overexpression of E2F1 correlates with upregulation of CDCA7 in HeLa cells. 
Moreover, E2F1 increases the activities of both human and mouse CDCA7/Cdca7 
promoter (Goto et al., 2006).  
It is known that both MYC and E2F1 can regulate the cell cycle, especially 
progression through the G1/S checkpoint (McMahon et al., 1998; Meyer andPenn, 
2008). Both MYC and E2F1 can activate CDC25A, which is required for G1/S 
transition. MYC further activates cyclin D1, cyclin D2 and CDK4 which are all 
essential for G1/S checkpoint control (Ciemerych andSicinski, 2005). Together these 
suggest that CDCA7, a common target of MYC and E2F1, may facilitate cell cycle 
progression (Iwanaga et al., 2006). 
Cdca7 is expressed in the embryonic telencephalon in mouse (Castro et al. 2011; 
www.genepaint.org). A genome-wide search for Mash1/Ascl1 targets in E12.5 basal 
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ganglia has found that targets of Ascl1 include not only pro-neural genes such as 
Foxm1 and Gadd45g, but also proliferative genes such as E2f1, Cdk1, Cdk2 and 
Cdca7 (Castro et al., 2011). Furthermore, Cdca7 is down-regulated in the ventral 
telencephalon in Ascl1-/- mice, but whether the function of Cdca7 is proliferative or 
neurogenic remains elusive.  
Cdca7 is also involved in Notch signalling and is required during the haematopoietic 
process (Guiu et al., 2014). Notch signalling is activated by cell to cell contact and is 
required for T cell differentiation in adulthood. In addition, Notch is also essential for 
the generation of haematopoietic stem cells (HSCs) during embryonic development 
and its downstream targets have recently been identified (Bigas andEspinosa, 2012; 
Guiu et al., 2014). Based on a ChIP-on-chip experiment with E11.5 aorta-gonad-
mesonephros (AGM) tissues, Cdca7 was found to be a direct target of Notch and the 
Cdca7 promoter was further shown to be activated by Notch signalling. Furthermore, 
down-regulation of Cdca7 using shRNA in vitro strongly promotes haematopoietic 
stem cell differentiation, while knockdown of the gene by morpholino oligos in 
zebrafish causes a reduced number of HSCs. Taken together, Cdca7 is one of the 
down-stream targets of Notch and is involved in haematopoiesis in a Notch-
dependent manner (Guiu et al., 2014).  
A recent report has found that the function of Cdca7 is closely related to 
Immunodeficiency, Centromeric Instability and Facial Anomalies (ICF) syndrome. 
ICF is an autosomal recessive genetic disorder causing low levels of B cells in blood 
and distinct facial anomalies in patients (Hagleitner et al., 2008; Thijssen et al., 2015; 
Weemaes et al., 2013). A CpG hypomethylation in the juxtacentromeric satellite is a 
characteristic feature of ICF and mutations in DNA methyltransferase 3B (DNMT3B) 
and zinc-finger and BTB domain containing 24 (ZBTB24) are responsible for 
approximately 80% of the disease incidence (deGreef et al., 2011; Weemaes et al., 
2013). Using whole-exome sequencing with ICF patients free of DNMT3B and 
ZBTB24 mutations in comparison with healthy family members, it has been found 
that individuals carrying missense mutations in the zinc finger domain of Cdca7 also 
develop ICF syndrome (Thijssen et al., 2015). 
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In summary, CDCA7/Cdca7 was originally discovered as a MYC target involving in 
MYC-dependent oncogenic process. The gene was further identified as a direct target 
of E2F1 and a putative target of Ascl1, suggesting its putative function in cell cycle 
progression in embryonic telencephalon. Cdca7 is up-regulated in embryonic 
telencephalon in the Pax6Sey/Sey mutant, and its mRNA expression pattern is 
complementary to that of Pax6 in WT dTel at E12.5 (Mi et al., 2013a). Recent 
evidence has identified a function of Cdca7 in the emergence of HSCs and provided 
insights into its role in fate determination in progenitor cells (Guiu et al., 2014).  
 
1.4 Aims of this thesis 
Based on previous knowledge, in this thesis I would like to study the functions of 
Cdca7 in neural progenitor cell proliferation as well as its relationship to Pax6. In 
Chapter 3 I aim to compare the mRNA expression patterns of Pax6 and Cdca7 at 
different developmental stages in embryonic brain sections from three genetic 
backgrounds of mice with altered Pax6 expression levels, I aim to reveal details of 
how Pax6 may regulate the expression of Cdca7. In Chapter 4 I would like to 
confirm whether Cdca7 is a direct target of Pax6 using chromatin 
immunoprecipitation (ChIP) and luciferase-based promoter assay. Finally in Chapter 
5 experiments have been conducted to verify if Cdca7 is involved in the decision 
between proliferation and differentiation of neural progenitor cells in mouse 
embryonic telencephalon. 
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Chapter 2 : Materials and Methods 
2.1 Animals 
Pax6-null embryos, designated Pax6Sey/Sey or Pax6-/- were obtained from crossing 
Pax6Sey/+ heterozygote mice (Hill et al., 1991). PAX77 homozygous mice carry 10-14 
copies of human PAX6 transgene and phenotypically overexpress both Pax6/PAX6 
mRNA and protein (Schedl et al., 1996). PAX6 transgene was detected by genomic 
PCR that specifically amplified human PAX6. All mice were maintained on an albino 
CD1 background and bred in accordance to UK Home Office Animals (Scientific 
Procedures) Act 1986 regulations. The morning of vaginal plug appeared was 
designated E0.5.  
Human PAX6 primer for genotyping: 
  Forward: 5’- CCGTGTGCCTCAACCGTA 
  Reverse: 5’- CACGGTTTACTGGGTCTGG 
  Annealing Temp: 55°C 
 
2.2 Histology 
2.2.1 Embryo collection and fixation 
All mice embryos used in the experiments were terminated under Schedule 1 to the 
animals (Scientific Procedures) Act 1986 according to Home Office, UK publication. 
Embryonic heads were fixed in 4% para-formaldehyde/PBS (PFA/PBS) solution 
overnight and then transferred into 70% ethanol for paraffin wax embedding or 30% 
sucrose/PBS for cryo-protection overnight. Embryos after sucrose protection were 
embedded in the 50% sucrose/OCT solution and stored in the -20°C freezer. 
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2.2.2 Wax sectioning 
Embryos were dehydrated through ethanol gradients and embedded in paraffin wax. 
Microtome (Leica RM2245) was set to cut 10µm-thickness sections, which were 
then mounted on Superfrost Plus glass slides (Thermo). Sections on slides were 
firstly air-dried in the room temperature (RT) and moved to a 37°C oven overnight. 
Sections were kept in the RT for short-term or fridge for long-term storage. 
 
2.2.3 Cryostat sectioning 
Tissues blocks kept in the 50% sucrose/OCT solution were used for cryo-section. 
Cryostat machine (Leica CM3050S) was normally set at -23°C to -25°C and cut for 
10µm-thickness. Sections were also mounted on the Superfrost Plus glass slides 
(Thermo) and once the sections were air-dried, they were stored in the -20°C freezer.  
 
2.2.4 In Situ Hybridisation (ISH) 
In situ hybridisation (ISH) was performed on the cryo-sections.  
Pre-hybridisation (first day) 
Cryo-sections were removed to RT at least 30 minutes before prehybridisation. 
Antisense RNA probes (200µL/slide) were pre-heated at 90°C for 10 minutes before 
applying to cryo-sections. Sections with RNA probes were placed in a hybridization 
box with pre-hybridisation buffer in a 70°C oven overnight.  
    
10X Salt solution  
Reagents Weight or Volume Final concentration 
NaCl 11.4 g 2M 
Tris-HCl  1.404g 90mM 
Tris 0.34g 10mM 
NaH2PO4·2H2O 0.78g 50mM 
Na2HPO4 0.71g 50mM 
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0.5M EDTA 10 mL 50mM 
ddH2O (RNase free) To 100 mL  
    
 
Pre-hybridisation buffer  
Reagents Final concentration 
10X Salt 10.5X (dilute with ddH2O) 
Formamide 50% 
 
Post-hybridisation (second day) 
Sections were washed in 2xSSC/50% Formamide/0.1% Tween-20 buffer for 30 
minute in the 70°C oven and then washed in MABT buffer for 1 hours at RT. 
Sections were blocked in 2% blocking reagent (Roche Cat no.11096176001) (w/v) 
/20% sheep serum/MABT for 1 hour at RT and incubated with anti-DIG antibody 
(1:1500 dilution, Roche Cat no. 11093274910) overnight.   
 
20X SSC (pH=7.0)  
Reagents Final concentration 
NaCl 3M 
Tri-sodium citrate 0.3M 
 
2xSSC/50% Formamide/0.1% Tween-20 buffer 
Reagents Weight or Volume Final concentration 
20X SSC 15 mL  2X 
Formamide 150 mL 50% 
Tween-30 0.3 mL 0.1% 
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ddH2O  To 300 mL  
 
MABT (pH=7.5)  
Reagents Final concentration 
Maleic Acid 0.1M 
NaCl 0.15M 
 
Post-antibody and colour development (third day) 
Sections were washed in MABT buffer for 1 hour at RT and further incubated in the 
staining buffer for 30 minutes for equilibrium purpose. Sections then were finally 
under a colour development reaction in 1.8 %NBT-BCIP (Roche Cat 
no.11681451001)/staining buffer at RT avoiding exposing to light and the incubation 
times were purely dependent on the individual probe and signal/background 
condition.  
 
2.2.5 Immunofluorescence staining (IF staining) 
Samples for IF are either from wax or cryostat sectioning. Wax sections were needed 
to pre-treated with xylene, 15 minutes twice to remove paraffin and subsequently 
rehydration was performed by immersing slides in alcohol solutions with grading 
concentrations (from 100% to 70%), 5 minutes in each concentration. Cryostat 
Staining buffer  
Reagents Final concentration 
NaCl 100mM 
Tris-HCl  100mM 
MgCl2 50mM 
Tween-20 0.1% 
ddH2O  To 300 mL 
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sections removing from freezer were placed at RT for 30 minutes before using. After 
above procedures, sections from both preparations were treated in the same manner.  
Slides were firstly washed in 1x PBS for 5 minutes and then in antigen retrieval 
buffer (10mM citric acid buffer, pH=6.0) for 10 minutes. Slides underwent antigen 
retrieval treatment by microwaving at 800W for 5 minutes, 4 times. After 
microwaving, slides were allowed to cool to RT followed by washing in 1x PBS-
0.1% Triton-X 100 solution. Subsequent blocking step was performed in blocking 
solution (20% donkey serum/1x PBS-0.1% Triton-X 100) for 1 hour at RT. Primary 
antibodies were diluted in blocking solution according to its own conditions and left 
overnight at 4°C.   
 
Antigen retrieval buffer, 10 mM citrate acid  
Reagents Weight or Volume 
Tri-sodium citrate·dihydrate (Mw= 294) 2.94g 
ddH2O  To 1000 mL 
 Adjust pH value to 6.0 
 
On the next day, slides were washed in 1x PBS-0.1% Triton-X 100 solution for 5 
mins x 6 times and then incubated with secondary antibodies according to the 
primary antibody for 1 hour at RT in the dark. All secondary antibodies were diluted 
in blocking solution. After incubation, slides were washed in 1x PBS-0.1% Triton-X 
100 solution for 5 mins x 6 times. Final nuclear counter staining were either in DAPI 
or Topro-3 solution, 1:1000 in ddH2O for 5 minutes at RT. Slides were then washed 
in 1x PBS for 5 minutes and mounted in Vectorshield HardSet antifade solution. 
Slides were stored in the fridge avoiding to light.  
List of primary antibody and usage conditions. 
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Table 2.1 List of primary antibodies and usage conditions 
Antibody name Company Catalogue no. Application Dilution 
Pax6 Covance PRB-278P Immunofluorescence 1:200 
Cdca7 ProteinTech 15249-1-AP Immunofluorescence 1:100 
GFP Abcam Ab6673 Immunofluorescence 1:200 
DAPI Invitrogen D3571 Immunofluorescence 1:1000 
Tbr2 Abcam Ab23345 Immunofluorescence 1:100 
Tbr1 Abcam ab31940 Immunofluorescence 1:100 
BrdU Abcam ab6326 Immunofluorescence 1:200 
Pax6 Covance PRB-278P Western blotting 1:2000 
GAPDH Ambion AM4300 Western blotting 1:5000 
HA Sigma H6533 Western blotting 1:1000 
 
2.3 Generation of RNA probe for in situ hybridisation 
Pax6 anti-sense probe generated by Dr Catherine Carr can recognise full-length Pax6 
mRNA (Mi et al., 2013b). This full-length Pax6 probe is able to detect mRNA in 
wild-type and Pax6Sey/Sey mutants as there is a single nucleotide nonsense mutation in 
Pax6Sey/Sey, which does not affect the recognition of the probe. Pax6 probe also 
detects overexpressed PAX6 mRNA in PAX77. The protein sequence of human and 
mouse PAX6/Pax6 is 99% identical. Pairwise alignment of their coding DNA 
sequence showed a 94% identity. Full length Cdca7 cDNA was obtained from 
reverse transcription of E14.5 cortex tissues mRNA extraction followed by PCR step 
using specific primer sets. The Cdca7 probe fragment was cloned into pGEMT-easy 
vector. SacII restriction enzyme was used for linearization and SP6 RNA polymerase 
was used for antisense probe generation.  
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Pax6 pCR-Blunt II-TOPO BamHI T7 1.8 kb 
Cdca7 pGEMT-easy SacII SP6 745 bps 
 
Cdca7 probe primer: 
  Forward: 5’-TCTGAGAGCTCTGCAAACGA 
  Reverse: 5’-AGCTGCAGTTGCAAATTCCT 
  Annealing Temp: 50°C 
 
2.4 Cloning of DNA constructs 
2.4.1 Cdca7 promoter region construct for luciferase assay 
To predict Pax6 binding sites in the Cdca7 genomic region, three Pax6 conserved 
binding motifs Pax6CON (J.Epstein et al., 1994), M00979, (Duncan et al., 1998; 
Zhou et al., 2000; Transfac) and PC0010 (Coutinho et al., 2011) were utilised to 
generate a custom track by Dr Ian Simpson for prediction (See Figure 4.2 for 
details). In addition, Transfac, which utilises a well-established transcription factor 
PWM database, was also adopted to collectively predict putative sites. In the 
Transfac programme, the match and matrix score was set at 0.8 to reduce false 
positive hits. Taken together, there are six putative sites located in the 5 kb region 
upstream of the transcriptional start site (TSS) of Cdca7 and five of them are located 
within 2.6 kb to the TSS site.  
To obtain the 4.4 kb and 2.6 kb DNA fragments upstream to the transcriptional start 
site (TSS) of Cdca7, a BAC clone (RPCI-121B8) was used as template to amplify 
the genomic fragment. For PCR reaction, Platinum®  Taq DNA Polymerase High 
Fidelity (Cat no. 11304-011) was used according to the manual. Two Cdca7 genomic 
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fragments both flanked by restriction enzyme SalI were cloned into pGEMT-easy 
vector and then subcloned into pGL4.10 promoter-less firefly luciferase vector 
through XhoI restriction site (Promega).  
Primers: 
  4.4 kb Forward: 5’-ACGCAGTCGACCAGTATCAAGTTTCAAACAAGAAGC 
  2.6 kb Forward: 5’-ACGCAGTCGACGGTGGGGGTCTGGGAG 
  Shared Reverse primer: 5’-ACGCAGTCGACGTTGGCGGCGGGTAC 
(GTCGAC: SalI recognition sequence) 
 
2.4.2 Cdca7 expression construct for in utero electroporation 
Cdca7 cDNA open reading frame (ORF) clone (NM_025866) was obtained from 
Origene. ORF fragments were PCR amplified with attached either the N-terminus or 
the C-terminus influenza hemagglutinin (HA) tag sequence for detection. Extra NheI 
restriction enzyme flanking both ends were also added to the ORF fragments for 
cloning into the final expression vector IRES-NLS-GFP_pCAGGS plasmid.  
Primers: 
N-HA-Cdca7-IRES-NLS-GFP_pCAGGS 
  Forward: 5’-cata GCTAGC ATG TACCCATACGATGTTCCAGATTACGCT    
                  GAGGCTCGCCGCGCG 
  Reverse: 5’-cata GCTAGC CTACGCTTGC ATTTCAAATT CCTG 
 
C-HA-Cdca7-IRES-NLS-GFP_pCAGGS 
  Forward: 5’-cata GCTAGC ATG GAGGCTCGCCGC 
  Reverse: 5’-cata GCTAGC AGCGTAATCTGGAACATCGTATGGGTA CG  
                 CTTGCATTTC AAATTCCTG 
 GCTAGC: NheI recognition sequence 
 TACCCATACGATGTTCCAGATTACGCT: HA tag sequence 
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2.5 Cell culture and Luciferase assays 
HEK293 cells were maintained in T75 flasks (Corning) containing DMEM growth 
medium supplemented with 10% foetal bovine serum (FBS). Cell were incubated at 
37°C with 5% CO2 level.  
One day before transfection, cells were split to 24-well plates at a density of 1x105 
cells per well. Next day (16~18 hours after splitting), cells reached 80-90% 
confluency in monolayer. Transfection was carried by using Lipofectamin 2000 
(Invitrogen) according to the manual. DNAs used in the transfection include firefly 
luciferase construct with or without Cdca7 genomic locus, Renilla luciferase 
construct (pRL SV40, Promega) for internal transfection efficiency control and Pax6 
expression construct or empty expression construct alone control. Full length Pax6 
cDNA was cloned into pCMV-Script by Dr Da Mi and expression of Pax6 was 
driven by CMV promoter (Mi et al., 2013a). There is also a GFP expression indicator 
in the Pax6 expression construct, which can be used for visualisation of transfection. 
DNA was mixed in 50µL of OPTI-MEM (Invitrogen) and Lipofectamin was diluted 
in equal volume of OPTI-MEM. Added DNA solution to Lipofectamin and allowed 
the mixture to stand for 20 minutes at RT before adding to cells. 4 hours later, fresh 
DMEM-10% FBS medium was applied to cell to remove the old medium and 
transfection regents. 24 hours later, transfection was monitored by fluorescence 
microscopy. 48 hours post transfection, cells were harvested and lysed in Passive 
Lysis Buffer (Promega) according to the manufacturer’s instructions.  
Cell lysates collected by the Passive Lysis Buffer were used for determining the 
expression levels of Pax6 by western blotting and for luciferase detection. Luciferase 
assays were carried by Dual Luciferase Reporter Assay system (Promega) according 
to the instructions. Firefly and renilla luciferase activities were detected by Promega 
Glomax Luminometer. For each sample, the activities of firefly and renilla luciferase 
were represented by Relative Light Unit.    
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2.6 Western Blotting 
Cell lysates were collected after Passive Lysis Buffer treatment during luciferase 
assays. All samples were mixed with 4x sample loading buffer (Li-Cor) to a final 
concentration of 1x and sent for boiling at 90°C for 5 minutes. 4%-12% Bis-Tris 
mini Nu-Page gels (Thermo) were used to resolve the samples in a condition of 200V 
for 50 minutes in 1x MOPS buffer (Thermo). After gel running, proteins on the gel 
were transferred onto nitrocellulose membrane under 190 mA for 2 hours. After 
protein transfer step, nitrocellulose membrane was blocked with Odyssey Blocking 
Buffer (Li-cor) for 1 hour at RT and incubated with primary antibodies (see antibody 
list for concentrations) diluted in Odyssey blocking Buffer overnight at 4°C. On the 
next day, membrane was washed with 1x PBS-0.1%Tween-20 buffer, 3 times and 10 
minutes each time followed by incubation with secondary antibodies (IRDye 1:5000, 
Li-cor) for 1 hour at RT and washed again with 1x PBS-0.1%Tween-20 buffer, 3 
times and 10 minutes each time. Finally membrane was washed with 1x PBS for 5 
minutes and ready for detection by Li-cor scanning system. 
 
2.7 Quantitative Chromatin Immunoprecipitation (qChIP) 
Chromatin was collected from 20-25 E12.5 embryonic cortices from Pax6+/+ and 
Pax6Sey/Sey. Chromatin complex was cross-linked by formaldehyde and fragmented 
by sonication to approximately 500 bp long. DNA-protein complexes from wild-type 
and Pax6-null samples were precipitated by anti-Pax6 antibody (Millipore Cat no. 
AB2237) on the rotation platform overnight at 4°C. After precipitation and 
purification of the genomic DNA, the DNA was analysed by quantitative PCR using 
Quantitect SYBR Green PCR Kit (Qiagen). The enrichment of each binding site that 
amplified by its specific primer set was first calculated by dividing the q-PCR 
outputs from Pax6 wildtype by the outputs from Pax6-null (formula A). The ratio for 
each binding region from formula A was then further divided by the ratio of the Syt8 
negative control (formula B) to calculate the final enrichment for each binding 
region. More experimental details are described in Appendix 1.   
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    q-PCR output for each primer from Pax6+/+        
    q-PCR output for each primer from Pax6 -/-  
 
         X for each primer set  
    X for Syt8 negative control 
 
Table 2.3 List of primers for q-PCR 























Pou3f4 Forward 5’-GAGAGAGGGAGAGGCAGAGGGAAT 
= X ------------ (Formula A) 
= fold enrichment --------------------------- (Formula B) 
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2.8 In Utero Electroporation (IUE) 
Wild-type CD1 pregnant females were used for in utero electroporation. Purified 
plasmid DNA (N-HA-Cdca7-IRES-NLS-GFP_pCAGGS, C-HA-Cdca7-IRES-NLS-
GFP_pCAGGS or IRES-NLS-GFP_pCAGGS control) was adjusted to 2µg/µl. On 
the electroporation day, animals were given one dose of analgesia agent Vetergesic 
(Buprenorphine) subcutaneously and anaesthetic inhalation agent Isoflurane using an 
anaesthetic rig throughout whole operation process. Plasmids (approximate 2µg) 
were injected into the first ventricle of embryos at aged E12.5 or E14.5. Plasmids 
then were forced to enter the lateral telencephalon by electrical shock provided by 
CUY21-Sonidel Limited ® , 32 volt for E12.5 and 35 volt for E14.5 embryos in 50ms 
duration and 950 ms interval. All procedures were included in the Home Office 
Project License (60/4545; personal license: 60/13925), followed the on-site BRR 
regulations and approved by the veterinary physicians. 15.5 hours post 
electroporation, a single dose of bromodeoxyuridine (BrdU, Sigma) was 
intraperitoneally administrated into pregnant females at 70µg/g of body weight. 30 
minutes after injection, pregnant females were terminated and embryos were sent for 
cryo-fixed and immunofluorescent staining. 
 
2.9 Microscope and imaging software 
For in situ hybridisation, light microscope Leica LB30T microscope and LAS 
version 3.6 software were used for taking images. For immunofluorescent staining, 
fluorescent microscope Leica DM5500 B and LAS fluorescent 2.6.3 software were 
used for acquiring low magnified images (5-20 folds). 40x magnification images 
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were acquired by Nikon A1R confocal microscope and NIS Elements software. All 
image analysis was performed using Fiji software.  
 
2.10 Statistical analysis  
One-way and two-way Analysis of variance (ANOVA), Tukey and the TwoStep 
cluster analysis were carried out by SPSS package (IBM Corporation) version 20. 
Student’s t-test was performed by Microsoft Excel software. The significance level 
was set at P < 0.05.  
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Chapter 3 : Expression patterns of Pax6 and Cdca7 in the 
developing cortex 
3.1 Introduction 
Correct formation of the complex brain structure requires all progenitors to sense 
both intracellular and environmental signals which mediate neural development. 
Many signalling molecules and transcription factors (TFs) are involved in this 
developmental process to establish subdivisions along the dorsoventral (DV) and the 
anteroposterior (AP) axis (Puelles andRubenstein, 1993; Tucker et al., 2008). These 
molecules and TFs set up overlapping gradients in developing cortex to exert their 
functions in building the correct cytoarchitectural map. A previous study from 
human embryonic cortical tissues between 8-12.5 PCW has shown that there are 
several differentially expressed genes along the AP axis. For example, ROBO1 and 
CTIP2 are enhanced anteriorally while FGF receptor 3, COUP-TF1 and EMX2 are 
upregulated posteriorally (Ip et al., 2010). Further studies of gene expression 
gradients have been done in rodents (Muzio et al., 2002; O’Leary et al., 2007; Rakic 
et al., 2009). One notable example is Fgf signalling, which regulates the 
regionalisation of neocortex.  An Fgf secreting signalling centre is located at the 
rostral midline of the neocortex and one of the Fgf molecules (Bachler andNeubüser, 
2001), Fgf8, has been demonstrated to regulate rostral area specification of motor 
cortex (Fukuchi-Shimogori andGrove, 2001).  It is also known that COUP-TF1 and 
EMX2 are repressed by FGF8 signal (Fukuchi-Shimogori andGrove, 2003; Garel, 
2003). Both factors exhibit a high caudo-medial to low rostro-lateral expression 
pattern in the cerebral cortex. Loss of function mutations of the two factors cause a 
mis-arealisation in neocortex which results in significant enlargement of motor 
cortex (Sansom andLivesey, 2009). The anatomical changes caused by abnormal 
expression of Fgf8 and their receptors as well as TFs have been documented in 
previous studies listed above, however the underlying cellular mechanisms are not 
widely understood.  
In a previous study, my colleagues have dissected the regulatory role of Pax6 in 
cortical progenitor proliferation via direct repression of Cdk6 production and 
hypophosphorylation of pRb (Mi et al., 2013). Expression of Pax6 mRNA and 
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protein follows a gradient pattern which is high rostro-laterally and low caudo-
medially in the cerebral cortex during early corticogenesis (Bishop et al., 2000; 
Georgala et al., 2011; Sansom andLivesey, 2009; Walther andGruss, 1991). Cdk6 
was identified as a direct downstream target of Pax6 by ChIP and promoter assay and 
Cdk6 is negatively regulated by Pax6. Furthermore, the study also showed that a 
shortened cell cycle in neural progenitors in Pax6Sey/Sey compared to wild-type (WT) 
embryos is only observed in regions with high or moderate Pax6 expression (Mi et 
al., 2013). It is known that Cdk6 can phosphorylate its downstream target, Rb, and 
thereby to free E2f factors to enter the nucleus and trigger G1/S transition (Blais 
andDynlacht, 2007; Helin et al., 1993; Lees et al., 1993). It has also been proven that 
the total duration of cell cycle is shorter in neural progenitor cells than that in post-
mitotic cells (Roccio et al., 2013). Taken together, it is suggested that Pax6 can 
influence the length of cell cycle in neural progenitor cells and further affect decision 
between proliferation or differentiation in neural progenitor cells 
A previous microarray-based study has identified Cdca7 as a potential target of Pax6, 
and subsequent RT-qPCR validation has found that the expression of Cdca7 mRNA 
is upregulated in Pax6Sey/Sey and in Pax6 conditional knockout embryos (Mi et al. 
2013; Martin Manuel unpublished). In addition, the mRNA expression patterns of 
Pax6 and Cdca7 at E12.5 suggested that they may be expressed in counter-gradients 
in developing cortex (Mi et al., 2013). The exact relationship between Pax6 and 
Cdca7 and the temporal and spatial expression of Cdca7 are still unknown. 
In this chapter I have done a series of gene expression pattern analyses from E12.5 to 
E15.5 in mice with different Pax6 expression levels to investigate the potential 
relationships between Pax6 and Cdca7 and to study the function of Cdca7 given its 
graded expression pattern during brain development. 
 
3.2 Results 
3.2.1 Embryonic stage E12.5 
ISH was performed to reveal the mRNA expression patterns of Pax6 and Cdca7 in 
WT (n=4), Pax6Sey/Sey (n=4) and PAX77 (n=3) embryos at E12.5 (Figure 3.1-3.3).  In 
WT embryos, Pax6 mRNA is expressed in a high-lateral to low-medial gradient in 
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the dTel with the highest level near the pallial-subpallial boundary (PSPB) region. 
The expression level gradually increases from medial to lateral direction in the dTel 
and disappears rapidly after the PSPB (Figure 3.1). Cdca7 mRNA is not expressed in 
an obvious gradient, but its level is exceptionally weak around the PSPB, indicating 
that the two genes are expressed at opposing levels in this specific region of the 
brain. 
In addition to the telencephalon, Cdca7 mRNA is also present in the thalamus, 
prethalamus and hippocampus but is absent in the zona limitans intrathalamica (ZLI). 
In Pax6Sey/Sey embryos where no functional Pax6 protein is present, the pattern of 
Pax6 mRNA expression in the dorsal telencephalon (dTel) is similar to that in WT 
samples (Figure 3.2), but the graded expression of Cdca7 mRNA seems less clear 
across the dorsal to ventral parts of the telencephalon. In one noticeable area, the 
PSPB region, where the expression of Cdca7 mRNA is very low in WT, no such 
reduction was observed in Pax6Sey/Sey embryos, suggesting that Pax6 may act as a 
potential negative regulator of Cdca7. 
In PAX77 embryos where the human form of PAX6 protein is overexpressed, the 
patterns of Pax6 and Cdca7 mRNA expression in the dorsal region are very similar 
to those seen in WT samples (Figure 3.3). However in the ventral telencephalon 
(vTel), Pax6 mRNA is noticeably lower compared to the WT and the difference 
between the two genotypes seems to maximise at this embryonic stage (see also 
Figure 4.17B). In contrast, Cdca7 mRNA exhibits a similar expression pattern to that 
seen in the WT at this stage (Figure 3.3). 
Figure 3.4 shows the expression patterns of Pax6 and Cdca7 mRNA in WT and 
Pax6Sey/Sey embryos in a sagittal orientation. Pax6 mRNA appears high rostrally and 
low caudally while Cdca7 mRNA was found in an opposite graded direction in the 
WT. The highest level of Pax6 mRNA was observed around the PSPB, where the  
lowest level Cdca7 mRNA was seen. No apparent graded expression of Pax6 or 
Cdca7 was detected in the dTel in Pax6Sey/Sey embryos; although the mRNA level of 
Pax6 also peaks around the PSPB, no reduction of Cdca7 mRNA was seen in this 
region in Pax6Sey/Sey embryos. 
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Figure 3.1 Expression of Pax6 and Cdca7 mRNA at various positions in E12.5 
wild-type coronal sections 
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Figure 3.1 Expression of Pax6 and Cdca7 mRNA at various positions in E12.5 
wild-type coronal sections  
The graded expression pattern of Pax6 from caudal to rostral forebrain. (A-C) Representative 
ISH results produced from caudal, medial, and rostral sections, respectively, showing that 
Pax6 mRNA is expressed in a low-medial to high-lateral gradient in the dorsal telencephalon 
(dTel). The expression is sharply reduced in the ventral telencephalon (vTel) ventral to the 
PSPB. (A'-C') High magnification images enlarged from the rectangle areas in Panel A-C, 
respectively. Pax6 mRNA reaches its highest expression level near the PSPB region and 
declines rapidly after passing the highest point. (D-F) The mRNA expression pattern of 
Cdca7 possesses a counter gradient compared to the Pax6 pattern, with its lowest level at the 
PSPB region. (D'-F') High magnification views enlarged from the rectangles in Panel D-F, 
respectively. Cdca7 mRNA is low around the PSPB and increases greatly after the PSPB. 
Panel A and D, B and E, C and F are anatomically similar (adjacent sections), therefore the 
regional labels shown in A-C are also shared in D-F. MGE: medial ganglionic eminences; 
LGE: lateral ganglionic eminence; Hip: Hippocampus; Zli: zona limitans intrathalamica; Th: 
Thalamus; PTh: Pre-thalamus; PSPB: pallial-subpallial boundary. Scale bars: 200 µm. 
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Figure 3.2 Expression of Pax6 and Cdca7 at various positions in E12.5 
Pax6Sey/Sey coronal sections 
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Figure 3.2 Expression of Pax6 and Cdca7 at various positions in E12.5 
Pax6Sey/Sey coronal sections 
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing that Pax6 mRNA is expressed evenly in the dTel. (A'-C') High 
magnification images enlarged from the rectangle areas in Panel A-C, respectively. In the 
caudal section, Pax6 mRNA remains highly expressed in the vTel, while in the medial and 
rostral sections, the mRNA expression reduces in this region. (D-F) Representative ISH 
images showing Cdca7 mRNA has an even expression pattern from the dTel to the vTel. 
(D'-F') High magnification views of the rectangle areas in Panel D-F, respectively. These 
results indicate no obvious changes in the expression intensity of Cdca7 dorsal or ventral to 
the PSPB. Panel A and D, B and E, C and F are anatomically similar (adjacent sections), 
therefore the regional labels shown in A-C are also shared in D-F. Scale bars: 200 µm. 
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Figure 3.3 Expression of Pax6 and Cdca7 at various positions in E12.5 
PAX77 coronal sections 
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Figure 3.3 Expression of Pax6 and Cdca7 at various positions in E12.5 PAX77 
coronal sections  
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing that Pax6 mRNA is expressed in a low-medial to high-lateral gradient 
in the dTel, and is sharply reduced in the vTel after crossing the PSPB region, similar to the 
pattern seen in WT embryos. (A'-C') High magnification images enlarged from the rectangle 
areas in Panel A-C, respectively. The Pax6 mRNA reaches its highest point near the PSPB 
region and decreases immediately after crossing this region into the vTel. (D-F) 
Representative ISH images of Cdca7 mRNA expression, showing a counter gradient 
compared to the Pax6 pattern. The expression reaches its lowest level at the PSPB region. 
(D'-F') High magnification views of the rectangles in Panel D-F, respectively. Cdca7 
mRNA level is low around the PSPB and the level increases after crossing the PSPB into 
the vTel. Panel A and D, B and E, C and F are anatomically similar (adjacent sections), 
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Figure 3.4 Expression of Pax6 and Cdca7 on E12.5 wild-type and Pax6Sey/Sey 
sagittal sections 
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Figure 3.4 Expression of Pax6 and Cdca7 on E12.5 wild-type and Pax6Sey/Sey 
sagittal sections  
(A-A') A representative ISH image produced from a sagittal section, showing Pax6 
mRNA expression in WT forebrain. Panel A' contains a high magnification view of the  
area inside the rectangle in Panel A. Pax6 is expressed in a low-caudal to high-rostral 
gradient, reaching its highest level near the PSPB. (B-B') Cdca7 mRNA is expressed in an 
opposite pattern compared to the Pax6 mRNA in the dTel. The expression level is low at 
the PSPB and increases sharply in the adjacent vTel. (C- C', D-D') No obvious graded 
expression patterns of Pax6 and Cdca7 are seen in the dTel in Pax6Sey/Sey. Although Pax6 
mRNA still reaches its highest level near the PSPB, no reduction of Cdca7 mRNA is seen 
at this region. Scale bars: 200 µm. 
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3.2.2 Embryonic stage E13.5 
At E13.5, the mRNA expression pattern of Pax6 is indistinguishable between WT 
(n=3) and PAX77 (n=2) embryos. The pattern also appears less graded in the dTel at 
this stage compared to E12.5 (Figure 3.5-7). Pax6 mRNA is expressed throughout 
the whole dTel up to the PSPB region, where the expression level peaks, the 
expression rapidly decreases after crossing the PSPB into the vTel and very low level 
is present in the remaining part of the vTel. In Pax6Sey/Sey embryos (n=3), Pax6 
mRNA is expressed in a high-medial to low-lateral gradient in the dTel, in agreement 
with the pattern seen in the same genotype at E12.5 but in contrast to the opposite 
patterns seen in WT and PAX77 samples at this stage. In the vTel, Pax6 mRNA 
expression is similar between WT and PAX77 tissues at E13.5, with a gradient less 
obvious compared to samples at E12.5. In Pax6Sey/Sey the expression decreases 
continuously from the dorsal-medial telencephalon to the vTel, indicating that the 
strongest level is located at the dorsal-medial telencephalon instead of the PSPB. 
Cdca7 mRNA expression in WT and PAX77 embryos at E13.5 possess similar 
patterns to those seen in samples at E12.5, in which a weak gradient was observed in 
the dTel (Figure 3.5-7). In the vTel, no significant difference between E12.5 and 
E13.5 samples were seen. Overall the expression level is very low in the lateral 
telencephalon and the weakest area is seen around the PSPB in WT and PAX77 
embryos. In Pax6Sey/Sey mutants, the level of Cdca7 mRNA appears in a gradient 
which gradually increases from the dorsal-medial telencephalon to the vTel. Cdca7 
expression also appears higher in the subventricular zone (SVZ) in the lateral 
telencephalon as well as in the vTel (Figure 3.6, arrows). The change in the 
expression territory from the VZ to the SVZ is very clear in Pax6Sey/Sey mutants from 
E13.5 onwards but is not seen in WT and PAX77. Whether this change indicates 
behavioural alteration of progenitors is still unknown.  
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Figure 3.5 Expression of Pax6 and Cdca7 at various positions in E13.5 wild-
type coronal sections 
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Figure 3.5 Expression of Pax6 and Cdca7 at various positions in E13.5 wild-
type coronal sections 
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing Pax6 mRNA expression in the dTel and around the PSPB region. (A'-
C') High magnification views of the areas inside the rectangles in Panel A-C, respectively. 
The level of Pax6 mRNA expression is higher near the PSPB region compared to the dTel, 
and declines rapidly after crossing the PSPB into the vTel. (D-F) Representative ISH images 
showing the mRNA expression of Cdca7 which possesses an even pattern across the dTel. 
(D'-F') High magnification views of the areas inside the rectangles in Panel D-F, 
respectively. It can be seen that the expression level of Cdca7 mRNA is slightly lower at the 
PSPB region compared to the adjacent ventricular and subventricular zones of the vTel. 
Panel A and D, B and E, C and F are anatomically similar (adjacent sections), therefore the 
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Figure 3.6 Expression of Pax6 and Cdca7 at various positions in E13.5 
Pax6Sey/Sey coronal sections. 
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Figure 3.6 Expression of Pax6 and Cdca7 at various positions in E13.5 
Pax6Sey/Sey coronal sections.  
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing the expression pattern of Pax6 mRNA which possesses a high-medial 
to low-lateral gradient in the dTel. Unlike the pattern in WT, the expression does not peak at 
the PSPB region. (A'-C') High magnification images enlarged from the rectangle areas in 
Panel A-C, respectively. Pax6 mRNA is lowly expressed in the lateral telencephalon and 
continuously declines in the vTel. (D-F) Representative ISH images of Cdca7 mRNA 
showing an opposite gradient compared to the Pax6 mRNA in the dTel towards the PSPB 
region. (D'-F') High magnification views of the regions inside the rectangle areas in Panel D-
F, respectively. No obvious change in the expression intensity can be seen between the PSPB 
and the vTel. Generally, Cdca7 mRNA is highly expressed in the subventricular zone (SVZ) 
of the lateral and ventral telencephalon (arrows). Panel A and D, B and E, C and F are 
anatomically similar (adjacent sections), therefore the regional labels shown in A-C are also 
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Figure 3.7 Expression of Pax6 and Cdca7 at various positions in E13.5 PAX77 
coronal sections 
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Figure 3.7 Expression of Pax6 and Cdca7 at various positions in E13.5 PAX77 
coronal sections 
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing the expression of Pax6 mRNA which has a low-medial to high-lateral 
gradient in the dTel. The gradient is less obvious compared to E12.5. (A'-C') High 
magnification images of the areas inside the rectangles in Panel A-C, respectively. The 
mRNA expression of Pax6 reaches its highest level near the PSPB region, and decreases 
immediately after crossing this region into the vTel. (D-F) Cdca7 mRNA is expressed in an 
opposite gradient compared to the pattern of Pax6 mRNA, with its lowest level at the PSPB 
region. (D'-F') High magnification views of the rectangle areas in Panel D-F, respectively. 
The expression of Cdca7 mRNA is lowest around the PSPB and the level increases after 
crossing the PSPB into the vTel. Panel A and D, B and E, C and F are anatomically similar 
(adjacent sections), therefore the regional labels shown in A-C are also shared in D-F. Scale 
bars: 200 µm. 
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3.2.3 Embryonic stage E14.5 
At E14.5, Pax6 and Cdca7 mRNA expression patterns seem identical between WT 
(n=4) and PAX77 (n=3) samples and no obvious change can be seen in the dTel 
between E13.5 and E14.5 (Figure 3.8 and 3.10). The expression of Pax6 mRNA can 
be seen evenly in the dTel, turning slightly stronger at the PSPB and disappears 
immediately after crossing the PSPB into the vTel. In WT and PAX77 embryos, 
Cdca7 mRNA is also evenly expressed in most areas of the dTel, the level is very 
low at the PSPB, where the highest level of Pax6 mRNA expression is present. In 
consistence with the finding in E13.5 samples, the expression of Cdca7 mRNA 
becomes stronger after crossing the PSPB into the vTel in both WT and PAX77 
embryos.  
In Pax6Sey/Sey samples (n=4), compared to samples at E13.5, the medialhigh to 
laterallow expression gradient of Pax6 seems stronger at E14.5 in the dTel, indicating 
a greater reduction in expression from the medial to the lateral telencephalon (Figure 
3.9). In the vTel, Pax6 mRNA expression reduces continuously in a lateral to medial 
direction but does not disappear abruptly after the PSPB. Cdca7 expression is strong 
from the lateral to the ventral telencephalon. In contrast to WT and PAX77 samples, 
Cdca7 mRNA is not downregulated at the PSPB region in Pax6Sey/Sey embryos, 
suggesting the loss of functional Pax6 protein has affected the expression of Cdca7 
mRNA. It was also found that Cdca7 mRNA is highly expressed in the SVZ in the 
lateral and the ventral telencephalon in Pax6Sey/Sey samples (Figure 3.9 D-F, indicated 
by arrows). 
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Figure 3.8 Expression of Pax6 and Cdca7 at various positions in E14.5 wild-
type coronal sections 
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Figure 3.8 Expression of Pax6 and Cdca7 at various positions in E14.5 wild-
type coronal sections  
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing the expression of Pax6 mRNA in forebrain. (A'-C') High 
magnification images enlarged from the rectangle areas in Panel A-C, respectively. Pax6 
mRNA is highly expressed near the PSPB compared to the dTel, and declines rapidly after 
crossing this region into the vTel. (D-F) Cdca7 mRNA is expressed in a high-medial to 
low-lateral gradient across the dTel. (D'-F') High magnification views of the areas inside 
the rectangles in Panel D-F, respectively. The expression level of Cdca7 mRNA is lowest 
at the PSPB region and increases immediately after crossing the PSPB into the vTel. 
Additionally the level is higher in the SVZ than in the VZ in the vTel. Panel A and D, B 
and E, C and F are anatomically similar (adjacent sections), therefore the regional labels 
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Figure 3.9 Expression of Pax6 and Cdca7 at various positions in E14.5 Pax6Sey/Sey 
coronal sections 
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Figure 3.9 Expression of Pax6 and Cdca7 at various positions in E14.5 
Pax6Sey/Sey coronal sections  
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing that Pax6 mRNA is expressed in a high-medial to low-lateral 
gradient in the dTel, the level decreases even further in the vTel. (A'-C') High 
magnification images enlarged from the rectangle areas in Panel A-C, respectively. Pax6 
mRNA is lowly expressed in the lateral telencephalon and the level declines continuously 
in the vTel. (D-F) Cdca7 mRNA is expressed in an opposite gradient compared to the 
pattern of Pax6 mRNA in the dTel and the PSPB, and is highly expressed in the lateral 
telencephalon. (D'-F') High magnification views of the areas inside the rectangles in Panel 
D-F, respectively. Cdca7 mRNA is highly expressed in the SVZ of the lateral and the 
ventral telencephalon (arrows in D-F). In contrast to the pattern seen in WT and PAX77, 
no obvious difference in the Cdca7 expression intensity can be seen dorsal and ventral to 
the PSPB in Pax6Sey/Sey mutants. Panel A and D, B and E, C and F are anatomically similar 
(adjacent sections), therefore the regional labels shown in A-C are also shared in D-F. 
Scale bars: 200 µm. 
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Figure 3.10 Expression of Pax6 and Cdca7 at various positions in E14.5 PAX77 
coronal sections  
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Figure 3.10 Expression of Pax6 and Cdca7 at various positions in E14.5 
PAX77 coronal sections  
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing that Pax6 mRNA is evenly expressed in the dTel. (A'-C') High 
magnification images enlarged from the rectangle areas in Panel A-C, respectively. The 
expression level of Pax6 mRNA is high in the vTel in the caudal section, and decreases 
slightly in the medial and rostral sections. (D-F) The expression of Cdca7 mRNA does not 
alter from the dTel to the vTel. (D'-F') High magnification images of the areas inside the 
rectangles in Panel D-F, respectively. No clear change in Cdca7 expression level can be 
seen around the PSPB in the caudal and medial sections, while in the rostral section the 
level is lower dorsal to the PSPB. Panel A and D, B and E, C and F are anatomically 
similar (adjacent sections), therefore the regional labels shown in A-C are also shared in 
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3.2.4 Embryonic stage E15.5 
At E15.5, Pax6 mRNA is expressed evenly across the dTel with no obvious 
upregulation at the PSPB region in WT (n=4) and PAX77 (n=4) tissues (Figure 3.11, 
3.13). Consistent with previous time points, Pax6 mRNA is not detected after 
crossing the PSPB into the vTel. In Pax6Sey/Sey mutants (n=4) (Figure 3.12), Pax6 
mRNA is expressed in a strong gradient which is high in the dorsal-medial 
telencephalon and low in the vTel, similar to the finding at earlier developmental 
stages in this genotype. Cdca7 mRNA is also expressed evenly across most of the 
telencephalon in WT and PAX77 samples, with an exception around the PSPB where 
the mRNA level is reduced. The overall expression intensity of Cdca7 mRNA is 
lower in PAX77 compared to Pax6Sey/Sey samples, in which the expression is also 
evenly distributed across the dorsal and the ventral telencephalon. 
In addition, although it is difficult to define the absolute expression level of mRNAs 
using ISH, it is clear, especially at later developmental stages, that Pax6 mRNA is 
more abundant in the Pax6Sey/Sey mutant and in PAX77 compared to WT, while Cdca7 
expression is slightly higher in Pax6Sey/Sey and lower in PAX77 and WT embryos. 
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Figure 3.11 Expression of Pax6 and Cdca7 at various positions in E15.5 wild-
type coronal sections 
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Figure 3.11 Expression of Pax6 and Cdca7 at various positions in E15.5 
wild-type coronal sections  
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing that Pax6 mRNA is expressed evenly in the dTel until the PSPB. 
(A'-C') High magnification images enlarged from the rectangle areas in Panel A-C, 
respectively. Pax6 mRNA is highly expressed near the PSPB compared to the dTel, and 
declines rapidly ventral to the PSPB in the medial and rostral sections. (D-F) The 
expression of Cdca7 mRNA appears even in most parts of the dTel but declines in the 
lateral telencephalon. (D'-F') High magnification views of the rectangle areas in Panel D-
F, respectively. The expression level of Cdca7 mRNA is lowest at the PSPB region and 
increases immediately after crossing the PSPB into the vTel, where the level is higher in 
the SVZ than in the VZ.  Panel A and D, B and E, C and F are anatomically similar 
(adjacent sections), therefore the regional labels shown in A-C are also shared in D-F. 
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Figure 3.12 Expressions of Pax6 and Cdca7 at different positions in E15.5 
Pax6Sey/Sey coronal sections 
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Figure 3.12 Expressions of Pax6 and Cdca7 at different positions in E15.5 
Pax6Sey/Sey coronal sections  
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing that Pax6 mRNA is expressed in a high-medial to low-lateral 
gradient in the dTel. (A'-C') High magnification images enlarged from the rectangle areas 
in Panel A-C, respectively. Pax6 mRNA is lowly expressed in the lateral telencephalon 
and the level decreases further in the vTel. (D-F) Cdca7 mRNA is expressed in an 
opposite gradient compared to the pattern of Pax6 mRNA in the dTel up to the PSPB, and 
is highly expressed in the lateral telencephalon. (D'-F') High magnification views of the 
areas inside the rectangles in Panel D-F, respectively. Cdca7 mRNA is highly expressed 
in the SVZ of the lateral and the ventral telencephalon (arrows in D-F). In contrast to the 
pattern seen in WT and PAX77, no obvious difference in the Cdca7 expression intensity 
can be seen dorsal and ventral to the PSPB in Pax6Sey/Sey mutants. Panel A and D, B and E, 
C and F are anatomically similar (adjacent sections), therefore the regional labels shown 
in A-C are also shared in D-F. Scale bars: 200 µm. 
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Figure 3.13 Expression of Pax6 and Cdca7 at various positions in E15.5 PAX77 
coronal sections 
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Figure 3.13 Expression of Pax6 and Cdca7 at various positions in E15.5 
PAX77 coronal sections  
(A-C) Representative ISH images produced from caudal, medial, and rostral sections, 
respectively, showing that Pax6 mRNA is expressed evenly in the dTel until the PSPB. 
(A'-C') High magnification images enlarged from the rectangle areas in Panel A-C, 
respectively. The expression level of Pax6 mRNA remains high in the vTel in the caudal 
section, and decreases slightly in the medial and rostral sections. (D-F) No noticeable 
change in the expression level of Cdca7 mRNA can be seen in the dTel except in the 
caudal section, where the intensity decreases in the lateral telencephalon. (D'-F') High 
magnification views of the rectangle areas in Panel D-F, respectively. A slight reduction 
in Cdca7 mRNA level can be seen dorsal to the PSPB in the caudal section, and the level 
is high in the SVZ in the vTel in both the medial and the rostral sections (arrows in E’ and 
F’).  Panel A and D, B and E, C and F are anatomically similar (adjacent sections), 
therefore the regional labels shown in A-C are also shared in D-F. Scale bars: 200 µm. 
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3.2.5 Comparing the overall expression level between 
developmental stages, genotypes and positions 
In order to understand how the mRNA levels of Pax6 and Cdca7 differ between 
genotypes during neurogenesis, in-depth quantitative image analysis was conducted 
as follows: 
WT, Pax6Sey/Sey and PAX77 embryos were gathered at embryonic stage E12.5 to 
E15.5. WT and Pax6Sey/Sey samples collected from the same litter were arrayed on the 
same slide to minimise experimental batch effects. Full heads were cryo-sectioned in 
coronal or sagittal orientation and 10µm-thick sections were collected in series. 
Colorimetric ISH for Pax6 and Cdca7 mRNA was carried out on adjacent slides for 
further analysis. 
ISH images were taken on a Leica LB30T microscope with LAS software version 
3.6 and were further analysed by Fiji software. For each image, it was first converted 
to an 8-bit image (0-255) and either the left or the right hemisphere was selected for 
pixel intensity analysis. A ribbon with the width corresponding to the gene 
expression area was drawn from the medial to lateral dTel and further to the lateral 
ganglionic eminences (LGE) (Figure 3.14A).  Pixel intensity was calculated and 
average taken approximately every 10 µm (bin size=10). The data was then further 
divided into two parts according to the expression intensity of Pax6 mRNA and the 
anatomical position, which is near the PSPB. A region where neither Pax6 nor Cdca7 
are expressed was selected as the background area and the pixel intensity value of the 
background was used as a baseline from which other areas of the same section 
subtract to correct the data. Finally, background corrected data were multiplied by -1 
and were plotted on a scatter graph (Figure 3.14B). Since the pixel intensity reading 
ranges from 0 to 255 (8-bit figure), where 0 indicates the weakest and 255 indicates 
the strongest expression. Background corrected data multiplied by -1 provides a 
much intuitive representation of the change in expression level when readings from 
various points along a certain axis on the section are plotted, where a trend line with 
a positive slope corresponds to increasing expression level and one with a negative 
slope illustrates diminishing expression along the axis. For example, positive slope 
values seen in the dorsal area represent gene expression is mediallow to lateralhigh. 
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When the slope of the trend line is close to zero, it represents an even expression 
across the region. In order to understand whether the expression of Pax6 and Cdca7 
is correlated, the slopes of the trend lines of the two genes across the medial dTel-





                                                         
 
(A) A yellow ribbon from medial dTel to the vTel was drawn and a background area was 
selected (quadrangle, arrowhead). Pixel intensity values were then calculated by Fiji. The 
dashed line represents the PSPB region and corresponds to the dashed line in Panel B. The 
blue arrow indicates the expression gradient which is low in the medial and high in the 
lateral dTel. (B) Pixel intensity values along the yellow ribbon in (A) were recorded in the 
direction from medial cortex to the vTel (blue arrow in (A).) Background signal was 
measured in a region where neither Pax6 or Cdca7 was expressed. Pixel intensity values 
collected from yellow ribbon area were corrected by subtracting the values with the 
background expression intensity. Background corrected data were further multiplied by -1 to 
create intuitive representation of the change in expression level (see text for explanation). 
Finally, processed data were plotted and separated into dorsal and ventral parts divided by 
the dashed line. The slopes of the trend lines for both dorsal and ventral pixel intensities 
were then calculated. Scale bar: 100 µm. 
Figure 3.14 Pixel intensity analysis of the mRNA expression 
A B 
The regulatory role of Pax6 on Cell Division Cycle Associated 7 and cortical progenitor cell proliferation 
Chapter 3: Expression patterns of Pax6 and Cdca7 in the developing cortex 84 
 
Because both Pax6 and Cdca7 possess different expression patterns before and after 
the PSPB across the axis, after collecting all data, the first step I performed was to 
separate the data into dorsal to ventral parts based on previous definitions and then 
plot the values of the slopes in a line chart along the developmental stages (Figure 
3.15). The slope values of Pax6 and Cdca7 in the dTel region from WT, Pax6Sey/Sey 
and PAX77 embryos, respectively are shown in Figure 3.15A-C. Pax6 values were 
similar in WT and PAX77, which were strongly positive at E12.5 and decreased with 
time. The slopes of Cdca7 were also similar in WT and PAX77, with negative values 
in most timepoints. Figure 3.15A and 3.15C indicate the expression gradient of Pax6 
and Cdca7 was negatively correlated in the dTel. In WT and PAX77, Pax6 had a 
positive slope at E12.5 and the values decreased over time to zero, suggesting the 
mediallow to lateralhigh expression gradient faded as development progressed. The 
slope value of Cdca7 was negative at E12.5 and increased to close to zero at E14.5 in 
WT and PAX77, indicating the laterallow to medailhigh gradient of Cdca7 diminished at 
this later stage. The expression slope values of Cdca7 in Pax6Sey/Sey mutants (Figure 
3.15B), which lacks functional Pax6 protein, were close to zero at E12.5 and 
gradually increased over time until E14.5, indicating a mediallow to lateralhigh gradient 
was formed. This pattern is distinctive from those in WT and PAX77 samples. In 
summary, Pax6 and Cdca7 were expressed in counter-gradient in PAX77 and WT, 
while this dynamic was disrupted in Pax6Sey/Sey. Overlay of the slope patterns in all 
three gentypes (Figure 3.15D-E) further illustrates that Pax6 and Cdca7 were 
expressed in a similar manner between WT and PAX77, while the pattern was altered 
in Pax6Sey/Sey. The difference between Pax6 and Cdca7 over time was significant 
both in WT and Pax6Sey/Sey (P<0.05, two-way ANOVA). PAX77 samples were not 
included in the statistical analysis as values for E13.5 were taken from only two 
embryos. Data from the vTel is shown in Figure 3.15F-J. In contrast with the dTel, 
positive slope value in this region correspond to a laterallow to medialhigh expression 
gradient. The slope values of Pax6 mRNA were negative at all stages in both WT and 
PAX77, with PAX77 having stronger negative values than WT, indicating a more 
robust decrease in Pax6 transcript level in PAX77 in the vTel. Conversly the slopes 
of Cdca7 mRNA in WT and PAX77 were positive in most cases and did not fluctuate 
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over time in PAX77, indicating the expression gradients were laterallow to medialhigh 
(Figure 3.15F and H). Similar to the data from the dTel, the patterns of Pax6 and 
Cdca7 expression in the vTel in Pax6Sey/Sey mutants were distinctive from those in 
WT, with negative slope values decreasing over time for both genes. Overlay of Pax6 
expression gradients showed unique patterns between genotypes at E12.5, the 
difference faded over time and the slopes gradually moved towards zero (Figure 
5.15I). In comparison, Cdca7 was expressed in a low-lateral to high-medial fashion 
in WT and PAX77 (Figure 3.15J), while the expression slopes in Pax6Sey/Sey mutant 
fluctuated from near zero at E12.5 to -0.07 at E15.5, indicating a reduction of mRNA 
expression from lateral to medial area in the vTel at later stage of development.  
Taken together, the mRNA expression level of Pax6 and Cdca7 were negatively 
correlated in WT and PAX77 embryos, both in the dorsal and the ventral 
telencephalon from E12.5 to E14.5. These counter-gradients seemed abolished or 
altered in direction in the Pax6Sey/Sey mutant, where no functional Pax6 protein was 
present. At E15.5, the expression gradients of the two genes became less apparent in 
all three genotypes in the dorsal area, except for Pax6 mRNA in the Pax6Sey/Sey 
mutant which is not expected to form functional protein. The opposite gradients of 
the two genes were still visible in the ventral part in WT and PAX77 at E15.5, while 
in the Pax6Sey/Sey mutants, this negative correlation was lost, suggesting this 
mutually-exclusive expression pattern required functional Pax6 protein. 
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Figure 3.15 The slope values of mRNA expression gradient over time in wild-
type, Pax6Sey/Sey and PAX77 samples in the dorsal and ventral telencephalon.  
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Figure 3.15 The slope values of mRNA expression gradient over time in wild-
type, Pax6Sey/Sey and PAX77 samples in the dorsal and ventral telencephalon.  
(A-E) Expression slope data measured from the dorsal telencephalon samples between E12.5 
and E15.5. (A-C) The slope values of Pax6 and Cdca7 transcript gradient were plotted to 
illustrate the relative pattern between the two genes in each of the three genotypes. (D-E) 
The slope values of Pax6 and Cdca7 mRNA expression, respectively, in all three genotypes 
were overlayed. (F-J) Expression slope data measured from the ventral telencephalon 
samples between E12.5 and E15.5. (F-H) The slope values of Pax6 and Cdca7 transcript 
gradient were plotted to illustrate the relative pattern between the two genes in each of the 
three genotypes. (I-J) The slope values of Pax6 and Cdca7 mRNA expression, respectively, 
in all three genotypes were overlayed. Three to four embryos were measured in each 
genotype at each developmental stage, except for PAX77 at E13.5, where only two embryos 
were measured. Difference between Pax6 and Cdca7 over time was significant both in WT 
and Pax6Sey/Sey from the dorsal region (A, C) and the significance was not observed in the 
ventral area, neither in WT and Pax6Sey/Sey (P<0.05, Two-way ANOVA). Data set generated 
from PAX77 was not used for statistical analysis due to low n number. 
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In Figure 3.16, data obtained from the dorsal and the ventral regions were analysed 
separately. Each point represents the average value of data obtained from all the 
three genotypes at one time point. In the dorsal region, the slope value of Pax6 
expression gradient moves from positive towards zero and then to the negative side 
over time. The change in the Cdca7 expression gradient over time follows an 
opposite pattern, which shifts towards positive slope values from E12.5-E14.5, 
however the value at E15.5 is negative. 
In the ventral region, no significant difference can be seen between the slope values 
of the Cdca7 expression gradient (i.e. Y-axis) at all four stages, although it is worth 
noting that all slope values are significantly positive, meaning that the mRNA 
expression of Cdca7 is increased from the lateral to medial ventral telencephalon. In 
contrast all Pax6 slopes are significantly negative, this further suggests that the 
expression of the two genes are mutually exclusive.  
Since it is clear that the expression patterns of Pax6 and Cdca7 are different in 
Pax6Sey/Sey compared to those in WT and PAX77, next I will discuss data from 
different genotypes separately.  
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Figure 3.16 A general trend of Pax6 and Cada7 mRNA expression gradient at 
different developmental stages 
All data were gathered together and then separated by their positions (dorsal or ventral 
parts) and developmental stages. The X-axis and Y-axis represent the mRNA expression 
slope of Pax6 and Cdca7, respectively. Each point depicts the average slope values of all 
three genotypes. Error bars represent the standard errors.  
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If Pax6 protein has multiple effects on Cdca7 expression, in order to distinguish 
these effects, the slope value of Pax6 mRNA expression was plotted against that of 
Cdca7 mRNA in each sample in all three genotypes (Figure 3.17). Data collected 
from both dorsal and ventral regions across all examined embryonic stages were 
pooled in this analysis and data from dorsal and ventral were distinguished by 
colours. The patterns in WT and PAX77 are similar to each other (Figure 3.17A and 
3.17C) but the dots are much dispersed (Standard deviation or SD= 0.13 in WT and 
0.20 in PAX77) in PAX77. The correlation between Pax6 and Cdca7 is distinctive in 
Pax6Sey/Sey mutants compared to WT and PAX77 samples (Figure 3.17B). In 
summary, dorsal and ventral data from WT and PAX77 were located near zero point 
and the up-left quadrant, respectively and data from dorsal and ventral were 
separated clearly. Dorsal and ventral data from Pax6Sey/Sey mutant showed higher 
degree of mixtuxe compared to those from WT and PAX77, suggesting a less-defined 
dorsal-ventral separation of the telencephalon.   
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Figure 3.17 The mRNA expression gradients of different ages 
 
Figure 1.10 The mRNA expression gradients of different ages 
 
Figure 1.11 The mRNA expression gradients of different ages 
 
Figu e 1.12 The mRNA expression gradients of different ages 
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Figure 3.17 The mRNA expression gradients of different ages 
(A-C) Data points include all developmental stages in (A) WT, (B) Pax6Sey/Sey and (C) 
PAX77, plotted separately for dorsal (red) and ventral (blue) telecephalon. The X-axis and Y-
axis represent the mRNA expression slopes of Pax6 and Cdca7, respectively. Dorsal slopes 
in WT and PAX77 were located near zero point, while ventral slopes in these two 
genotypes were in the up-left quadrant. Dorsal and ventral data in Pax6Sey/Sey mutant 
showed a high degree of overlap compared to those in WT and PAX77, suggesting a less-
defined dorsal-ventral separation of the telencephalon.   
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In order to focus on the change of Cdca7 mRNA expression in the presence of 
Pax6/PAX6 protein, similar scatter plot analysis was performed but all data from 
Pax6Sey/Sey mutants were eliminated (Figure 3.18). The four panels in the figure 
represent four different embryonic stages from E12.5 to E15.5 (Figure 3.18A-D). 
Data points from the dorsal region,indicated by the red dots, located near zero in the 
lower-right quadrant while those from the ventral region, indicated by the blue dots, 
located in the up-left quadrant, suggesting a negative correlation of two genes in all 
ages. The slope values of Pax6 mRNA (X-axis) were mainly positive at early stages, 
diffusing towards negative values over time. The slope values of Cdca7 mRNA (Y-
axis) in the dorsal region did not vary significantly over time, while variation in the 
ventral region increased as development progressed, suggesting a diminishing effect 
of Pax6 on Cdca7 over time, especially in the vTel, where Pax6 is lowly expressed.  
In summary, the expression level of Pax6 mRNA negatively correlates with the level 
of Cdca7 mRNA in both WT and the PAX77 over-expression model throughout the 
examined ages from E12.5 to E15.5, and this correlation is abolished in the loss-of-
function Pax6Sey/Sey mutants (Figure 3.17B), in agreement with the hypothesis that 
Pax6 protein inhibits the production of Cdca7 mRNA.  
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To evaluate the effect on Cdca7 mRNA expression by the presence of PAX6/Pax6 protein, 
data were only collected from WT and PAX77 samples from E12.5-E15.5, and plotted into 
panel A-D according to the stages. Data from doral and ventral regions were indicated by red 
and blue colours, respectively. Slope values of Pax6 mRNA (X-axis) in the dorsal region 
were mainly positive at E12.5 and spreaded wider toward negative through time. Slope 
values of Pax6 mRNA in the ventral region scattered the widest range at E12.5 and become 
more limited at later stages. Cdca7 slope values (X-axis) in the dorsal region were mainly 
negative at E12.5 and scattered wider across zero point at later ages. Cdca7 slope values (X-
axis) in the ventral region also showed a more constrained location at E12.5 and distributed 
broader at later ages.  
 
Figure 3.18 The mRNA expression gradients of Pax6 and Cdca7 in different 
ages from WT and PAX77 samples 
 
Figur  1.73 The mRNA expression gradients of Pax6 and Cdca7 in different 
ages from WT a d PAX77 samples 
 
Figure 1.74 The mRNA expression gradients of Pax6 and Cdca7 in differ nt 
ages from WT and PAX77 s mples 
 
Figure 1.75 The mRNA expression gradients of Pax6 and Cdca7 in different 
ages from WT and PAX77 samples 
 
Figure 1.76 The mRNA expression gradients of Pax6 and Cdca7 in different 
ages from WT and PAX77 samples 
 
Figure 1.77 The mRNA expression gradients of Pax6 and Cdca7 in different 
ages from WT and PAX77 samples 
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3.2.6 Cluster analysis  
In order to further understand the effects of PAX6/Pax6 proteins on the expression of 
Cdca7 mRNA, I performed a two-step cluster analysis using SPSS software to 
separate the gradient slope data into clusters and to observe factors contributing 
towards each cluster. Data points from all genotypes, anatomical positions and 
developmental stages were gathered together and both Pax6 and Cdca7 expression 
slopes were used as continuous variables. The analysis was set up to automatically 
divide all points into clusters (up to 15) (Figure 3.19A). The result shows that the 
gradient slopes can be separated into two groups according mainly to their sourcing 
positions (either dorsal or ventral), and the Pax6 and Cdca7 slope values between the 
two groups are significantly different (analysis of variance or ANOVA, P<0.001). 
Figure 3.19B and 3.19C illustrate the compositions of each group. In Group 1 
(Figure 3.19B), 82% of this group consist of dorsal data and the rest of them are 
contributed by ventral data obtained from PAX77 and Pax6Sey/Sey samples. The 
composition of Group 2 (Figure 3.19C) is even more uniform, almost 97% of this 
group consist of data obtained from the ventral region and only 2.9 % of the group 
derive from dorsal data from Pax6Sey/Sey. 
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(A) Scatter plot showing all collected data and the X-axis and Y-axis represent the slope 
values of the mRNA expression gradients of Pax6 and Cdca7, respectively. Two step 
cluster analysis by SPSS was set up to automatically divide all points into groups (up to 
15). All data were clustered into two groups which mainly reflect their anatomical 
positions. The slope values of Pax6 and Cdca7 gradients between the two groups are 
significantly different (ANOVA, P<0.001). (B) Pie chart indicating the composition of 
Group 1. 82% of data in this group are of dorsal origin, and the remaining derives from 
ventral areas from Pax6Sey/Sey and PAX77 samples. (C) Pie chart indicating the composition 
of the Group 2. The majority (97%) of data in this group derive from the ventral data and 
2.9 % are from the dorsal area of Pax6Sey/Sey. 
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Figure 3.19 The comparison of mRNA expression slopes across time from 
WT, Pax6Sey/Sey and PAX77 samples. 
 
Figure 1.136 The comparison f mRNA expression sl pe  across time fr m 
WT, Pax6Sey/Sey and PAX77 samples. 
 
Figure 1.137 The comparison of mRNA expression slopes across time from 
WT, Pax6Sey/Sey and PAX77 sample . 
 
Figure 1.138 The comparison of mRNA expression slopes across time from 
WT, Pax6Sey/Sey and PAX77 samples. 
 
Figure 1.139 The comparison of mRNA expression slopes across time from 
WT, Pax6Sey/Sey and PAX77 samples. 
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The analysis indicates that anatomical regions have a predominant influence on the 
cluster segregation. To discover other factors contributing to the expression pattern, 
all collected data were further divided into dorsal and ventral groups and were 
analysed separately. Figure 3.20 shows the analysis for the dorsal data using the 
same clustering parameters as the previous analysis. These data were clustered into 
two groups and the slope values of Pax6 and Cdca7 between the two groups are 
significantly different (ANOVA, P<0.001). Data obtained from WT and PAX77 make 
up 83% of Group 1, while 87.9% of Group 2 data are obtained from Pax6Sey/Sey, 
indicating the clustering is mainly influenced by the presence of Pax6/PAX6 proteins 
(Figure 3.20B-C).  
Figure 3.21A illustrates clustering result using data from the ventral region which is 
similar to the clustering using dorsal data, however the influence by the genotype is 
not as obvious. 50% of the data in Group 1 are contributed by the Pax6Sey/Sey mutant 
(Figure 3.21B), while Group 2 (Figure 3.21C) are made up primarily by data 
obtained from WT and PAX77 samples. 
In summary, clustering analyses reveal that the predominant factor affecting the 
relative expression patterns of Pax6 and Cdca7 is the anatomical region in 
telencephalon, whereas within a specific anatomical region the most influential factor 
for this relative pattern is the presence or absence of PAX6/Pax6 protein. 
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(A) Scatter plot showing all collected data from the dorsal area. The X-axis and Y-axis 
represent the slope values of the mRNA expression gradients of Pax6 and Cdca7, 
respectively. The software automatically divided the data into two groups, mainly 
depending on the presence of PAX6/Pax6 protein and the slope values of Pax6 and Cdca7 
between the two groups are significantly different (ANOVA, P<0.001). (B) Almost 83% of 
data in Group 1 are of WT and PAX77 origin, the remaining 17.2% are contributed by 
Pax6Sey/Sey samples. (C) The majority (88%) of Group 2 data are of Pax6Sey/Sey origin.  
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Figure 3.20 The comparison of mRNA expression slope across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the dorsal area. 
 
Figure 1.199 The comparison of mRNA expression slope across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the dorsal area. 
 
Figur  1.200 The comparison of mRNA expression slope across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the dorsal area. 
 
Figure 1.201 The comparison of mRNA expression slope across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the dorsal area. 
 
Figure 1.202 The comparison of mRNA expression slope across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the dorsal area. 
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(A) Scatter plot showing all data obtained from the ventral area. The X-axis and Y-axis 
represent the slope values of the mRNA expression gradients of Pax6 and Cdca7, 
respectively. The two clusters were separated largely by the presence of PAX6/Pax6 protein 
and the slope values of Pax6 and Cdca7 between two groups are significantly different 
(ANOVA, P<0.001). (B) Pie chart showing the composition of Group 1, in which 
approximately 50% of the data are contributed by WT and PAX77 samples and the rest by 
Pax6Sey/Sey. (C)  Pie chart showing the composition of Group 2, in which almost 90% of the 
data originate from WT and PAX77 samples, proving that the presence of PAX6/Pax6 is the 
main determinant for the clustering.  
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Figure 3.21 The comparison of mRNA expression slopes across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the ventral area 
 
Figure 1.262 The comparison of mRNA expression slopes across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the ventral area 
 
Figure 1.263 The comparison of mRNA expression slopes across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the ventral area 
 
Figure 1.264 The comparison of mRNA expression slopes across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the ventral area 
 
Figure 1.265 The c mparison of mRNA expression slopes across time from 
wild-type, Pax6Sey/Sey and PAX77 samples in the ventral area 
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3.2.7 The relative gene expression of Pax6 and Cdca7 
It is difficult to compare absolute mRNA level between samples using colorimetric 
ISH. To make comparisons, I performed ISH on anatomically matched sections of 
E14.5 embryos of all three genotypes placed on the same slide, to minimise staining 
variations between sections and experiment batches (Figure 3.22). The result shows 
that the expression level of Cdca7 mRNA is similar in WT and PAX77, especially in 
the medial and rostral sections. The high-medial to low-lateral gradients can also be 
seen in these two genotypes. In agreement with the previous RT-qPCR-based 
experiment, in Pax6Sey/Sey mutants, Cdca7 mRNA expression is enhanced compared 
to the corresponding sections of WT and PAX77, and the gradient pattern is either 
lost or in some batches, opposite to those in WT and PAX77. These results further 
support that Pax6 protein negatively regulates the expression of Cdca7 mRNA, and 
this repression requires functional Pax6 protein.  
Finally I investigated whether the graded expression of Pax6 and Cdca7 is also 
observed at the protein level. Here I applied double immunofluorescence staining on 
WT tissue at E12.5 to visualise the protein expression of these two genes (Figure 
3.23). The staining shows that Pax6 protein is indeed expressed in a medial-low to 
lateral-high gradient in the cortex, in agreement with the pattern of the mRNA 
expression. Likewise, Cdca7 protein is expressed in a gradient opposite to Pax6 
(Figure 23A-C). Higher magnification pictures reveal more details around lateral 
telencephalon and the PSPB region (Figure 23A'-C'). Around this region, the 
expression of Pax6 protein is very strong while Cdca7 level is very low. Moving 
towards LGE, Pax6 protein expression suddenly reduces while Cdca7 increases, 
especially in the SVZ. Together the negative correlation between the expression of 
Pax6 and Cdca7 can be seen at both the transcript and the protein levels. 
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Sections with similar anatomical position from three genotypes were arrayed and stained on 
the same slides and at the same time in order to compare the relative expression level of 
Cdca7 mRNA between the genotypes. (A, D, G) Cdca7 mRNA expression at the caudal 
position in the three genotypes, with the highest level in the Pax6Sey/Sey group. A high-medial 
to low-lateral gradient in the dTel is visible in both PAX77 and WT images. (B, E, H) Cdca7 
mRNA expression at the medial position, with the highest level in the Pax6Sey/Sey group and 
no obvious difference between PAX77 and WT. (C, F, I) Cdca7 mRNA expression at the 
rostral position. The patterns are very similar to those at the medial position. The expression 
level is high in the SVZ in the vTel in all three genotypes. Scale bar: 200 µm. 
Figure 3.22 The comparison of Cdca7 mRNA expression from PAX77, wild-
type and Pax6Sey/Sey  
 
Figure 1.325 The comparison of Cdca7 mRNA expression from PAX77, wild-
type and Pax6Sey/Sey  
 
Figure 1.326 The comparison of Cdca7 mRNA expression from PAX77, wild-
type and Pax6Sey/Sey  
 
Figure 1.327 The comparison of Cdca7 mRNA expression from PAX77, wild-
type and Pax6Sey/Sey  
 
Figure 1.328 The comparison of Cdca7 mRNA expression from PAX77, wild-
type and Pax6Sey/Sey  
 
Figure 1.329 The comparison of Cdca7 mRNA expression from PAX77, wild-
type and Pax6Sey/Sey  
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(A, A') Panel A shows the Pax6 protein expression in the cortex, which is high-medially to 
low-laterally and is rapidly reduced in the lateral ganglionic eminences (LGE). Panel A' 
shows a higher magnification view of Panel A. The highest expression level of Pax6 is seen 
around the PSPB. (B, B') The pattern of Cdca7 protein expression in the cortex and the LGE. 
The expression of Cdca7 has an opposite gradient compared to that of Pax6, which is high in 
medial to low in lateral cortex and the lowest point is seen around the PSPB region. (C, C') 
Overlays showing the expression of both proteins in cortex and ganglionic eminences. Scale 
bars: 200 µm. 
Figure 3.23 Expression patterns of Pax6 and Cdca7 protein in the wild-type at 
E12.5 
 
Figure 1.388 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS.Figure 1.389 Expression patterns of Pax6 and 
Cdca7 protein in the wild-type at E12.5 
 
Figure 1.390 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS. 
 
Figure 1.391 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS.Figure 1.392 Expression patterns of Pax6 and 
Cdca7 protein in the wild-type at E12.5 
 
Figure 1.393 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS.Figure 1.394 Expression patterns of Pax6 and 
Cdca7 protein in the wild-type at E12.5 
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3.3 Discussion 
3.3.1 The spatial and temporal expression dynamics of Pax6 and 
Cdca7 
During forebrain development, combinatorial effects of various morphogens and 
transcription factors are required to precisely define the sub-regions along the dorso-
ventral and the antero-posterior axis. Pax6 is one of the transcription factors showing 
differential expression both spatially and temporally in this region. The gene is 
expressed in a rostro-lateralhigh to caudo-mediallow gradient in the dTel during early 
neurogenesis around E12.5 to E13.5 in rodent. This gradient is lost at later stages of 
neurogenesis (Bishop et al., 2000; Georgala et al., 2011; Sansom andLivesey, 2009; 
Walther andGruss, 1991). The expression gradient of Pax6 and Cdca7 in the pallium 
and the dorsal-most part of subpallium are complementary to each other during early 
neurogenesis in WT and PAX77 embryos. At E15.5, the expression gradients of the 
two genes become milder in the neocortex but the gradient of Cdca7 in the subcortex 
is maintained. This may indicate that the expression of Cdca7 is influenced by other 
factors in the subcortical area, where the influence of Pax6 becomes weaker. In 
Pax6Sey/Sey, a clear difference in the direction of Pax6 expression gradient in the dTel 
can be seen. This is accompanied by a loss of Cdca7 gradient at E12.5, and an 
opposite pattern of Cdca7 gradient at E14.5 compared to WT and PAX77, suggesting 
the regional specificity of Cdca7 expression requires functional Pax6 protein. 
Generally the complementary patterns of the two genes in the vTel are not as clear as 
those in the dTel, suggesting that Cdca7 is regulated by other factors in the vTel. 
 
3.3.2 The expression territory of the Cdca7 mRNA throughout the 
developmental stages 
In WT and PAX77 tissues, Cdca7 mRNA is expressed in the VZ of the telencephalon 
at E12.5. As neurogenesis proceeds from E13.5 to E15.5, the expression pattern 
spreads out to cover the SVZ and is highly enriched in the SVZ of the vTel. In 
Pax6Sey/Sey, in addition to the vTel, Cdca7 expression is also enhanced in the lateral 
and the most ventral part of dTel from E12.5 to E15.5, indicating a possible 
disruption of regional identity.  
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It is known that in Pax6Sey/Sey embryos, the boundary between pallium and 
subpallium is disrupted (Carney et al., 2009). In addition, dorsalisation of sub-pallial 
markers is also observed (Kroll andO’Leary, 2005; Stoykova et al., 2000; Toresson 
et al., 2000). Therefore it is worth finding out unknown factors which may influence 
the expression of Cdca7 in the vTel as well as the change of expression territory of 
Cdca7 in Pax6Sey/Sey mutants.  
The homeobox transcription factor Vax1 is expressed in the subpallium, where its 
expression pattern is similar to Gsx and Dlx, (Anderson et al., 1999) and also in the 
anterior entopeduncular, preoptic area, hypothalamus and the septum (Taglialatela et 
al., 2004). The expression pattern of Vax1 is also very similar to that of Cdca7 in the 
subpallium. It is known that loss of Vax1 results in decreased tangential migration of 
GABAergic interneurons into the neocortical VZ and also differentiation defects in 
LGE and MGE, while having no effect on the pallium-subpallium boarder and the 
expression pattern of the pallium marker Pax6 (Taglialatela et al., 2004). Cdca7 is a 
putative downstream target of Mash1 (Ascl1) (Castro et al., 2011) and Mash1 is 
known to modulate Notch signalling and is essential for proliferation of progenitors 
in the subcortical telencephalon (Yun et al., 2002). Although there is no clear 
relationship between Vax1 and Mash1, Cdca7 may be their downstream co-mediator 
which modulates their physiological functions in the ganglionic eminences. 
In Pax6Sey/Sey mutant mice, the ventral-most part of the dTel is largely ventralised, 
with ectopic expression of vTel markers and the presence of GABAergic 
interneurons, possibly due to dorsal cells acquiring ventral identity (Georgala et al., 
2011; Kroll andO’Leary, 2005). In my ISH results, the mutant is also characterised 
by an enhancement of Cdca7 expression in the SVZ in the lateral telencephalon from 
E13.5, while in WT such enhancement is not observed. Whether the dysregulation of 
Cdca7 is causative of the regional misspecification in the mutant is still unknown.  
 
3.3.3 More accurate methods needed to assess the relationship of 
Pax6 and Cdca7  
Previous studies have used ISH to visualise the pattern of gene expression. The 
visualisation relies on signals produced by oligonucleotides or antisense RNA probes 
labelled with radioactive substances such as 32P, or non-radioactive molecules such 
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as biotin. Both radioactive and colorimetric ISH can only provide a semi-quantitative 
readout of RNA expression levels (Ip et al. 2011; Sariñana et al. 2014). Limitations 
imposed by the detection method, such as autoradiography and photography, often 
result in a restricted linear range of signal detection, in which the signal intensity 
proportionally reflects the amount of gene expression. The readout is also relative 
and cannot provide absolute quantitation of the transcripts (Lazic, 2009), making 
comparison between experiments and/or staining batches difficult. Various steps 
during data processing may also introduce bias such as background correction, which 
eliminates pixels with intensity below a certain value and thereby making 
quantitation of gradients inaccurate, and the non-linear conversion between greyscale 
values and optical density (OD). In my ISH experiments, since my goal is to measure 
changes in the gradient of gene expression in the telencephalon, I did not set the 
background cut-off and have converted all pixels to grayscale, which are 8-bit values 
ranging from 0-255, with 0 being the least expressed and 255 being the most. I used 
a scatter plot which includes all pixel readings from the starting point in the medial 
dTel to the end point in the vTel, plotted against the distance from the starting point, 
and then I used the slope of the fitted linear regression line as the readout for the 
gradient of gene expression in the examined regions. Data generated with this 
method can be compared between samples and batches, however this does not give 
absolute quantitation of gene expression.  
There are other methods which can be used to measure the levels of transcripts more 
accurately such as fluorescent ISH or quantitative RT-PCR. The latter is commonly 
applied as it reflects the actual amount of transcripts. In a previous study, my 
colleague has shown by quantitative RT-PCR that Cdca7 mRNA expression 
increases in Pax6-/- embryos at E12.5 and in Pax6 conditional mutant cortex three 
days after Pax6 elimination (Mi et al., 2013). However quantitative RT-PCR requires 
precise regional tissue dissection and cannot visualise the overall pattern of gene 
expression, therefore I decided to use colorimetric ISH to study the interactive 
dynamics of Pax6 and Cdca7 patterns by comparing between genotypes with 
differential Pax6 expression across developmental stages. My results have indeed 
shown that functional Pax6 protein reduces of level of Cdca7 transcripts, this 
suppression may not be direct and varies between anatomical regions and 
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developmental stages, suggesting a more complex molecular network may involve in 
Cdca7 regulation.  
 
3.3.4 Effects of overexpression of human PAX6 on the expression 
of Cdca7 
PAX77+ (PAX77) mouse carrys 5-7 copies of Yeast Artificial Chromosome 593 
(Y593), which contains 420kb of human genomic PAX6 region, covering the PAX6 
gene and 200 kb flanking sequence on each side (Schedl et al., 1996). 
Overexpression of human PAX6 protein has been demonstrated to cause defects in 
eye development (Manuel et al., 2007; Schedl et al., 1996). In the cortex, PAX6 
overexpression causes proliferation defects in radial glia cells in the rostal and 
central cortex but not in the caudal cortex and has little effect on cortical arealisation. 
Endogenous PAX6/Pax6 expression in PAX77 is elevated by two-fold compared to 
that in wild-type, indicating a negative autoregulation in protein expression (Manuel 
et al., 2007). This autoregulation may be important for maintaining a stable level of 
protein in the environment. Autoregulation is also seen at the mRNA level, where 
Pax6 mRNA is upregulated in the Pax6Sey/Sey mutant and downregulated in PAX77 
mice (Manuel et al., 2007; Muzio et al., 2002). Although quantitation of Pax6 
transcript level cannot be reliably achieved with colorimetric in situ hybridization in 
my experiment,  the opposing expression patterns between Pax6 and Cdca7 suggest a 
possible role of Pax6 in negatively regulating Cdca7 transcription. This opposing 
pattern was consistent between wild-type and PAX77 mice, suggesting this negative 
regulation was not affected by PAX6 overexpression. Figure 3.22 provides a semi-
quantitative readout of Cdca7 transcript level in wild-type, Pax6Sey/Sey and PAX77. 
The relatively high abundance of Cdca7 was apparent in Pax6Sey/Sey, further 
supporting the function of Pax6 as a negative regulator of Cdca7 expression. The 
difference in Cdca7 transcript level between wild-type and PAX77 was very little and 
may require fluorescent in situ hybridization and qRT-PCR for more valid results. 
In the next chapter, I have further investigated whether Cdca7 is a direct target of 
Pax6 by identifying potential Pax6 binding motifs in the Cdca7 genomic locus 
followed by validation of potential binding sites by chromatin immunoprecipitation. 
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In addition, the effect of Pax6 on Cdca7 expression has also been examined by the 
promoter assay.   
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Chapter 4 : Identification of Pax6 binding sites in the Cdca7 
locus 
4.1 Introduction 
4.1.1 Importance of regulation through direct binding and binding 
site prediction 
Complex biological processes during development and organogenesis require tight 
regulation of signalling molecules and transcription factors, both temporally and 
spatially. Through direct binding to their target genomic locus, transcription factors 
can effectively control target protein expressions as well as the related physiological 
processes. Traditionally it is hard and time-consuming to identify factors that bind to 
chromosomes or to locate the exact position where those proteins interact with 
chromosomes (Bulyk, 2003).  In recent years with advances in sequencing 
technologies and increasing availability of database platforms, scientists can predict 
potential binding sites by computational or in silico analysis to narrow down the 
target range (Qiu, 2003). 
PAX6/Pax6 is one of the key regulators during development of tissues such as eyes, 
forebrain, and pancreas (Grindley et al., 1995; St-Onge et al., 1997; Walther 
andGruss, 1991). It is important to understand the mechanisms behind how Pax6 
regulates those developmental processes. As a transcription factor, Pax6 can directly 
bind to its genomic target sequences and then recruit either activators or inhibitors to 
affect target gene expressions (Walcher et al., 2013).  There are two DNA binding 
domains, a paired domain (PD) and a homeodomain (HD), in the Pax6 protein. The 
PD can be divided into PAI and RED subdomains and each subdomain forms a 
helix-turn-helix structure which recognises different DNA sequences and binds to 
DNA individually or cooperatively between the two subdomains and the HD (Czerny 
et al., 1993; Jun andDesplan, 1996).  
A previous study had looked into Pax6 binding sites and collectively identified an 
“optimal sequence”, or P6CON motif, for Pax6 PD recognition (Epstein et al., 1994). 
In the literature, several consensus sequences, including the P6CON motif, have been 
proposed to possess high Pax6-binding affinity. It has also been found that in those 
putative binding motifs, DNA sequences are often highly degenerate (Dermitzakis 
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andClark, 2002; Zhang, 2006). Therefore in order to identify motif sequence patterns 
in a precise manner, the position weight matrix (PWM) was introduced to provide a 
predictive model. The PWM for a particular binding motif is generated by aligning 
several DNA sequences known to be bound by a particular protein or a transcription 
factor and by calculating the likelihood of each nucleotide being located at a specific 
position within that particular binding motif. Results are presented as scores for each 
nucleotide at each DNA position. Higher scores indicate that the particular 
nucleotide is more likely to occur at the specific position within the motif. Using 
PWMs, algorithms can be generated for any transcription factors of interest to screen 
for novel binding regions at a genome-wide scale (Stormo, 2000). A number of 
previous studies have taken a genome-wide approach to find undiscovered Pax6 
direct targets in human, mouse and zebrafish (Coutinho et al., 2011; Sansom et al., 
2009; Xie et al., 2013) 
 
4.1.2 How may Pax6 affect Cdca7 expression? 
In previous studies, Cdca7 was shown to be upregulated in Pax6Sey/Sey E12.5 cortex 
by microarray and quantitative RT-PCR analyses (Mi et al., 2013). This implies that 
Pax6 may negatively regulate the expression of Cdca7 RNA. Since CDCA7 is a 
known direct target of E2F1 and is positively regulated by E2F1 (Goto et al., 2006), 
one possible mechanism by which Pax6 regulates the expression of Cdca7 is through 
the inhibition of Cdk6 expression, which further reduces the phosphorylation of pRb 
protein. It has been demonstrated that the phosphorylation of pRb is increased in 
Pax6Sey/Sey E12.5 cortex, which promotes the dissociation of the pRb/E2f complex 
(Mi et al., 2013). Hypophosphorylated pRb interacts with E2f1 and constrains the 
factor in the cytoplasm. Upon pRb phosphorylation, dissociated E2f factors can enter 
into the nucleus and upregulate its downstream targets, including Cdca7, thereby 
accelerating cell cycle transition from G1 to S phase (Bartek andLukas, 2001). 
To find out whether there is direct interaction of Pax6 with Cdca7 genomic regions 
and the regulating role of Pax6 on Cdca7 expression, in this chapter I adopted the 
computational approach to screen for putative Pax6 binding sites in the Cdca7 locus. 
Cdca7 genomic fragments containing putative Pax6 binding sites were used as 
enhancer regions for luciferase expression assays to test if Pax6 affects Cdca7 
The regulatory role of Pax6 on Cell Division Cycle Associated 7 and cortical progenitor cell proliferation 
Chapter 5: Understanding functions of Cdca7 in cortical progenitor cells 110 
 
expression. Since it has previously proved that the expression of Cdca7 is 
downregulated at E12.5 in Pax6-null mutant (Mi et al., 2013), the putative binding 
sites were verified by chromatin immunoprecipitation (ChIP) to reveal actual 
interaction between Pax6 and Cdca7 genomic loci in E12.5 forebrain tissue.  
  
4.2 Results 
4.2.1 Identification of putative Pax6 binding sites in the regulatory 
elements of Cdca7  
Cdca7 is located on Chromosome 2q31.1 in human and Chromosome 2 in mouse. 
The genomic region spans approximately 10,000 bp on the forward strand of 
Chromosome 2. The mouse gene homolog contains 9 exons and encodes a protein 
consisting of 392 amino acids with a predicted size of 43 kDa (Figure 4.1).  Cdca7 
produces five different splicing variants, Cdca7_001-005; only two of which, 
Cdca7_001 and Cdca7_005, encode proteins. The Cdca7_005 transcript encodes a 
much shorter protein with 192 amino acids and only contains exons 1-5 and with no 
known function (Ensembl).  
In order to understand whether Pax6 has direct regulatory effects on Cdca7 gene 
expression, the first approach I used was to identify potential Pax6 binding sites in 
the Cdca7 genomic region. Here I collaborated with Dr Ian Simpson at The 
University of Edinburgh. He generated a customised track which used three different 
Pax6 binding motifs, Pax6CON (Epstein et al., 1994), M00979 (Transfac) (Duncan 
et al., 1998; Zhou et al., 2000) and PC0010 (Coutinho et al., 2011) (Figure 4.2), to 
look for putative binding sites in the Cdca7 genomic locus and the 5 kb region 
surrounding it. These motifs were represented in the form of PWMs which were 
created by mathematical scoring of optimal Pax6 binding patterns. I also used 
Transfac, which utilises a well-established transcription factor PWM database, to 
collectively predict putative sites. In the Transfac programme, the match and matrix 
score was set at 0.8 to reduce false positive hits. The output from the two algorithms 
(the customise track and Transfac database) showed there were 8, 12 and 10 hits in 
the region upstream, within and downstream of the Cdca7 gene, respectively. After 
excluding hits with lower scores of possibility of matrix similarity, I settled on six 
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putative sites located in the 5 kb region upstream of the transcriptional start site 
(TSS) of Cdca7 as targets for further studies. The sequences of the six putative sites 
are listed in Table 4.1.   
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Cdca7 is located on Chromosome 2 (Ensembl, ENSMUSG00000055612) in mouse. It 
contains 9 exons and encodes a protein of 392 amino acids with predicted molecular weight 
of 43 kDa in mouse. The highlighted region presented 6 putative Pax6 binding sites (BS1-6) 
predicted by computational analysis and a NBR was defined as non-binding control region 
(NBR). The number underneath each putative binding site and the NBR represents its 
genomic position relative to the Cdca7 transcriptional start site (TSS). The motifs used for 
prediction are shown in figure 4.2. 
Figure 4.1 Cdca7 genomic region and computationally predicted Pax6 binding 
sites relative to its TSS. 
 
Figure 1.636 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS. 
 
Figure 1.637 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS. 
 
Figure 1.638 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS. 
 
Figure 1.639 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS. 
 
Figure 1.640 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS. 
 
Figure 1.641 Cdca7 genomic region and computationally predicted Pax6 
binding sites relative to its TSS. 
 
Figure 1.642 Cdca7 genomic region and computationally predicted Pax6 
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Optimal Pax6 binding motifs were represented as position weight matrix (PWM) form. (A) 
M00979 is one of the predicted binding motifs which recognise pair domain (PD) binding 
sequence.  This binding motif was adopted by Transfac and the algorithm generated by Dr 
Ian Simpson (Duncan et al., 1998; Zhou et al., 2000). (B) The conventional Pax6 binding 
motif P6CON is generated also by PD domain recognition sequence (Epstein et al., 1994). 
(C) Another binding motif PC0010 was first identified and used by Coutinho et. al. 











































































Figure 4.2 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.699 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.700 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.701 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.702 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.703 Optimal Pax6 binding motifs for in silico predictions. 
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Table 4.1The sequences were predicted by multiple Pax6 binding motifs within 





The six potential Pax6 binding sites in the Cdca7 genomic locus 5 kb upstream to the Cdca7 








Predicted BS Recognised by Predicted binding site sequences 
BS1 M00979 CCTGTACTGGAGCTG 
BS2 P6CON CTGCTTTCTGTTTGATTTTCC 
BS3 M00979 CTGTTCTGGAACCA 
BS4 PC0010 GTTCCAAGAAGAGTAAA 
BS5 M00979 CCAGAGCTGGGACGC 
BS6 M00979 CTGTCCCGGAGCTC 
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4.2.2 Functional characterisation of Pax6 binding regions in the 
regulatory element of Cdca7 
Luciferase assays were performed to understand the biological consequences upon 
Pax6 binding onto its putative targets in the genome. Using PCR with a BAC clone 
(RP23-121B8) template, I amplified a genomic region spanning 2.6 kb upstream of 
the Cdca7 TSS site, which contains putative binding sites 2-6 (BS2-BS6). The 2.6 kb 
genomic region was cloned into a pGEM-T-easy plasmid and then subcloned into 
firefly luciferase expression plasmid pGL4.10. The final plasmid is named 
“pGL4.10_2.6 kb up Cdca7”. A schematic view of this region and the final plasmid 
map are shown in figure 4.3A-B. The pGL4.10 plasmid does not contain a promoter 
region upstream of the firefly luciferase coding region, therefore the enzyme 
production requires an insertion of an upstream sequence which can act as a 
transcription enhancer. A SV40 late poly(A) sequence was placed downstream of the 
luciferase reporter gene to increase the stability of the transcribed RNA and thereby 
increasing the translation of the reporter (Proudfoot, 1991). A synthetic poly(A) 
signal/transcriptional pause site was inserted immediately before the 2.6 kb genomic 
region to provide a termination signal to any spurious luciferase transcription and 
thereby reducing background signals (Enriquez-Harris et al., 1991; Levitt et al., 
1989). For luciferase experiments, this plasmid construct, together with the Renilla 
luciferase expression vector pRL-SV40 and different doses of Pax6 expression 
construct were transiently transfected into HEK293 cells. 48 hours after transfection, 
cells were harvested and total lysates were extracted. The luciferase activities in the 
lysates were quantitated using the Promega Glomax Luminometer. The luciferase 
readouts of Renilla luciferase served as an internal control for transfection efficiency 
in each sample. Normally, for consistency between data, the firefly luciferase activity 
in cells transfected with empty pGL4.10 plasmid is used as a baseline to which the 
genomic region-containing experimental group is normalised. However in this 
experiment the activity readings in these control cells were 1-2% of those in the 
experimental group. As a consequence minute variations in the absolute readings 
within the control group would cause significant variations in the experimental group 
after normalisation. Therefore all samples were instead normalised to the activity in 
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cells transfected with the “pGL4.10_2.6 kb up Cdca7” plasmid in the absence of the 
Pax6 expression construct. 
Based on the RNA expression pattern visualised by in situ hybridisation in the 
previous chapter, Pax6 may act as a negative regulator of Cdca7 transcription. Figure 
4.3C shows Pax6 protein at low levels negatively regulates the promoter activity of 
Cdca7, with a reduction of approximately 10% in samples transfected with 200ng of 
the Pax6 expression vector compared to the no-Pax6 group however this is not 
statistically significant. This inhibition is absent in the group with the highest dose of 
Pax6, which instead enhances the promoter activity by 10% as shown in cells 
transfected with 500ng of the Pax6 vector, compared to the no-Pax6 control. Cells 
transfected with the highest dose of the Pax6 expression construct produced 
significantly higher Cdca7 promoter activity compared to cells receiving other doses 
apart from the no-Pax6 group (Tukey, P<0.05, n=3). Taken together, the Pax6 
expression construct has a dosage-dependent effect on the luciferase expression, 
suggesting that Pax6 protein affects the promoter/enhancer activity of the 2.6 kb 
fragment (one-way ANOVA, P=0.003). 
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Figure 4.3 Schematic representation of the firefly luciferase construct and 
Pax6 mediated regulation via 2.6 kb upstream region. 
 
Figure 1.947 Schematic representation of the firefly luciferase construct and 
Pax6 mediated regulation via 2.6 kb upstream region. 
 
Figure 1.948 Schematic representation of the firefly luciferase construct and 
Pax6 mediated regulation via 2.6 kb upstream region. 
 
Figure 1.949 Schematic representation of th  firefly luciferase construct and 
Pax6 mediated regulation via 2.6 kb upstream region. 
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Figure 4.3 Schematic representation of the firefly luciferase construct and 
Pax6 mediated regulation via 2.6 kb upstream region. 
(A) 2.6 kb region upstream to the Cdca7 TSS which contained the potential Pax6 binding 
sites 2-6 was inserted into a promoter-less luciferase backbone pGL4.10. (B) 2.6 kb insertion 
is upstream to the firefly luciferase coding sequence followed by a SV40 late poly (A) region 
to increase the stability of the transcribed mRNA. The final construct is almost 7 kb 
including an ampicillin resistance gene for selection and a synthetic poly(A) 
signal/transcriptional pause site before the 2.6 kb fragment to provide a termination signal to 
prevent background signals produced by spurious luciferase transcriptions (Enriquez-Harris 
et al., 1991; Levitt et al., 1989). (C) To assess the Pax6-mediated inhibition of Cdca7 
expression, firefly luciferase construct together with the transfection efficiency control 
Renilla luciferase vector were transiently transfected into HEK293 cells and lysates were 
extracted 48 hours after transfection for analysis. Bar chart showing different doses of the 
Pax6 expression construct, and thus the level of Pax6 protein, have differential effects on the 
promoter/enhancer activity of the 2.6 kb fragment (one-way ANOVA, P=0.003). Individual 
lines above the bars mark statistically significant differences between the indicated groups 
(Tukey, P<0.05, n=3). 
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A construct similar to “pGL4.10_2.6 kb up Cdca7” containing a larger genomic 
region upstream of Cdca7 which includes all six putative Pax6 binding sites was then 
made. The construct is named “pGL4.10_4.4 kb up Cdca7”. The schematic view of 
this region and the plasmid map are shown in Figure 4.4A-B.  
Unexpectedly, the promoter assay using the “pGL4.10_4.4 kb up Cdca7” construct 
revealed a dynamic different from the previous experiment using the 2.6 kb fragment 
as the enhancer element (Figure 4.4C). Instead of the opposite effects between 
samples with low and high level of Pax6, a steady dosage-dependent increase in the 
promoter activity was observed (one-way ANOVA, P=0.012, n=3). With 500ng of 
the Pax6 expression construct, the maximum amount in this experiment, promoter 
activity was enhanced by 30% compared to the no-Pax6 control (Tukey, P<0.05). 
This suggests that the effect of Pax6 protein on Cdca7 transcription is dependent on 
the context of the enhancer elements.    
To ensure the transfection of Pax6-expressing vector had in fact produced Pax6 
protein, a western blot was performed using the same lysates extracted for the 
luciferase assay (Figure 4.5). The CMV promoter-driven expression of Pax6 protein 
was detected by a Pax6-specific antibody in cells transfected with the expression 
vector, in a dosage dependent manner which appeared to plateau at 400ng of the 
transfected plasmid. GAPDH was used as the western blot loading control. The Pax6 
antibody used for this experiment recognises two isoforms, Pax6 and Pax6 (+5a) 
with different molecular weights 46 and 48kDa, respectively (Figure 4.5).  
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Figure 4.4 Schematic representation of the firefly luciferase construct and 
Pax6 mediated regulation via 4.4 kb upstream region. 
 
Figure 1.1423 Overexpression of Pax6 protein in HEK293 cells.Figure 1.1424 
Schematic representation of the firefly luciferase construct and Pax6 mediated 
regulation via 4.4 kb upstream region. 
 
Figure 1.1425 Overexpression of Pax6 protein in HEK293 cells.  
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Figure 4.4 Schematic representation of the firefly luciferase construct and 
Pax6 mediated regulation via 4.4 kb upstream region. 
(A) 4.4 kb region upstream to the Cdca7 TSS which contained all six potential Pax6 binding 
sites was inserted into a promoter-less firefly luciferase backbone pGL4.10. (B) 4.4 kb 
insertion is upstream to the firefly luciferase coding sequence followed by a SV40 late poly 
(A) region to increase the stability of the transcribed mRNA. The final construct is 8.7 kb in 
size, including an ampicillin resistance gene for selection and a synthetic poly(A) 
signal/transcriptional pause site before the 4.4 kb fragment to provide a termination signal 
for any spurious luciferase transcription (Enriquez-Harris et al., 1991; Levitt et al., 1989). 
(C) To assess the Pax6-mediated inhibition of Cdca7 expression, firefly luciferase construct 
together with the transfection efficiency control Renilla luciferase vector were transiently 
transfected into HEK293 cells and lysates were extracted 48 hours after transfection for 
analysis.  Bar chart showing the effect of different doses of the Pax6 expression construct on 
the promoter/enhancer activity of the 4.4 kb fragment (one-way ANOVA, P=0.012). With 
500ng of the Pax6 expression construct, promoter activity is enhanced by 30% compared to 
the no-Pax6 control. The line between the 500ng and the 0ng group marks the statistically 
significant difference between the two groups (Tukey, P<0.05, n=3). The data showed that 
instead of being a transcriptional inhibitor, the presence of Pax6 leads to increased Cdca7 
promoter activity. 
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HEK293 cells were transiently transfected with different doses of the CMV promoter-driven 
Pax6 expression vector. The resulting protein levels of Pax6 were revealed with an antibody 
against Pax6 by western blot, with the level of GAPDH protein as the loading control for 
each lysate. The transfection of the Pax6 expression construct resulted in increased cellular 
level of Pax6 protein in a dosage dependent manner, which appeared to plateau at 400ng of 
the transfected plasmid. The specific Pax6 antibody also detected two different isoforms of 
Pax6, Pax6+5a and Pax6-5a (Pax6) with molecular weight at 48kDa and 46kDa, 
respectively.  
Figure 4.5 Overexpression of Pax6 protein in HEK293 cells.  
 
 
Figure 1.1671 Overexpression of Pax6 protein in HEK293 cells.  
 
 
Figure 1.1672 Overexpression of Pax6 protein in HEK293 cells.  
 
 
Figure 1.1673 Overexpression of Pax6 protein in HEK293 cells.  
 
 
Figure 1.1674 Overexpression of Pax6 protein in HEK293 cells.  
 
 
Figure 1.1675 Overexpression of Pax6 protein in HEK293 cells.  
 
 
Figure 1.1676 Overexpression of Pax6 protein in HEK293 cells.  
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In summary, the result of the luciferase assay with the 2.6 kb fragment as the 
enhancer region indicates that the expression of Cdca7 is inhibited only when Pax6 is 
present at a low level, while overexpressed Pax6 protein has an activation effect on 
Cdca7 expression. Therefore a correct amount of Pax6 protein is important for its 
physiological role (Quinn et al., 2007). The discrepancy between the two Cdca7 
constructs suggests a context-dependent regulation in the Cdca7 genomic region, as 
well as possible involvement of other activators such as E2f1 within the extra 1.8 kb 
region in the pGL4.10_4.4 kb up Cdca7 construct which may influence Cdca7 
expression (See discussion 4.3.1 for more details). 
 
4.2.3 Does Pax6 bind the Cdca7 regulatory region in vivo? 
In order to understand whether the regulation of Cdca7 expression by Pax6 is 
dependent on the direct binding of the transcription factor to the Cdca7 regulatory 
elements, ChIP was performed using an antibody against Pax6, followed by 
quantitative PCR (qPCR) measurement of the precipitated samples with primer pairs 
specific for each of the six putative Pax6 binding sites in the Cdca7 genomic region. 
ChIP is a powerful tool for identifying protein-DNA interaction, which is useful for 
discovering specific binding regions of transcription factors. Conventional ChIP 
protocols normally start by crosslinking proteins with chromosomes in the cell or 
tissue samples using formaldehyde, followed by extraction of the crosslinked 
chromatin complex. The extracted chromatins are then incubated with either the 
antibody against the protein of interest or the IgG isotype control. Antibody-bound 
chromatins are then precipitated and genomic DNA is isolated from the precipitated 
complex. Purified genomic DNA is then used as the template for qPCR using 
primers detecting the regions of interest. The binding preference of a transcription 
factor to specific genomic sites is examined by dividing the qPCR outcomes from 
samples incubated with the gene-specific antibody with that from the isotype control 
(Kuras, 2004). In order to avoid skewing of experimental results by the low level of 
random background noise of the control IgG, I conducted ChIP with tissues from 
Pax6+/+ and Pax6Sey/Sey E12.5 cortex and precipitated chromatin complex using only 
antibody against Pax6. The truncated form of Pax6 protein in Pax6Sey/Sey mice cannot 
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be recognised by the Pax6 antibody and therefore the sample can act as a control for 
non-specific binding by the antibody. 
Cellular extracts from the two sample groups were prepared and sonicated, which 
produced sheared DNA fragments ranging from 100 to 700 bp (Figure 4.6A). The 
sonicated samples were incubated with the Pax6 antibody, followed by precipitation 
and DNA purification. 
Abundance of the six putative Pax6 binding regions and one putative non-bound 
region within the examined Cdca7 genomic region in the precipitated samples was 
measured by qPCR. All data were normalised by dividing the quantity of the 
amplicon in Pax6+/+ samples by that in Pax6Sey/Sey counterparts (formula A). Binding 
enrichment of each site was further calculated by dividing the results from formula A 
by that of the Syt8 negative control (formula B), which was previously reported as a 
non-Pax6 binding region (Mi et al., 2013; Sansom et al., 2009). Primers for Pou3f4 
(Ninkovic et al., 2013) fragments were used as a positive binding control for Pax6.   
 
    qPCR output for each primer from Pax6+/+ samples 
    qPCR output for each primer from Pax6-/- samples 
 
         X for each primer set  
    X for Syt8 negative control 
 
Results in Figure 4.6B show no significant enrichment of Pax6 binding to any 
examined sites, including the positive control, in relation to the negative control. All 
predicted binding sites and the putative non-bound region possess similar binding 
affinity to Pax6 protein compared the Syt8 control. The enrichment is also absent in 
the Pou3f4 positive control. This may indicate that there is no actual binding of Pax6 
on the Cdca7 genomic region but the reason behind the lack of enrichment in the 
positive control is unknown. Possible reasons will be discussed later in the 4.3.2 
 
= X ------------ (Formula A) 
= fold enrichment --------------------------- (Formula B) 
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Positions of the six putative Pax6 binding sites (BS1-6) and one chosen non-binding 
control region (NBR) were shown in figure 4.1. (A) Samples used in ChIP experiments 
were extracted from either Pax6+/+ or Pax6Sey/Sey E12.5 cortex. Sonication of isolated 
chromatin resulted in sheared DNA fragments ranging from 100-700 bp. (B) The 
sonicated chromatin samples from Pax6+/+ or Pax6Sey/Sey tissues (n=3) were precipitated 
separately with the antibody against Pax6. The precipitated DNA was purified and the 
abundance of BS1-6, NBR, Pou3f4 (positive control for Pax6 binding) and Syt8 (negative 
control for Pax6 binding) were measured by quantitative PCR. NBR is located 3790 bp 
upstream to the Cdca7 TSS with no putative Pax6 binding site within its 450bp flanking 
regions. All data were normalised by dividing the average abundance in Pax6+/+ samples 
by that in the Pax6Sey/Sey counterpart for each site. The enrichment of each binding site is 
defined as the fold-change from the Syt8 result (Formula A and B, see text for details). 
The results show no apparent enrichment among all examined sites, including the positive 
control Pou3f4 which is a known Pax6-binding region. The lack of enrichment suggests 



























































Figure 4.6 Validation of direct in vivo Pax6 binding to the Cdca7 upstream 
regulatory elements by quantitative chromatin precipitation (qChIP). 
 
Figure 1.1919 Validation of direct in vivo Pax6 binding to the Cdca7 upstream 
regulatory elements by quantitative chromatin precipitation (qChIP). 
 
Figure 1.1920 Validation of direct in vivo Pax6 binding to the Cdca7 upstream 
regulatory elements by quantitative chromatin precipitation (qChIP). 
 
Figure 1.1921 Validation of direct in vivo Pax6 binding to the Cdca7 upstream 
regulatory elements by quantitative chromatin precipitation (qChIP). 
 
Figure 1.1922 Validation of direct in vivo Pax6 binding to the Cdca7 upstream 
regulatory elements by quantitative chromatin precipitation (qChIP). 
 
Figure 1.1923 Validation of direct in vivo Pax6 binding to the Cdca7 upstream 
regulatory elements by quantitative chromatin precipitation (qChIP). 
 
Figure 1.1924 Validation of direct in vivo Pax6 binding to the Cdca7 upstream 
regulatory elements by quantitative chromatin precipitation (qChIP). 
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4.3.1 The regulatory function of Pax6 on Cdca7 expression 
In the previous chapter, Pax6 was thought to negatively regulate Cdca7 expression 
due to the mRNA expression patterns of the two genes as well as previous 
microarray and qPCR results (Mi et al., 2013). However in this chapter a more 
complex regulation has been revealed by the luciferase assay. Using the 2.6 kb 
Cdca7 genomic fragment as the luciferase expression enhancer, Pax6 at low level 
causes approximately 10% reduction in Cdca7 expression, whereas at high level the 
effect of Pax6 becomes activating. When the 4.4 kb genomic fragment was used, 
there was no reduction of luciferase expression with any dosage of Pax6. Instead, 
overexpression of Pax6 resulted in an enhanced output from the Cdca7 upstream 
regulatory element which led to a 30% increase in Cdca7 expression in samples with 
the highest dosage compared to the non-Pax6 control.  
One possible mechanism by which Pax6 could inhibit Cdca7 expression is by 
negatively regulating the phosphorylation of pRb through downregulating expression 
of the direct Pax6 target gene Cdk6, thereby preventing the separation of the E2f/pRb 
complex and downregulating expression of E2f downstream targets in the normal 
physiological environment (Mi et al., 2013). The luciferase assay results in this 
chapter correlate with such theory, with Pax6 at a low level inhibiting the promoter 
output of the 2.6 kb region upstream of the Cdca7 TSS. The fact that the inhibitory 
effect of Pax6 was absent when a longer 4.4 kb region was used suggests this 
regulation is dependent on the genomic context. One possible explanation is the extra 
1.8 kb region between the 2.6 kb and the 4.4 kb fragments may recruit unknown 
activators which mask the inhibitory effects of Pax6 This theory requires future 
validation by mutating the putative Pax6 binding site BS1 which is contained in this 
1.8kb region, and by searching for binding sites for other transcription factors such as 
E2f1 and c-Myc. It should also be noted that the luciferase assay was carried out in 
Human Embryonic Kidney (HEK) 293 cells and the functions of Pax6 may be 
different in neural progenitors and in embryonic kidney cells. Although some 
neuronal features such as neurofilament subunits are expressed in HEK293 cells, this 
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cell line has been identified derive from the embryonic adrenal cells in a recent study 
(Lin et al., 2014; Shaw et al., 2002) and therefore may possess a very different set of 
transcription factors which may affect Pax6 functions in the cell.  
It is known that Cdca7 is a direct target of E2F1 transcription factor in HeLa cells 
(Goto et al., 2006). Other E2F family members E2F2 and E2F4 also bind to CDCA7 
genomic region (Goto et al., 2006). A computational prediction using JASPAR 
CORE 2014 database performed by Mr Zrinko Kozic has identified new putative 
binding sites in the region from 4.5 kb to 2.6 kb upstream to the Cdca7 TSS (Zrinko 
Kozic unpublished). PWMs were obtained from JASPAR CORE 2014 database and 
non-redundant vertebrate matrices were selected. The 4.5 kb upstream region was 
scanned for putative binding sites using R language with Biostrings package and 
both sense and antisense sequences were aligned to the motifs in the database. Only 
the motif hits with alignment score equal or higher than 90% of the maximum score 
were chosen (Mathelier et al., 2014). From the alignment, several putative binding 
sites were found to locate in the region spanning 4.5 kb to 2.6 kb upstream to the 
Cdca7 TSS, these include one E2f1 site, one E2f4 site, one Sox2 site and three 
Sox10 sites. Although the expression level and the function of E2F1 are not fully 
understood in HEK 293 cells, a previous study using this cell line has found an 
inhibitory effect of Pax6 on the Cdk6 promoter which could consequentially reduce 
the activity of E2F1 (Mi et al., 2013). Given the direct role of E2F1 in CDCA7 
upregulation in HeLa cells and the possible down-regulating effect of Pax6 on E2F1 
function in HEK 293 cells, whether the enhanced Cdca7 promoter activity caused by 
Pax6 overexpression is mediated by E2F1 requires further validation.  
Online database BioGrid which collects physical protein-protein interaction results 
indicates that Pax6 is physically bound to Sox2 in mouse and Sox10 in rat (Appendix 
2) (Ravasi et al., 2010; Wissmüller et al., 2006). Whether Sox2 and Sox10 proteins 
are endogenously expressed in HEK 293 cells is currently not known, however if 
they are present, the overexpression of Pax6 may increase their recruitment to the 
Cdca7 regulatory element and thereby influence the expression of Cdca7. 
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4.3.2 Current ChIP procedures and possible experimental errors  
Chromatin immunoprecipitation is a great tool for investigating chromatin 
modifications and protein: DNA interactions. As described in the results section, 
ChIP normally uses a common cell lysate as the starting material and compares the 
DNA precipitated by the antibody against the protein of interest with that 
precipitated by a IgG isotype control raised in the same species (Kuras, 2004). DNA 
precipitated by the isotype control is regarded as random or background signal, 
which is used to normalise the signal produced by the antibody against the protein of 
interest. 
A conventional ChIP experiment requires a minimum of four days to perform. 
Recently various improvements in the experimental procedures have been applied to 
simplify and shorten sample preparation processes and to accelerate antibody 
precipitation (Haring et al., 2007; Nelson et al., 2006; Schoppee Bortz andWamhoff, 
2011). 
In my experiments, I adopted the procedures from previous publications and used 
Syt8, a negative control region previously shown to contain no Pax6 binding site (Mi 
et al., 2013; Sansom et al., 2009). I also used a Pax6 antibody manufactured by 
Millipore that is widely used in ChIP experiments (Díaz-Alonso et al., 2014; Xie et 
al., 2013). The antibody only recognises the amino-terminal of Pax6 protein, which 
is absent in Pax6Sey/Sey tissues. However, the results shown in Section 4.2.5 suggest 
no difference in Pax6-binding affinity between all putative binding sites and the Syt8 
negative controls. There is also no affinity difference between the Pou3f4 positive 
control and Syt8. 
One technical error may have occurred during the sonication step. The sonicated 
fragments have a length distribution between 100 bp and 700 bp. Long DNA 
fragments are more likely to produce background noises due to the higher possibility 
of containing both Syt8 and Pax6-binding motifs, and therefore may produce Syt8 
signals in Pax6 antibody precipitated samples. 
Another possible error is that Pax6 antibody may have failed to specifically 
precipitate chromatin complex in this experiment. To verify the differential binding 
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affinity of the antibody to wild-type Pax6 and the mutant form, immunofluorescent 
staining was performed on wild-type and Pax6Sey/Sey sections. The Pax6 antibody 
used in this ChIP experiment produced a specific staining pattern in wild-type tissues 
but not in Pax6Sey/Sey, suggesting a specific binding to the wild-type protein (data not 
shown). To assess the specificity of the chromatin precipitation, western blot analysis 
can be done to confirm whether Pax6 protein is present at different levels in the 
precipitated samples between wild-type and Pax6Sey/Sey before the DNA purification 
step.  
Other issues that may affect the signal-to-noise ratio in the qPCR results are non-
specific binding of chromatin to the protein A/G agarose or magnetic beads and/or to 
the plastic tubes used in the experiments. To prevent the former problem, beads can 
be blocked with non-specific serum or BSA to reduce background binding (Haring et 
al., 2007). In my experiments a blocking buffer containing 0.5% BSA was used to 
minimise non-specific binding. For the latter issue, siliconized tubes or plastic tubes 
pre-incubated with BSA or non-related DNA can be used to reduce non-specific 
binding of chromatins to the tubes. 
Normalisation of qPCR results can also create unnecessary skews that may mask the 
true differences between samples. Conventionally, signals from the experimental 
ChIP group (using antibody against the protein of interest) are divided by signals 
from the non-specific antibody such as an isotype IgG to reveal the experimental 
ChIP signal as “fold change or fold enrichment” from the background levels (Haring 
et al., 2007; Mathieu et al., 2005; Mi et al., 2013). Because random binding signals 
from the control IgG antibody are very low, DNA fragments precipitated by the 
control IgG may produce nearly undetectable readouts in the qPCR. Any variation 
between these low values will falsely amplify the results in the experimental group if 
they were used as references for normalisation. Also because the binding affinity of 
non-specific control antibody to all DNA-binding proteins is low and the chromatin 
it precipitates should be random, using non-specific IgG control is to assume that the 
background noise level for each qPCR primer target region is similar, if this 
assumption is erroneous then the noise level produced by the IgG control may also 
skew the experimental results. To avoid those possibilities, a previous study used a 
single antibody against the protein of interest to pull down the chromatin complex 
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(Kaeser andIggo, 2002). In my ChIP procedures, a single antibody against Pax6 
protein was applied to precipitate wild-type (experimental) and Pax6Sey/Sey (control) 
tissues, and the qPCR result of each primer set in the wild-type sample is normalised 
against that in the control sample, thereby avoiding the skewing effects of the IgG 
antibody. 
Another normalisation method is called the “percentage of input”. This method uses 
un-precipitated chromatin complex as the “input DNA”. The qPCR results from the 
input DNA are used to normalise the ChIP results, therefore the signals produced by 
protein-specific and control antibodies are expressed as the percentage of the input 
DNA (Haring et al., 2007; Nagaki et al., 2003). To apply this method to my results, a 
possible way to improve my current experiment is to obtain the qPCR results before 
and after the precipitation process within wild-type and Pax6Sey/Sey group. For each 
putative binding site as well as the Pou3f4 positive and the Syt8 negative controls, 
DNA purified from the WT and Pax6Sey/Sey tissue lysates before antibody 
precipitation can be used to obtain the level of input DNAs, which can be used to 
normalise the qPCR results from the precipitated samples. For each examined primer 
set, ratios of the precipitated vs. input DNA from the two genotypes can be created 
separately. Therefore by comparing the ratios, it is possible to identify differential 
binding affinities between genomic regions and genotypes. 
In summary, it is currently difficult to confirm the binding of Pax6 in the tested 
regions. To improve the experiment, measures need to be taken to minimise the 
background noises caused by the experimental conditions, the presence of Pax6 
protein in precipitate samples needs to be confirmed by western blot, additional 
negative control primer sets should be tested, and new normalisation methods should 
be implemented in the future.  
 
4.3.3 Re-exploring potential Pax6 target sites in the Cdca7 
genomic region   
In this project, the original target region for putative Pax6 binding site discovery was 
the Cdca7 genomic locus and the 5 kb region flanking the area. Computational 
predictions showed region upstream to the Cdca7 genomic region contained several 
highly potential hits from the customised track. A 4.2kb upstream genomic fragment, 
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containing putative Pax6 binding sites without Cdca7 coding region, was selected 
and cloned. Given the result that all identified putative binding sites within this 
region did not show preferential binging affinity to Pax6,  an expansion in the 
genomic region to be anlysed, as well as new identification strategies, are required to 
uncover potential Pax6 binging motifs. A number of highly scored putative sites 
within the Cdca7 genomic region, as well as sites located downstream the region, are 
listed in Table 4.2. The position weight matrices for optimal Pax6 binding sequence 
are shown in Figure 4.7. 
 
Table 4.2 In silico prediction of Pax6 binding sites near and within the Cdca7 
genomic region 
Genomic locus Recognised by Predicted binding site sequences 
72477524 72477538 M00979 ATCTTCACACATAAA 
72478073 72478090 PC:C0000010     TCATGAAAATGAAGCCCA 
72482079 72482096 PC:C0000010      ATTGTTTGGAAAATGGAG 
72483980 72484001 P6CON GATTTTGGAGTTTTGCATCAAC 
72484246 72484257 M00808 CTGAGGAGATGG 
72486489 72486500 M00808 GCCATTTCCCAG 
72489460 72489471 M00808 CAAAAATGACAT 
72489484 72489495 M00808 GTAACCACGGAG 
72489486 72489500 M00979 AACCACGGAGAATGA 
72490349 72490360 M00808 GACACACAGACA 
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In addition to the motifs in Figure 4.2, two alternative optimal Pax6 binding motifs 
are represented in position weight matrix (PWM) form. (A) M00808 recognises 
Pax family proteins in human and mouse (Transfac). (B) PH0132.1 binding motif 







Figure 4.7 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.1982 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.1983 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.1984 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.1985 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.1986 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.1987 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.1988 Optimal Pax6 binding motifs for in silico predictions. 
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New strategies regarding to look for promising Pax6 binding motifs were related to 
DNA structure and chromosome folding/unfolding during gene expression. DNA in 
mammalian cells is packed into chromatin complex, with various folding 
mechanisms creating tissue-specific interactions between genomic regions. In recent 
years, three-dimentional chromatin organisation within cells can be visualised by 
chromosome confirmation capture (3C). The fundamental concept of 3C is to 
crosslink chromatin structure with formaldehyde, followed by chromatin digestion 
with restriction enzymes. Genomic regions sharing close physical interactions are 
ligated so their linkage is preserved. These interacting DNA motifs can be identified 
by standard PCR or high-throughput sequencing (Dekker et al., 2013).   
Recently with advance in high-resolution chromosome confirmation capture (Hi-C), 
chromosomes are believed to be segmented into topological associated domains 
(TADs). Based on the same principle of 3C, Hi-C can further sequence whole 
genomic region in a non-biased method. After Hi-C analysis, chromosome regions 
that interact with other can be identified. Scientists have found that the interaction 
frequency is higher within individual chromosome than between chromosomes. 
Furthermore, within individual chromosome, there are segamented units which firstly 
separated by the interaction frequencies. The interaction frequency is higher within 
each unit than between units. Later the unit is called TAD and further investigation 
has suggested individual TAD is possibly separated by enriched CTCF binding 
(Dekker et al., 2013; Dixon et al., 2012). The size of TADs in average is 880kb in 
mouse ES cells, where all identified TADs cover 91% of the genome (Dixon et al., 
2012). Distal rearrangement of chromosome may result from interactions between 
promoter and enhancer elements, and Hi-C can provide genome-wide unbiased 
detection of protein-binding regions, which can be used to predict long-range 
regulatory elements, or even to predict co-expression of genes within the genome 
(Babaei et al., 2015; Lajoie et al., 2015; Pope et al., 2014).  
Hi-C has been used in embryonic mouse forebrain to provide potential promoter-
enhancer binding information (GEO no. GSE60838) (Reilly et al., 2015; Shen et al., 
2012). I have combined those information, together with Pax6 ChIP-seq results in 
embryonic E12.5 mouse cortex (GEO no. GSE66961 Sun et al., 2015), to predict the 
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regulatory elements of Cdca7 as well as potential Pax6 binding sites in these 
elements.  
Figure 4.8 shows TADs in vicinity to the Cdca7 genomic locus (chromosome 
2:72314276-72324947; mouse mm9) on mouse chromosome 2. The Pax6 ChIP-seq 
data was also added to illustrate Pax6 binding sites within this region (Sun et al., 
2015). The TAD covering the Cdca7 genomic region spans chr2:72040001 to 
73280000 and contains two Pax6 binding sites according to the ChIP-seq result. The 
two sites locate downstream to the Cdca7 genomic locus, they are 600kb and 800kb 
away from the Cdca7 transcription start site and might serve as distal regulatory 
elements for Cdca7 expression.  
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Figure showing the topological associated domain (TAD, black bar) that covers the 
Cdca7 genomic region (red square). Pax6 binding sites from ChIP-seq data were 
overlayed as orange lines. Two Pax6 binding sites could be seen downstream of the 
Cdca7 genomic region.  
(Hi-C browser http://promoter.bx.psu.edu/hi-c/download.html, (Dixon et al., 2012)). 
 
Figure 4.8 The topological associated domain and Pax6 binding sites near 
the Cdca7 genomic region.  
 
Figure 1.2045 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2046 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2047 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2048 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2049 Optimal Pax6 binding motifs for in silico predictions. 
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Figure showing three different epigenetic marks in the TAD that covers the Cdca7 
genomic region (marked in red square). H3K27ac and H3K4me1 are the enhancer 
marks and H3K4me3 is the promoter region mark.   
 
Figure 4.9 Epigenetic marks in the TAD covering the Cdca7 genomic region. 
 
Figure 1.2108 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2109 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2110 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2111 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2112 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2113 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2114 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2115 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2116 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2117 Optimal Pax6 binding motifs for in silico predictions. 
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Figure 4.9 shows epigenetic marks within the TAD containing the Cdca7 genomic 
region (Barski et al., 2007; Wang et al., 2008). Overlaying of the putative Pax6 
binding regions with both promoter marker H3K4me3 and enhancer markers 
H3K4me1 and H3K27ac (GEO no. GSE60838) (Reilly et al., 2015) showed that one 
putative region at ch2: 72981193 co-localised with the enhancer marker H3K4me1. 
This region was further analysed for Pax6 binding motifs using JASPAR database 
(jaspar.genereg.net/). The score threshold was set at 80 % and a putative binding 
motif was identified within this region. The sequence of this motif was aligned with 
equivalent loci in multiple species using UCSC genome browser, and homologous 
sequences of this motif were found  between human, mouse, rat and many other 
model organisms (Figure 4.10), increasing the likelihood that this motif is a genuine 
Pax6 binding site in the physiological environment. Further validations using 
luciferase assay and ChIP are required to confirm this finding. 
Similar strategy was performed to screen for putative Pax6 binding sites around and 
within the Cdca7 genomic locus containing the promoter marker H3K4me3.  A 
region close to the Cdca7 transcription start site is enriched with H3K4me3 
(Figure4.11A). Further analysis of this region by JASPAR revealed two potential 
Pax6 binding sites, one of which is conserved between species (summary in 
Table4.3). Same analysis was also applied to the regions enriched with enhancer 
marks H3K4me1 and H3K27ac. Although all enhancer-enriched regions within the 
same TAD as Cdca7 locus should be screened for Pax6 interaction, in this case there 
were no other Pax6 binding sites suggested by Pax6 ChIP-seq within this region, 
therefore only the 15kb region flanking Cdca7 genomic locus was included in the 
analysis to maximise the possibility of getting genuine hits. Screening of Pax6 
binding motifs in the entire TAD region that covers the Cdca7 genomic locus could 
not be achieved by JASPAR website due to the size of fragment, therefore the 
analysis was done via MEME suite (meme-suite.org). Figure4.11B shows 3 putative 
Pax6 binding sites in vicinity to the Cdca7 locus were found in regions enriched with 
H3K27ac, and 2 sites were found in regions enriched with H3K4me1. Amongst the 
predicted sites, 2 of which were conserved across multiple species. All predicted 
sites are summarised in Table4.3. 
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In summary, combining data from Hi-C, Pax6 ChIP-seq, epigenetic marks screening 
and conservation analysis, I have found 3 potential Pax6 binding sites which may 
regulate the expression of Cdca7. These motifs require further experimental 
validations for Pax6 binding and their regulatory role in Cdca7 transcription. These 
validations will provide direct evidence for the role of Pax6 in controlling Cdca7 
expression, and whether the regulatory function is achieved by direct or indirect 
binding.   
Earlier in this chapter, six putative Pax6 binding sites were found by in silico 
prediction, none of which possess binding affinity to Pax6 in the experimental 
validation. Luciferase assays suggested possible inhibitory effect of Pax6 on Cdca7 
expression, however this effect was only present when the environmental Pax6 
protein level was limited. This result revealed a complex role of Pax6 in Cdca7 
regulation, possibly involving additional regulatory factors such as the E2f and Sox 
family members, in agreement with previous studies on the effect of Pax6 on genes 
downstream of E2f. The in vivo function of Cdca7 during neural development 
remains elusive. In the next chapter, I will be investigating the biological role of 
Cdca7 during neurogenesis in the mouse cortex. 
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One of the Pax6 binding sites predicted by ChIP-seq in the mouse embryonic cortex 
was shown to overlap with the enhancer mark H3K4me1. Multi-species alignment of 
the motif found that the sequence was evolutionary conserved, suggesting the motif 
was of physiological importance.  
 
 
Figure 4.10 Evolutionary conservation test on one of the predicted binding 
sites. 
 
Figure 1.2171 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2172 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2173 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2174 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2175 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2176 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2177 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2178 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2179 Optimal Pax6 binding motifs for in silico predictions. 
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Figures showing regions enriched with the promoter mark H3K4me3 (A) and 
enhancer mark H3K27ac and H3K4me1 (B). All enriched peaks are shown in black 
bars.  
 
Figure 4.11 Epigenetic marks found within and close to the Cdca7 genomic 
region. 
 
Figure 1.2234 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2235 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2236 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2237 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2238 Optimal Pax6 binding motifs for in silico predictions. 
 
Figure 1.2239 Optimal Pax6 binding motifs for in silico predictions. 
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1 PH0132.1 72315312 72315327 TACTTATTTAAGTGAT N 
2 PH0132.1 72315593 72315608 CTACTAATCAATTTAA Y 
3 P6CON 72981187 72981199 TTTCCTCATCAGTT Y 
4 P6CON 72317349 72317362 TTTACAAATGATTT Y 
5 PH0132.1 72318432 72318447 TGATAAAATAGTTCTA N 
6 PH0132.1 72319004 82319019 TTACTAATTGAGACAG N 
7 P6CON 72319437 72319450 TTTATGGATGAACT N 
Conservation test was carried out by pairwise comparison and for example the sequence 
similarity between mouse and human of binding 2 is 75%.  
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Chapter 5 : Understanding functions of Cdca7 in cortical 
progenitor cells 
5.1 Introduction 
5.1.1 Pax6 regulates the proliferation and differentiation of neural 
progenitors 
Radial glia cells (RGC) or apical progenitors (APs) reside and divide in the 
ventricular zone (VZ) of the dorsal telencephalon and give rise to glutamatergic 
neurons in the cerebral cortex (Heins et al., 2002; Malatesta et al., 2000; Miyata et 
al., 2001; Noctor et al., 2001). Another type of progenitor cells are named 
intermediate progenitor cells (IPCs) or basal progenitors (BPs): they are derived from 
asymmetric division of RGC located in the subventricular zone (SVZ) and also give 
rise to glutamatergic neurons (Haubensak et al., 2004; Miyata et al., 2001; Noctor et 
al., 2001). RGCs either undergo symmetric division to produce two RGCs and 
maintain the progenitor pool or asymmetric divisions to produce one RGC and one 
IPC or one neuron (Haubensak et al., 2004; Huttner andKosodo, 2005; Kawaguchi et 
al., 2004; Noctor et al., 2004). IPCs form a large inner SVZ and outer SVZ and 
undergo several rounds of division in primates, while in rodents IPCs reside in the 
SVZ and can only divide once to produce two neurons per cell (Fietz andHuttner, 
2011; Götz andHuttner, 2005). Identification of the two distinct progenitor 
populations as well as the post-mitotic neurons depends on their morphologies, 
anatomical positions as well as their expression of molecular markers. During the 
differentiation process in the neocortex, transcription factors Pax6, Tbr2 and Tbr1 are 
expressed in the RGC, IPC and post-mitotic neurons, respectively (Englund et al., 
2005), therefore these proteins are widely used as cell type-specific molecular 
markers. Unlike the Tbr2-expressing IPCs in the cerebral cortex, IPCs in the 
thalamus specifically express Olig2 and Olig3; they also express Neurogenin1 
(Ngn1) and Neurogenin2 (Ngn2), which are also detected in the cortex (Wang et al., 
2011). 
A previous experiment has found that loss of Pax6 in Pax6+/+↔Pax6−/− chimeras 
produced a reduced number of neurons. The decreased neurogenesis is due to an 
early depletion of progenitor pools and also a population of immaturely derived IPCs 
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which fail to express the Tbr2 marker. These defects indicate that Pax6 is essential 
for neurogenesis and Tbr2 expression in a cell-autonomous fashion (Quinn et al., 
2007). 
Apart from regulating neurogenesis in the neocortex, Pax6 also controls the balance 
between proliferation and differentiation of progenitors in the spinal cord. High 
levels of Pax6 can drive progenitors to exit the cell cycle and differentiate by 
upregulating Ngn2, which reduces the expression of Pax6 by negative feedback in 
cells that have committed to differentiation (Bel-Vialar et al., 2007).  
Pax6 is also found to regulate cell fate in mitral cells, a type of glutamatergic neuron 
in the olfactory bulb (OB). Mitral cells derive from Pax6+ cells. Pax6 levels are 
down-regulated in this type of cells while Tbr1 and Tbr2 levels are increased. 
Overexpression of Pax6 in the embryonic OB causes a reduced proportion of Tbr1+ 
Tbr2+ mitral progenitor cells and fewer progenitors commit to being mitral cells, 
indicating that Pax6 also affects cell fate in the OB (Imamura andGreer, 2013).  
 
5.1.2 Cell cycle kinetics change during neural differentiation 
During neurogenesis in mice, the total duration of a cell cycle is elongated from 8.1 
hours at E11 to 18.4 hours at E16, during which the length of G1 phase is 
correspondingly increased from 3 hours to 12 hours (Takahashi et al., 1995). This 
correlation indicates that the length of G1 phase is a good representation of the total 
duration of a cell cycle. An early model has proposed a cell-cycle length hypothesis 
in which a lengthened G1 can ultimately affect cell fates. The hypothesis assumes 
that the determinants of cell fate are unequally distributed between the two daughter 
cells. When the length of G1 reaches a critical threshold allowing enough 
environmental as well as intrinsic signals to be involved, the daughter cell which 
inherits more cell fate determinants will commit to differentiative division while the 
other daughter remains proliferative (See also Ch1.1.4 and Figure 1.4) (Calegari 
andHuttner, 2003; Götz andHuttner, 2005).  
Whether the prolonged G1 phase, and therefore the total cell cycle, is the cause or the 
consequence of neural differentiation remains elusive, but the theory described above 
couples G1 lengthening with fate decisions in stem cells (Lange andCalegari, 2010; 
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Orford andScadden, 2008; Singh andDalton, 2009). Various previous studies have 
manipulated the length of G1 by targeting CDKs and cyclins in cortical neural 
progenitors and have shown that the lengthened G1 triggers differentiation and 
inhibits proliferation (Calegari andHuttner, 2003; Glickstein et al., 2009; Lange et 
al., 2009; Pilaz et al., 2009). However this observation was only done in a broad 
view of the whole cortex regardless of different regions. A recent study at the single 
cell scale provides further support for this theory (Roccio et al., 2013). Using 
fluorescent ubiquitylation-based cell-cycle indicator (Fucci) probes to track the 
fluorescent intensity of single cells, new categorical markers were applied to separate 
proliferative neural stem cells (NSCs) from differentiative NSCs as they emit 
different fluorescent intensities in G1. The study further concluded that in more 
primitive stem cells, the length of G1, as well as the ratio of G1 to total cell cycle, is 
shorter compared to differentiated cells (Roccio et al., 2013). 
Manipulation of G1 period normally involves regulation of Cdks and cyclins (Lange 
andCalegari, 2010). Retinoblastoma protein (Rb) is one of the downstream targets of 
Cdk4 and Cdk6 (Khleif et al., 1996). Hypophosphorylated Rb forms a complex with 
E2f factors in the cytoplasm, which prevents E2fs from activating their downstream 
targets involved in cell cycle progression (Chittenden et al., 1991; Lees et al., 1993). 
Through direct inhibition of Cdk6 production, Pax6 regulates cell cycle progression 
by reducing Rb phosphorylation (Mi et al., 2013). Previous studies have observed a 
shortening of the cell cycle in the cortex at E12.5 in Pax6Sey/Sey embryos (Estivill-
Torrus et al., 2002; Mi et al., 2013), however the downstream mechanisms behind 
the shortening are still unclear. Given Cdca7 is one of the direct targets of E2f1 
(Goto et al., 2006) and the activity of E2f1 is influenced by the phosphorylation of 
Rb, understanding the biological functions of Cdca7 in the development of cortex 
and whether Cdca7 is one of the Pax6-downstream facilitators causing the shortened 
cell cycle in Pax6Sey/Sey mutants will provide a molecular paradigm of how Pax6 
regulates cell differentiation. Therefore, in this chapter, I manipulated the protein 
level of Cdca7 in vivo by in utero electroporation in the developing cortex of mouse 
embryos at E12.5 and E14.5, and observed the alterations of neurogenesis. 
Overexpression of Cdca7 in vivo may mimic the physiological situation in Pax6Sey/Sey 
The regulatory role of Pax6 on Cell Division Cycle Associated 7 and cortical progenitor cell proliferation 
Chapter 5: Understanding functions of Cdca7 in cortical progenitor cells 145 
 
cortex where the protein level is up-regulated. Therefore a shortening of the duration 
of the cell cycle as well as fewer neurons are expected to be observed.   
  
5.2 Results 
5.2.1 Overexpression of Cdca7 in vitro 
It is known that Cdca7 is up-regulated in Pax6Sey/Sey cortex but the exact functions of 
the protein are still unclear. To investigate its role in brain development, I adopted an 
in utero electroporation approach to overexpress Cdca7 in mouse embryonic cortex.  
Cdca7 expression clone MG205975 containing Cdca7 cDNA open reading frame 
(ORF, accession number NM_025866) sequence was ordered from Origene 
Technologies. This clone was used as the template DNA for PCR amplification to 
generate Cdca7 ORF with an influenza hemagglutinin (HA) epitope sequence, tagged 
at the N-terminal or the C-terminal of the Cdca7 cDNA sequence in order to 
distinguish this ectopically expressed protein from the endogenous form and to allow 
the protein to be detected in vivo. The HA-tagged Cdca7 ORF was cloned into an 
pCAGGS_IRES-NLS-GFP (Figure 5.1A) (Persson et al., 2002) plasmid for in utero 
electroporation, the vector expressing the N-terminal HA tag was named p_CAGGS-
IRES-NLS-GFP_N-HA-Cdca7 (Figure 5.1B), while the vector expressing the C-
terminal tag was named pCAGGS_IRES-NLS-GFP_C-HA-Cdca7 (referred to as N-
Cdca7 and C-Cdca7 respectively in the following text). 
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(A) pCAGGS_IRES-NLS-GFP plasmid was previously used for in utero electroporation 
(Persson et al., 2002). GFP transcript is translated by an internal ribosome entry site (IRES) 
sequence and the protein is transported into nucleus by its NLS signal peptide. There is also 
an ampicillin resistance gene for colony selection. (B-C) Cdca7 expression sequence (cDNA 
ORF, NM_025866) was amplified from Clone MG205975 (OriGene Technologies) and then 
inserted into pCAGGS_IRES-NLS-GFP plasmid at the NheI restriction enzyme site. Cdca7 
gene expression is driven by the CAG promoter. Cdca7 cDNA sequence is followed by the 
stop codon sequences for all three reading frames. An influenza hemagglutinin (HA) epitope 
sequence was added at the N-terminal (B) or C-terminal (C) of the Cdca7 ORF for protein 
detection by immunofluorescence and the plasmid is called p_CAGGS-IRES-NLS-
GFP_N-HA-Cdca7 (N-Cdca7) or p_CAGGS-IRES-NLS-GFP_C-HA-Cdca7 (C-

































































Figure 5.1 Cdca7 expression clones for in utero electroporation.  
 
 
Figure 1.2482 Cdca7 expression clones for in utero electroporation.  
 
 
Figure 1.2483 Cdca7 expression clones for in utero electroporation.  
 
 
Figure 1.2484 Cdca7 expression clones for in utero electroporation.  
 
 
Figure 1.2485 Cdca7 expression clones for in utero electroporation.  
 
 
Figure 1.2486 Cdca7 expression clones for in utero electroporation.  
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To validate the expression of the HA-tagged Cdca7 protein by the C-Cdca7 plasmid, 
the vector was transiently transfected into HEK293 cells. At 48 hours post 
transfection, cell lysates were collected for a western blotting analysis using an 
antibody against the HA epitope (Figure 5.2A). An antibody against GAPDH was 
used as a loading control. The expression of Cdca7 was found to correlate with the 
level of transfected vector, suggesting that Cdca7 was produced by the plasmid and 
this protein can be recognised by the anti-HA antibody.   
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(A)  IRES-NLS-GFP_pCAGGS (Control) or C-Cdca7 plasmid was transiently transfected 
into HEK293 cells. Cell lysates were collected 48 hours post transfection and Cdca7 
expression was verified using an antibody against the HA epitope. The molecular weight of 
Cdca7 was approximately 43 kDa. GAPDH was used as loading control. (B) After 
confirming the protein expression from the transfected Cdca7 clone, IRES-NLS-
GFP_pCAGGS, N-Cdca7 or C-Cdca7 plasmid was used for in utero electroporation. 1-2 µg 
of plasmids were injected into the first ventricle of embryos at E12.5 or E14.5 and plasmids 
were forced to enter the cortex region by electrical voltage. Plasmids were left in vivo for 16 
hours to allow protein expression and 5-Bromo-2’-deoxyuridine (BrdU) was injected 




























































Figure 5.2 In vitro expression of Cdca7 and in utero electroporation paradigm. 
 
Figure 1.2972 In vitro expression of Cdca7 and in utero electroporation 
paradigm. 
 
Figure 1.2973 In vitro expression of Cdca7 and in utero electroporatio  
paradigm. 
 
Figure 1.2974 I  vitro expression of Cdca7 and in utero lectroporation 
paradigm. 
 
Figure 1.2975 In vitro expression of Cdca7 and in utero electroporation 
paradigm. 
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5.2.2 Overexpression of Cdca7 in vivo 
Wild-type CD1 pregnant females carrying E12.5 or E14.5 embryos were used for in 
utero electroporation. Electroporations were normally performed between 1-4 pm 
and either control or the Cdca7 expression vector was left for 16 hours before the 
embryos were terminated. Single doses of the thymidine analog, 5-bromo-2'-
deoxyuridine (BrdU), were given to pregnant females via intraperitoneal injection 30 
minutes before the animals were culled (Figure 5.2B).  
To assess the efficiency of the transfected Cdca7 expression vector, embryos were 
collected at 16 hours post electroporation, they were fixed and cryo-sectioned for 
immunofluorescence staining. In the original experiment design, antibody against the 
HA epitope was expected to identify Cdca7 expressed by the plasmids in vivo. 
However the immunofluorescence staining using HA antibody did not produce a 
specific staining pattern (data not shown). Alternatively, in this experiment, a 
polyclonal antibody against Cdca7 which detects both endogenous and exogenous 
forms of the protein was used instead. Figure 5.3 shows the expression of Cdca7 and 
GFP by N- Cdca7 and C- Cdca7 plasmids. It was found that the Cdca7 antibody can 
recognise the overexpressed Cdca7 protein regardless of the HA-tag position. GFP 
expression signal was detected in the nucleus with the help of its nuclear localization 
sequence (NLS). In the overlaid channel, co-localisation of Cdca7 and GFP proteins 
was observed in samples overexpressing either the N-terminal or C-terminal HA tag 
construct. Contralateral sections representing the opposite hemisphere of the same 
embryos demonstrated there was no expression leaking to the other hemisphere after 
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Figure 5.3 Validation of in utero expression of Cdca7 after elec roporation. 
 
Figure 1.3526 Validation of in utero expression of Cdca7 after 
electroporation. 
 
Figure 1.3527 Validation of in utero expression of Cdca7 after 
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Figure 5.3 Validation of in utero expression of Cdca7 after electroporation.  
 
1-2 µg of N-Cdca7 or C-Cdca7 plasmid was used for in utero electroporation at E12.5. 16 
hours post electroporation, embryos were harvested, PFA-fixed, cryo-protected and 
sectioned and immunofluorescence stained. Antibody against Cdca7 was able to detect both 
endogenous and exogenous (overexpressed by the plasmid) Cdca7. GFP positive cells 
represent electroporated cells. (A-C’) Sections from N-Cdca7-electroporated embryos were 
stained to detect co-expression of Cdca7 and GFP. The electroporation target area was close 
to the ventral-most area of the dorsal telencephalon and the PSPB. Most cells with intensive 
Cdca7 staining, which indicates the plasmid-driven overexpressed protein, overlap with GFP 
staining, suggesting the Cdca7 overexpression couples with the expression of GFP in the 
nucleus of the same cells. (D) Contralateral photo of the same section in 5.3A-C showing the 
specificity of the electroporation with no GFP expression in the other hemisphere. (E-G’) 
Sections from C-Cdca7-electroporated embryos were stained to detect co-expression of 
Cdca7 and GFP. The electroporation target area was also close to the ventral-most region of 
the dorsal telencephalon and the PSPB. Cdca7 was highly expressed in cells with GFP 
protein expression, indicating that the exogenous plasmid-driven Cdca7 was co-expressed 
with GFP in the same cells. (H) Contralateral photo of the same section in 5.3E-G showing 
the specificity of the electroporation with no GFP expression in the other hemisphere. (Scale 
bars =100µm) 
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5.2.3 Understanding biological functions of Cdca7 in the 
developing cortex   
The target area of the plasmid delivery during the in utero electroporation spanned 
from the ventral-most part of the dorsal telencephalon (dTel) to the PSPB, where the 
expression of Pax6 and Cdca7 is the strongest and weakest, respectively. At 16 hours 
post electroporation, embryos were collected and their GFP expression was observed 
under a fluorescence microscope. The GFP+ embryos then underwent fixation, 
cryosection and immunofluorescence staining to assess the expression of a number of 
marker proteins.  
To understand whether the overexpressed Cdca7 affects the production of IPCs, 
sections from the control, N-Cdca7 or C-Cdca7 plasmid-electroporated group were 
stained with antibodies against GFP and Tbr2. By counting the percentage of Tbr2+ 
cells in the total electroporated cells (ie. GFP+ cells), it was found that at E13.5 the 
percentage of the Tbr2+ population was much lower in the C-Cdca7-transfected 
group (36%, n=3) than that in the control (47%, n=4) and the N-Cdca7 group (45%, 
n=4, P<0.05, Student’s t-test) (Figure 5.4). This indicates that the overexpressed C-
terminal HA-tagged Cdca7 had an impact on the generation of IPCs. The 
overexpressed N-Cdca7 plasmids did not cause the same effect as the C-Cdca7 but 
produced a similar result as the control construct. The function of N-terminal HA-
tagged Cdca7 protein in vivo is yet to be elucidated but it was eliminated at the later 
time point, E15.5, in this experiment.  
At E15.5, the population size of IPCs seemed unrelated to the level of Cdca7 protein, 
as a similar proportion of Tbr2+ cells was observed between the control (39.9%, n=3) 
and the C-Cdca7 group (38.3%, n=4, P= 0.8, Student’s t-test ) (Figure 5.5). Therefore 
in terms of IPC production, the overexpressed Cdca7 may only be effective at E13.5 
but not at a later stage, namely E15.5. 
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Figure 5.4 Overexpression of Cdca7 at E12.5 prevents the production of 
intermediate progenitor cells. 
 
Figure 1.3653 Overexpression of Cdca7 at E12.5 prevents the production of 
intermediate progenitor cells. 
 
Figure 1.3654 Overexpression of Cdca7 at E12.5 prevents the production of 
intermediate progenitor cells. 
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Figure 5.4 Overexpression of Cdca7 at E12.5 prevents the production of 
intermediate progenitor cells.  
Embryos collected from the control, N-Cdca7 and C-Cdca7 treatment groups at E12.5 were 
processed as described in Figure 5.2B. Fixed and cryo-protected embryos were sectioned and 
stained using antibodies against Tbr2 and GFP. Tbr2+ cells represent the intermediate 
progenitor cells (IPCs). (A,C,E) All the three plasmids were expressed close to the ventral-
most part of the dorsal telencephalon. High magnification views in Panel B’, D’ and F’ 
representing the indicated 200µm2 areas enlarged from Panel B, D and E, respectively. (A-
B’) Photos showing the expression of Tbr2 and GFP in vivo in an embryo electroporated 
with the control plasmid. High magnification image in Panel B’ indicates the expression of 
Tbr2 in the electroporated cells (arrows). (C-D’) A representative section from an N-Cdca7-
electroporated embryo stained for Tbr2 and GFP. High magnification image in Panel D’ 
indicating the expression of Tbr2 in the electroporated cells (arrows). (E-F’) A representative 
section showing the expressions of Tbr2 and GFP in the C-Cdca7 group. High magnification 
image in Panel F’ showing the overlapped expressions of Tbr2 and GFP (arrows; all scale 
bars: 50µm). (G) Bar chart showing the proportion of Tbr2+ cells in the total electroporated 
cells in each plasmid group. IPCs make up 47% of all electroporated cells in the control 
group (n=4) and 45% in the N-Cdca7 (n=4) group, the difference between the two groups is 
not statistically significant; The C-Cdca7 group has 36% of all electroporated cells being 
IPCs (n=3), this proportion is significantly lower than those in the control and the N-Cdca7 
groups (P<0.05, Student’s t-test).   
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Figure 5.5 Overexpression of Cdca7 at E14.5 does not alter the production of 
intermediate progenitor cells. 
 
Figure 1.4207 Overexpression of Cdca7 at E14.5 does not alter the production 
of intermediate progenitor cells. 
 
Figure 1.4208 Overexpression of Cdca7 at E14.5 does not alter the production 
of intermediate progenitor cells. 
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Figure 5.5 Overexpression of Cdca7 at E14.5 does not alter the production of 
intermediate progenitor cells.  
Embryos receiving either control or C-Cdca7 plasmid at E14.5 were collected as previously 
described in Figure 5.2B. All sections were fixed and stained for Tbr2 and GFP expressions. 
High magnification views in Panel B’ and D’ represent the 200µm2 areas enlarged from 
Panel B, and D, respectively. (A-B’) Electroporated cells (GFP+) from the control group 
locate at the ventral-most part of the dTel and the high magnification view in Panel B’ 
showing cells co-expressing GFP and the IPC marker Tbr2 (indicated by arrows). (C-D’) 
Electroporated cells from C-Cdca7 group locate at the dTel similarly to the cells in the 
control group. High magnification image in Panel D’ showing IPCs (Tbr2+) co-expressing 
marker for electroporated cells (GFP) (arrows, all scale bars: 50µm). (E) Bar chart 
representing the abundance of IPCs (Tbr2+) in the total electroporated cells (GFP+) in the 
two plasmid groups. IPCs in the control (n=3) and the C-Cdca7 (n=4) groups are 39.9 % and 
38.3% of all electroporated cells, respectively, and there is no significant difference between 
the groups (P=0.8, Student’s t-test). The results indicate that at middle stage of neurogenesis, 
overexpression of Cdca7 does not affect the production of IPCs. 
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To characterise the role of Cdca7 in terminal differentiation from RGCs into neurons, 
the same experiment was performed to monitor neuron production and Tbr1 was 
used to mark the post-mitotic neurons (Englund et al., 2005). In Figure 5.6 it was 
observed that the overexpression of C-Cdca7 in utero caused a reduced production of 
neurons at E13.5. The mean percentage of Tbr1+ cells in the total population of GFP+ 
cells was 13% in the C-Cdca7 group (n=3) compared to 20% in the control (n=4, 
P<0.05) and 22% in the N-Cdca7 group (n=3, P<0.05, Student’s t-test). No 
difference was observed in the neuron population size between the control and the N-
Cdca7 group (P=0.5, Student’s t-test). 
At E15.5, the GFP+ cells expressing the electroporated plasmids does not overlap 
with the Tbr1+ cells in both the control (n=4) and the C-Cdca7 group (n=4) (Figure 
5.7). This suggests that at 16 hours post electroporation, the electroporated cells did 
not have sufficient time to differentiate into neurons.  It may also mean that the 
electroporated cells were not able migrate to the Tbr1+ territory as the cortex has 
grown much bigger at E15.5 than at E13.5. 
The results from the two experiments indicate that overexpression of Cdca7 in the 
ventral-most part of the dTel close to the PSPB area affects regional IPC as well as 
neuron production especially in the early stage of the neurogenesis. To estimate the 
proportion of cells undergoing cell cycle progression, embryos from pregnant female 
mice receiving the control, N-Cdca7, or the C-Cdca7 plasmid via in utero 
electroporation at E12.5 or E14.5 were given a single dose of BrdU injected 30 
minutes before the animals were culled. BrdU, as a thymidine analog, incorporates 
into newly synthesised DNA during S-phase of the cell cycle. The embryos were 
fixed and cryo-protected and the spatial distribution of BrdU+ and GFP+ cells on the 
sections were revealed by double immunofluorescent staining.  
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Figure 5.6 Overexpression of Cdca7 at E12.5 prevents the prod ction of post-
mitotic neurons. 
 
Figure 1.4761 Overexpression of Cdca7 at E12.5 prevents the production of 
post-mitotic neurons. 
 
Figure 1.4762 Overexpression of Cdca7 at E12.5 prevents the production of 
post-mitotic neurons. 
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Figure 5.6 Overexpression of Cdca7 at E12.5 prevents the production of post-
mitotic neurons.   
Embryos receiving either the control, N-Cdca7 or C-Cdca7 plasmid at E12.5 were collected 
as previously described in Figure 5.2B. All sections were fixed and stained for GFP (marker 
for electroporated cells) and the neuronal marker Tbr1. (A,C, E) GFP+ cells locate at the 
ventral-most part of the dorsal telencephalon in all groups. High magnification views in 
Panel B’, D’ and F’ are enlarged from the 150µm-wide rectangles in Panel B, D and F, 
respectively. (A-B’) A representative section in the control group. High magnification image 
in Panel B’ showing cells co-expressing Tbr1 and GFP (indicated by arrows). (C-D’) A 
representative section in the N-Cdca7 group. High magnification image in Panel D’ showing 
cells co-expressing Tbr1 and GFP (indicated by arrows). GFP staining also labels cellular 
process. (E-F’) A representative section in the C-Cdca7 group. Cells with overlapping 
expressions of Tbr1 and GFP are shown in F and F’ (indicated by arrows, all scale bars: 
50µm.) (G) The abundance of neurons in all electroporated cells is 20.3%, 22% and 13.1% 
in the control (n=4), the N-Cdca7 (n=3) and the C-Cdca7 (n=3) group, respectively. The 
difference between the C-Cdca7 group and the control or the N-Cdca7 group is statistically 
significant (P<0.05, Student’s t-test) while the difference between the control and the N-
Cdca7 group is not statistically significant (P=0.5, Student’s t-test.). These results suggest 
that overexpression of Cdca7 can reduce the production of post-mitotic neurons.   
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Embryos electroporated with the control or the C-Cdca7 plasmid at E14.5 were collected as 
described in Figure 5.2B. All sections were fixed and stained for GFP (marker for 
electroporated cells) and the neuronal marker Tbr1. The electroporated cells locate close to 
the ventral-most part of the cerebral cortex (Ctx). (A-C) A representative section in the 
control vector group showing the location of the electroporated cells (GFP+) and the neurons. 
The two cell populations do not appear to overlap. (D-F)  A representative section in the C-
Cdca7 group showing the location of the electroporated cells and the neurons. Similar to the 
control group, the two cell populations do not overlap (all scale bars: 50µm). These results 
may suggest that within 16 hours, the electroporated cells have not had enough time to 
differentiate into post-mitotic neurons at E15.5.  
Figure 5.7 Overexpression of Cdca7 at E14.5 does not affect the production of 
post-mitotic neurons. 
 
Figure 1.5315 Overexpression of Cdca7 at E14.5 does not affect the 
production f post-mitotic neurons. 
 
Figure 1.5316 Overexpressi  of Cdca7 at E14.5 does not affect the 
producti n of post-mitotic neurons. 
 
Figure 1.5317 Overexpression of Cdca7 at E14.5 does not affect the 
production of post-mitotic neurons. 
 
Figure 1.5318 Overexpression of Cdca7 at E14.5 does not affect the 
production of post-mitotic neurons. 
 
Figure 1.5319 Overexpression of Cdca7 at E14.5 does not affect the 
production of post-mitotic neurons. 
 
Figure 1.5320 Overexpression of Cdca7 at E14.5 does not affect the 
production of post-mitotic neurons. 
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Figure 5.8 shows the abundance of BrdU+ cells in the total electroporated GFP+ cells 
at E13.5. The target area for the plasmid delivery was close to the ventral-most part 
of the dTel, where the expression of Cdca7 is the lowest across the telencephalon. 
High-magnification images shown in panel B’, D’ and F’ of Figure 5.8 displayed 
overlapping expressions of BrdU and GFP in the control, N-Cdca7 and the C-Cdca7 
groups, respectively. At E13.5, the mean percentage of BrdU incorporation in total 
GFP+ cells was 32% in the control (n=4), 27.7% in the N-Cdca7 (n=3) and 28.6% in 
the C-Cdca7 groups (n=3) and there were no significant differences between the 
groups. 
At E15.5, the abundance of BrdU+ cells in the total population of electroporated 
GFP+ cells is shown in Figure 5.9. Panel A-B and C-D represent embryos receiving 
the control and the C-Cdca7 plasmid, respectively. A co-expressing pattern of BrdU 
and GFP can be observed in the high-magnification images in Panel B’ and D’. 
21.8% and 27.5% of the total electroporated GFP+ cells in the control (n=3) and the 
C-Cdca7 (n=4) group, respectively, were BrdU+, there was no significant difference 
between the groups (P=0.39, Student’s t-test). The results of the BrdU incorporation 
experiment suggest that there is no difference in DNA synthesis nor cell division rate 
between the control and the Cdca7-overexpressing samples at both E13.5 and E15.5. 
However, whether there is a difference in the type of cells that undergo DNA 
synthesis between the two groups remains unclear. It is also unknown if cell cycling 
duration varies when Cdca7 level is manipulated. 
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Figure 5.8 Overexpression of Cdca7 at E12.5 does not affect the cell division 
rate in the cortex. 
 
Figure 1.5869 Overexpression of Cdca7 at E12.5 does not affect the cell 
division rate in the cortex. 
 
Figure 1.5870 Overexpression of Cdca7 at E12.5 does not affect the cell 
division rate in the cortex. 
 
Figure 1.5871 Overexpression of Cdca7 at E12.5 does not affect the cell 
division rate in the cortex. 
 
The regulatory role of Pax6 on Cell Division Cycle Associated 7 and cortical progenitor cell proliferation 
Chapter 5: Understanding functions of Cdca7 in cortical progenitor cells 163 
 
 
                       







Figure 5.8 Overexpression of Cdca7 at E12.5 does not affect the cell division 
rate in the cortex.  
Embryos electroporated with the control, N-Cdca7 or C-Cdca7 plasmid at E12.5 were 
collected and processed as described in Figure 5.2B. Fixed and cryo-protected embryos were 
sectioned and stained using antibodies against BrdU and GFP. BrdU incorporation identifies 
cells in the DNA synthesis phase or S phase of the cell cycle, while GFP marks the cells 
receiving the electroporated plasmid. (A,C,E) The electroporated cells locate close to the 
ventral-most part of the dTel in all three groups. High magnification views in Panel B’, D’ 
and F’ are enlarged from the 200µm2 square area in Panel B, D and F, respectively. (A-B’) A 
representative section in the control group showing the locations of BrdU+ and GFP+ cells. 
High magnification image in Panel B’ showing cells possessing both BrdU incorporation and 
GFP expression (indicated by arrows). (C-D’) A representative section in the N-Cdca7 group 
showing the locations of BrdU+ and GFP+ cells. High magnification image in Panel D’ 
showing cells co-labelled with BrdU and GFP (indicated by arrows). (E-F’) A representative 
section in the C-Cdca7 group showing the locations of BrdU+ and GFP+ cells. High 
magnification image in Panel F’ showing cells co-labelled with BrdU and GFP (indicated by 
arrows, all scale bars: 50 µm). (G) Bar chart showing the frequencies of BrdU+ cells in the 
total electroporated cells (GFP+) in all three groups, which are 32%, 27.7% and 28.6% in the 
control (n=4), N-Cdca7 (n=3) and C-Cdca7 (n=3) group, respectively. There is no significant 
difference between the groups.   
G 
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Figure 5.9 Overexpression of Cdca7 at E14.5 does not affect the cell division 
rate in the cortex. 
 
Figure 1.6220 Overexpression of Cdca7 at E14.5 does not affect the cell 
division rate in the cortex. 
 
Figure 1.6221 Overexpression of Cdca7 at E14.5 does not affect the cell 
division rate in the cortex. 
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Figure 5.9 Overexpression of Cdca7 at E14.5 does not affect the cell division 
rate in the cortex.  
Embryos receiving the control or C-Cdca7 plasmid at E12.5 were collected and processed as 
described in Figure 5.2B. Fixed and cryo-protected embryos were sectioned and stained 
using antibodies against BrdU and GFP. BrdU incorporation identifies cells in the DNA 
synthesis phase or S phase of the cell cycle, while GFP marks the cells receiving the 
electroporated plasmid. (A and C) The GFP+ cells locate in the middle part of the cerebral 
cortex in both groups. High magnification views in Panel B’ and D’ are enlarged from the 
200µm2 square in Panel B and D, respectively. (A-B’) A representative section in the control 
group showing the locations of BrdU+ and GFP+ cells. High magnification image in Panel B’ 
showing cells possessing both BrdU incorporation and GFP expression (indicated by 
arrows). (C-D’)  A representative section in the N-Cdca7 group showing the locations of 
BrdU+ and GFP+ cells. High magnification image in Panel D’ showing cells co-labelled with 
BrdU and GFP (indicated by arrows, all scale bars: 50µm). (E)  Bar chart showing the 
frequencies of BrdU+ cells in the total electroporated cells (GFP+) in both groups, which are  
21.8% and 27.5% in the control (n=3) and the C-Cdca7 (n=4) group, respectively. There is 
no significant difference between the groups (P=0.39, Student’s t-test.) These results suggest 
that overexpression of Cdca7 at E14.5 has no effect on the cell division rate.  
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5.3 Discussion 
5.3.1 Tag fusion protein: pros and cons  
Recombinant proteins containing a fusion polypeptide or an affinity tag are widely 
recognised to have several advantages (Terpe, 2003; Waugh, 2005). Common 
benefits include improved solubility of proteins (Costa et al., 2014; Kapust 
andWaugh, 1999), ease of protein purification (Einhauer andJungbauer, 2001; Lichty 
et al., 2005), increased yield of the recombinant protein (Lee et al., 2008), targeting 
of the protein to specific cellular locations (Pang et al., 2009) as well as enhanced 
detection of the protein in vitro and in vivo (Debeljak et al., 2006; Park et al., 2008). 
As the main application of this technique is to produce recombinant proteins such as 
enzymes and drugs in an economic way and at an industrial scale, the fusion tag must 
not interfere with the structure, function as well as the epitopic recognition of the 
target protein (Waugh, 2005). Additionally, the tag should also be easily removed by 
enzymatic cleavage to produce untagged proteins (Walker et al., 1994). There is no 
single tag sequence that possesses all the advantages, therefore the choice of which 
tag to use mainly depends on the ultimate purpose of the experiment.  
In my experiments, adding a HA tag to the Cdca7-expressing cDNA construct was to 
differentiate the exogenous plasmid-expressed Cdca7 proteins from the endogenous 
form and to visualise the co-expression of Cdca7 and GFP, which are driven by the 
same vector. The in vitro transfection experiment was able to detect the expression of 
the Cdca7 fusion protein using an antibody (Sigma) against the HA epitope (Figure 
5.2). However the HA-antibody produced by Sigma is pre-conjugated with 
horseradish peroxidase (HRP) which did not produce specific staining pattern on 
sections. Therefore another antibody manufactured by Abcam against the HA peptide 
was used for immunofluorescence staining for samples following the in utero 
electroporation. Unfortunately this new antibody did not detect specific HA 
expression from either the N-Cdca7 or the C-Cdca7 groups (data not shown). This 
may be a result of the variations between the manufacturers of the antibodies. A 
previous study has shown that variance in the immunodetection of hexa-His tagged 
proteins arises from different usage of anti-His antibodies and creates false detection 
results (Debeljak et al., 2006).   
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The main problem raised in my experiment was the different effect on neurogenesis 
by the two different HA-tagged Cdca7 fusion proteins. It was observed that both N-
terminal and C-terminal tagged Cdca7 located in the nucleus and was detected by the 
Cdca7 polyclonal antibody (Proteintech) (Figure 5.3). This indicates that the addition 
of the tag sequence does not interfere with the cellular location of Cdca7 protein, as 
well as the epitope recognition of the anti-Cdca7 antibody. Different tagging 
positions, such as the N-terminal, C-terminal or within the ORF, have been used 
widely in other proteins and some tagging-related issues have been identified. A 
previous study has reported that an N-terminal tag affected the expression as well as 
the subcellular localisation of the fusion protein while the C-terminal tagged fusion 
protein appeared to be normal (Palmer andFreeman, 2004). Another report has also 
shown that C-terminal His tag sequence has influences on the folding property of β-
lactamase in the thermophilic Bacillus licheniformis (Ledent et al., 1997). Although 
many studies have claimed that the HA-tag sequence does not interfere with the 
function of the fusion protein (Indraccolo et al., 2002; Lu et al., 2009; Surdej 
andJacobs-Lorena, 1994), there are also evidences showing that adding a short HA 
peptide to the fusion protein has impacts on its cellular localisation (Houle et al., 
2006), protein folding as well as its functions (Brothers et al., 2003; Seamon et al., 
2000; Young et al., 2012). A possible explanation for the discrepancy between the 
two tagged forms of Cdca7 in my experiment is that the N-terminal HA tag may 
cause a folding problem which prevents the normal functions of Cdca7 to be exerted. 
Further studies using protein folding prediction and crystallography are required to 
fully understand the differences between the two forms.   
  
5.3.2 Comparison of progenitor behaviours in Pax6Sey/Sey and 
wild-type with Cdca7 overexpression  
Pax6 was thought to negatively regulate Cdca7 expression based on the mRNA 
expression patterns of two genes (Chapter 3) as well as the up-regulated Cdca7 
expression in Pax6Sey/Sey mice and Pax6 conditional knock-out mice (Manuel, 
unpublished). It is known that Pax6 regulates the length of the cell cycle in a dose-
dependent fashion in the cortex, therefore the shortening of total cycle duration of the 
progenitors in areas with high or moderate levels of Pax6 expression should be 
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affected by the absence of Pax6 (Mi et al., 2013). It has also been observed that the 
production of neurons from E12.5 to E15.5 is insufficient in Pax6Sey/Sey mice 
(Estivill-Torrus et al., 2002).  
The dynamics of Cdca7 and Pax6 expression have been described in Chapter 3 and 
the PSPB is the location where the highest Pax6 expression and the weakest Cdca7 
expression are found in the telencephalon. Therefore in this chapter the target region 
for Cdca7 overexpression is close to the ventral-most part of the dTel, close to the 
PSPB. Cdca7 overexpression in the wild-type cortex, which mimics the upregulation 
of Cdca7 in Pax6Sey/Sey, was able to reduce the production of IPCs and post-mitotic 
neurons at E12.5-E13.5 in mice. These results suggest that Cdca7 is one of the Pax6 
downstream factors which facilitate cell cycle progression. Although the BrdU 
incorporation experiments demonstrated that there was no difference in the rate of 
cell division between the control and the Cdca7-overexpressing groups, the exact cell 
populations which undergo cell division in different groups may be different as it is 
known that cell cycle durations are diverse between cell types (Roccio et al., 2013). 
It is not clear if the length and progression through the cell cycle in neural 
progenitors change between the control and the Cdca7-overexpressed groups. There 
is no direct evidence showing how Cdca7 may modulate the length of G1 phase as 
well as total cell cycle. One study claims that the elongated G1 is not sufficient to 
facilitate differentiation in murine embryonic stem cells (ESCs) (Li et al., 2012). As 
discussed previously, regulation of G1 length is well recognised as a key factor for 
progenitors to select between proliferation and differentiation (Calegari andHuttner, 
2003; Götz andHuttner, 2005). In the future, manipulation of Cdca7 levels in the 
progenitors, followed by identification of changes in the cell cycle kinetics by 
cumulative BrdU injection or with the Fucci method may provide further mechanistic 
details of how Cdca7 affects neural development. 
 
5.3.3 Effects of Cdca7 overexpression in the mid-neurogenesis 
Cdca7 overexpression early in corticogenesis reduced not only the production of 
Tbr2+ intermediate progenitors but also the production of Tbr1+ cells. Division of 
Tbr2+ cells generate Tbr1+ neuronal precursors early in corticogenesis. The average 
length of cell cycle in the cerebral cortex is around 10h at E12.5, which is a few 
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hours shorter than the 16h between electroporation and sacrifice in our experiments 
(Caviness et al., 1995; Takahashi et al., 1995). It seems likely, therefore, that the 
expression plasmid entered some cells that had already started to move to the 
subventricular zone, where they underwent a further division to produce Tbr1+ 
neuronal precursors. At later time point in this experiment, all observed 
electroporated cells (GFP+) were scattered in the VZ or SVZ but none of them have 
migrated to the mentle zone, where Tbr1+ resided. The average length of cell cycle in 
the cerebral cortex at E15.5 is approximately 16 hours, same as the duration from 
electroporation to the end point sacrifice (Takahashi et al., 1995). Since the 
expression of the plasmids commences approximately 6 hours following the 
electroporation (data not shown), ending the experiment too early may prevent the 
overexpressed Cdca7 from affecting the production of neurons, since progenitors 
would have no time to complete a single cell cycle. Pilot study has demonstrated at 
E14.5 that many electroporated cells migrated into the mentle zone 48 hours after 
electroporation, and at E15.5 the majority of electroporated cells were still located in 
the VZ/SVZ (data not shown) 36 hours after electroporation. In order to understand 
the function of Cdca7 in the production of post-mitotic neurons, a longer time frame, 
between 36 to 48 hours, should be used for the experiment. It should be noted that 
Cdca7 may also influence direct neurogenesis in early and mid-neurogenesis. 
Mixture of neuron production from both direct and indirect neurogenesis may be 
observed by leaving the Cdca7 expression plasmid in vivo longer than the duration 
for two or more cycling time, which could mask the effect of Cdca7 on direct 
neurogenesis.  
In summary, the data suggest that overexpressed Cdca7 downregulated the 
production of intermediate progenitors and post-mitotic neurons at early 
neurogenesis (E12.5) but not at mid-neurogenesis (E14.5). This effect is not achieved 
by an overall alteration in proliferation. More likely it is caused by a change in the 
fates of the cells exposed to elevated Cdca7 levels.
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Chapter 6 : General Discussion 
6.1 Summary 
Cdca7 has been thought to be a Pax6 downstream target which may be involved in 
Pax6-related cell cycle regulation in cortical progenitors. The mRNA expression 
pattern of Cdca7 forms a gradient which is high medio-caudally and low latero-
rostrally, opposite to the pattern of Pax6 in both wild-type and PAX77 dTel during 
early corticogenesis (E12.5-E13.5) in mice. However the Cdca7 gradient is lost in 
the Pax6Sey/Sey mutants. The medialhigh to laterallow gradient of Cdca7 is also seen at 
the protein level and the expression of Cdca7 is very weak at the PSPB, where the 
highest protein level of Pax6 is present. 
Figure 6.1 summarises how Pax6 regulates the proliferation of cortical progenitors 
through control of cell cycle kinetics. In wild-type, Pax6 inhibits Cdk6 expression by 
directly binding to the Cdk6 promoter. This inhibition reduces the phosphorylation 
level of Rb and therefore restrains E2f1 from promoting G1/S checkpoint transition. 
In Pax6Sey/Sey mutants where no functional Pax6 protein is present, inhibition of Cdk6 
by Pax6 is lost and the phosphorylation level of Rb is upregulated. The consequential 
loss of binding affinity between hyperphosphorylated Rb and E2f1 enables freed 
E2f1 to enter the nucleus and trigger transcription of its downstream targets. It has 
been observed that the duration of G1 phase as well as total cell cycle length are 
shorter in Pax6 null mutants than in wild-type (Mi et al., 2013). It is also known that 
both the mRNA and protein levels of Cdca7 are upregulated in Pax6-null mutants 
(Mi et al. 2013; Chapter 3; Martine Manuel unpublished). My ChIP validation 
experiment in Chapter 4 has demonstrated that the Cdca7 proximal promoter is 
unlikely to be bound by Pax6, suggesting no direct control of Cdca7 production by 
Pax6, at least through this promoter region. However my experiments have not ruled 
out the possibility of Pax6 binding motifs located within or downstream the Cdca7 
genomic locus or in the distal regulatory elements far upstream to the Cdca7 TSS 
site. Further validations of potential Pax6 binding motifs in these regions are required 
to fully understand the regulatory role of Pax6 on Cdca7 gene expression. 
As shown by the luciferase assays described in Chapter 4, Pax6 is capable of 
inhibiting the activity of the Cdca7 promoter, indicating an effect of Pax6 on Cdca7 
The regulatory role of Pax6 on Cell Division Cycle Associated 7 and cortical progenitor cell proliferation 
Chapter 6: General Discussion 171 
 
transcription. Together these results point to a possibility that Pax6 indirectly 
controls Cdca7 via the Cdk6-Rb/E2f1 pathway, which eventually results in alteration 
of the cell cycle in neural progenitors. Overexpression of Cdca7 by in utero 
electroporation in mouse embryos leads to a decrease of IPCs and post-mitotic 
neurons during early neurogenesis, implying that the function of Cdca7 in vivo is to 
inhibit differentiation or to maintain the proliferative status of RGCs. However it 
remains elusive whether the downregulation of neuron differentiation is directly 
caused by the increased Cdca7 in RGCs and IPCs, or indirectly by the reduced 
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Figure 6.1 The function of Cdca7 in the Pax6-mediated regulation of cell 
cycle progression. 
 
Figure 1.6235 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons.Figure 6.1 The function of Cdca7 in 
the Pax6-mediated regulation of cell cycle progression. 
 
Figure 1.6236 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons. 
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Figure 6.1 The function of Cdca7 in the Pax6-mediaed regulation of cell 
cycle progression. 
Schematic diagrams showing the progression of cell cycle under three different 
physiological conditions. (A) In wild-type, through inhibition of the Cdk6 production, 
Pax6 controls the phosphorylation level of Rb, which further modulates the activity of 
E2f1 and G1/S checkpoint transition (Mi et al., 2013). It was hypothesised that Pax6 
directly regulates Cdca7, but the ChIP validation in Chapter 4 suggests that direct 
regulation is less likely; instead the regulatory role of Pax6 may be mainly through the 
Cdk6-Rb/E2f1 pathway. Cdca7 is a known direct target of E2f1, suggesting it may 
facilitate G1/S transition. (B) In Pax6Sey/Sey where no functional Pax6 protein is produced, 
the dysregulation of Cdk6 results in an increased level of Rb phosphorylation, which 
correlates with the increased free E2f1 as well as activation of E2f1-downstream targets 
such as Cdca7. It is also noted that the duration of G1 phase and total cell cycle length is 
shortened at E12.5 in Pax6Sey/Sey embryos (Mi et al., 2013). (C) Overexpression of Cdca7 
by in utero electroporation in mouse embryos results in decreased IPCs and post-mitotic 
neurons. However it is not clear whether the downregulation of neuron production is 
directly due to the role of Cdca7 on neuron differentiation, or indirectly caused by the 
reduced number of IPCs (Chapter 5).   
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6.2 The role of Cdca7 in relation to proliferation and 
differentiation of progenitors remains unclear 
CDCA7/Cdca7 has been identified as a direct target of several transcription factors 
including c-MYC, E2f1 and Ascl1, as well as a downstream modulator of Notch 
signalling (Castro et al., 2011; Goto et al., 2006; Guiu et al., 2014; Osthus et al., 
2005), suggesting that the regulation of Cdca7 is complicated and interactions 
between factors/pathways are likely to occur.  
To understand the importance of E2f factors during mouse development, various 
knockout (KO) strains have been developed (Chen et al., 2009; Ciemerych and 
Sicinski, 2005). E2f1-deficient mice are viable and fertile but suffer with testicular 
atrophy and increased incidence of tumours (Yamasaki et al., 1996). Mice with 
double KO in E2f1/E2f2 can also progress into viable adulthood but develop insulin-
deficient diabetes (Iglesias et al., 2004; Li et al., 2003). Moreover, the double mutant 
possesses an accumulated population of haematopoietic progenitors in S phase, 
suggesting a defective cell cycle when cells lack E2f1 and E2f2 (Iglesias et al., 2004; 
Li et al., 2003). Additionally, in vitro evidence has proved that triple KO of E2f1-3 
results in cell cycle arrest in embryonic fibroblasts through activation of the p53-p21 
pathway (D.Chen et al., 2009; Chong et al., 2009). Specific triple KO of E2f1-3 in 
retinal progenitors causes no developmental defects in lens during embryonic stages 
but the mice experience massive apoptosis and collapse of lens at P16 (Wenzel et al., 
2011). It is therefore suggested that E2f1-3 are not necessary for proliferation of 
progenitors but are instead important for the survival of post-mitotic cells. However a 
contradictory study shows the level of E2f1 is downregulated in differentiated 
oligodendrocytes compared to that in oligodendrocyte progenitor cells in murine 
white matter tracts (Magri et al., 2014). It is well accepted that the activation of E2f1 
facilitates G1/S transition, which links the gene to cell cycle progression. However 
the function of E2f1 in cortical progenitors has not been fully elucidated.  
MYC is a known oncoprotein and is often upregulated in several tumours. c-Myc and 
N-Myc (Mycn) are expressed in the neural progenitors in a mutually exclusive 
pattern, with N-Myc in progenitors and c-Myc in differentiating neurons in mouse 
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cortex (Zinin et al. 2014; www.genepaint.org). In relation to neuronal proliferation 
and differentiation, both c-Myc and N-Myc possess mitogenic roles as c-Myc/N-Myc 
double KO in mouse results in a smaller brain, especially the cerebellum (Wey et al., 
2010). The double KO mice are also characterised by reduced cerebellar granule 
neural progenitors and granule neurons, while other neuron types including astroglia, 
oligodendrocytes, and Purkinje neurons are increased. This finding indicates that the 
role of Myc proteins is more specific to the maintenance of the proliferative state of 
cerebellar granule neural progenitors (Wey et al., 2010). Other evidence has also 
proven that c-Myc co-operatively regulates neural stem cell progression with the 
tumour suppressor p19ARF. In the early embryonic stage, around E13.5, neural stem 
cells (NSCs) are highly self-proliferative and low in p19ARF expression; while at later 
stages, around E18.5, NSCs exhibit less self-proliferation and favour gliogenesis 
(Nagao et al., 2008). Overexpressed c-Myc protein or reduced p19ARF activity in the 
late embryonic stage causes NSCs to retain their self-renewal and high neurogenic 
capacity, while wild-type NSCs normally prefer gliogenesis. In contrast, forced 
expression of p19ARF and inactivation of c-Myc in the early stage leads to premature 
gliogenesis in the NSC population (Nagao et al., 2008). These studies support the 
role of c-Myc as mitogenic and promoting proliferation in stem cells. However, a 
recent study performed in chick embryos has demonstrated that MYC protein can 
promote neural differentiation by controlling the mode of cell division or cleavage 
plane and inhibiting Notch signalling. This neurogenic effect was further discovered 
to be dependent on the integrity of tissues as MYC has mitogenic function in 
dissociating RGCs (Zinin et al., 2014). Therefore, it should be noted that Myc protein 
exerts different functions in vivo and in vitro, likely due to its engagement with 
different downstream signalling pathways.  
Taken together, since Ascl1 is not expressed in the dTel and none of E2f1, c-Myc and 
N-Myc mRNA are expressed in a gradient pattern (Guillemot and Joyner, 1993; Lo et 
al., 1991 ; www.genepaint.org), the cause of Cdca7 graded expression remains 
unknown. Besides, the function of Cdca7 during neural development may be stage-
dependent since overexpression of Cdca7 at E14.5-15.5 did not alter the 
differentiation of progenitors (Chapter 5). It is still believed that Cdca7 is negatively 
regulated by Pax6, as their expression patterns are mutually exclusive at both mRNA 
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and protein levels, but the mechanism behind the inhibition may be indirect. Whether 
the regional effects exerted by Pax6 on progenitor progression involves Cdca7 is still 
poorly understood.  
Figure 6.2 illustrates the current understanding of factors that influence Cdca7 
expression. The role of c-Myc is controversial as it may drive differentiation by 
downregulating Notch signalling or promote proliferation. Notch signalling has been 
found to maintain the stemness of haematopoietic cells in the presence of Cdca7 
(Guiu et al., 2014). In the dTel at E12.5-E13.5, Pax6 inhibits the production of Cdk6 
and thereby inactivates the function of E2f1, which accelerates cell cycle progression 
(Mi et al., 2013), and its downstream target Cdca7, which inhibits differentiation. It 
should be noted that the regulation of progenitor behaviour is both context and stage-
dependent. Therefore based on the results from current and previous studies, Cdca7 
is an indirect target of Pax6 and both accelerates cell cycle progression in RGCs and 
inhibits differentiation of RGCs into IPCs in the dTel during E12.5-E13.5.  
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This summary diagram is based on findings in mouse cortex from E12.5 to E13.5, during 
which Pax6 negatively regulates Cdca7 through directly inhibiting Cdk6 expression. 
Cdca7 has been found to prevent the production of IPCs and neurons. Furthermore, Cdca7 
is also controlled by Notch signalling which is essential for the maintenance of 
haematopoietic stem cells in the presence of Cdca7. Myc can promote both proliferation 
and neurogenesis and its functions needs to be precisely dissected in a spatial, temporal, 
and context-specific manner. 
Figure 6.2 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons. 
 
Figure 1.6662 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons. 
 
Figure 1.6663 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons. 
 
Figure 1.6664 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons. 
 
Figure 1.6665 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons. 
 
Figure 1.6666 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons. 
 
Figure 1.6667 Current understanding of Cdca7 during the differentiation 
process from progenitors to neurons. 
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6.3 The relationship between Pax6 expression levels and 
neurogenesis   
Pax6 is highly expressed in RGCs and downregulated in IPCs in developing cortex 
(Englund et al., 2005). The sequential expression of Pax6 ->Ngn2 ->Tbr2 markers 
from RGCs to IPCs has also been identified during corticogenesis (Englund et al., 
2005; Scardigli et al., 2003). The sequence of development of the cortex, which 
commences rostrolaterally and ends caudomedially, correlates with the gradients of 
Pax6 and Tbr2 expression (Bulfone et al., 1999; Mutch et al., 2010). This further 
supports the finding that the regional effects exerted by Pax6 are essential for 
regional identity (Mi et al., 2013). The dynamic pattern of Pax6 expression during 
neurogenesis has been found to correlate with proliferation and cell fate decisions of 
retinal progenitors (Hsieh andYang, 2009), in which Pax6 is highly expressed during 
preneurogenic proliferation. During neurogenic division in retinal progenitors, Pax6 
is downregulated from G1 to S phase, cells then either regain Pax6 expression upon 
entry into G2/M phase and differentiate into retinal ganglion cells or amacrine cells, 
or lose their Pax6 expression and differentiate into cone photoreceptors (Hsieh 
andYang, 2009). Additionally, Pax6 activates the expression of Ngn2, whose level 
oscillates during cell cycle progression (Shimojo et al., 2008). Several important 
questions remain to be addressed by future studies: 1) whether the level of Pax6 
affects cell fate decision in the cortex as seen in the retina; 2) whether the level of 
Pax6 also oscillates during cell cycle progression; 3) is the graded expression of Pax6 
in the dTel involved in the fate decisions; 4) does Cdca7, being a direct target of 
Notch signalling, also oscillate and facilitate the process of progenitor 
differentiation?  
To answer whether Pax6 and Cdca7 oscillate during cell cycle progression, 
developing cortex from wild-type embryos can be dissected and separated into rostral 
and caudal parts followed by single cell dissociation. Isolated cortical cells can be 
co-labelled with a DNA marker, Hoechst, and sent for Fluorescence-activated cell 
sorting (FACS) analysis to look for correlations between the expression level of 
Pax6, Cdca7 and DNA content. After analysis, cells with differential levels of Pax6 
or Cdca7 can be sorted and further maintained in an in vitro culture system to 
observe the neural differentiation process.  
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To understand whether Pax6 is important for cell fate decisions in cortical progenitor 
cells, the Tis21-GFP transgenic mouse can be a suitable model (Haubensak et al., 
2004). Tis21 has been identified as an anti-proliferative marker expressed in 
progenitors that have committed to the neurogenic fate and also in progenitor-derived 
neurons (Iacopetti et al., 1999). In addition, all early-born neurons derive from 
Tis21-GFP cells and the majority of Tis21+ IPC-derived cells in developing cortex 
express neuronal features (Attardo et al., 2008; Haubensak et al., 2004). To utilise 
this model I would first cross the Tis21-GFP line with the Pax6Sey/+ line. Pax6+/+ 
Tis21-GFP+ cortex tissues can be dissected into rostral and caudal parts and 
dissociated as previous described. It is expected that cells with high levels of Pax6 
should be low in Tis21, but it is unknown whether this correlation differs between 
cortex regions (Kowalczyk et al., 2009; Wong et al., 2015). In addition, 
overexpression of Pax6 by in utero electroporation in the lateral cortex in Pax6Sey/Sey 
Tis21-GFP+ embryos can also provide insights into Pax6 function during neurogenic 
process. Tissue samples can be processed as previously described after the 
electroporation to validate if overexpression of Pax6 can rescue the phenotypes of 
the Pax6Sey/Sey mutant.  
Another transgenic model, the Fucci mouse, is a convenient tool for studying cell 
cycle progression. Cells from Fucci mice contain red fluorescence (RFP protein) in 
G1 phase and green fluorescence (GFP protein) in other phases of the cell cycle 
(Sakaue-Sawano et al., 2008). When coupled with siRNA-mediated regional 
knockdown of Pax6 by in utero electroporation, the Fucci model would allow us to 
detect differences in the length of G1 between Pax6+/+ and Pax6-inhibited cells 
through time-lapse imaging.  
The experiments planned above will allow us to visualise the expression level of 
Pax6 during different phases of the cell cycle, and also to understand whether Pax6 
possesses regulatory roles in G1 duration. By bridging these findings, it is hoped that 
the molecular mechanisms linking cell cycle regulation and the decision between 
proliferative and differentiative division in neural progenitor cells can be further 
deciphered.  
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11% Formaldehyde solution Freshly made before usage 
Reagents Weight or Volume Final concentration 
1M Hepes-KOH pH=7.5 50 µL 50 mM 
5M NaCl 20 µL 100 mM 
0.5M EDTA 1 µL 1 mM 
0.5M EGTA 2 µL 0.5 mM 
37% Formaldehyde (Sigma F8875) 298 µL 11% 
ddH2O  To 1 mL  
 
 
0.5% BSA Blocking solution Stored at 4°C and use in one week 
Reagents Weight or Volume Final concentration 
BSA 250 mg 0.5% 
1x PBS 50 mL  
 
 
Lysis buffer 1 (LB1) 0.2 µm filtered and stored at 4°C 
Reagents Weight or Volume Final concentration 
1M Hepes-KOH pH=7.5 5 mL 50 mM 
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5M NaCl 2.8 mL 140 mM 
0.5M EDTA 0.2 mL 1 mM 
50% Glycerol 20 mL 10% 
10% NP-40 5 mL 0.5% 
10% Triton X-100 2.5 mL 0.25% 
ddH2O  To 100 mL Filtered and  
    
 
Lysis buffer 2 (LB2) 0.2 µm filtered and stored at 4°C 
Reagents Weight or Volume Final concentration 
1M Tris-HCl pH=8.0 1 mL 10 mM 
5M NaCl 4 mL 200 mM 
0.5M EDTA 0.2 mL 1 mM 
0.5M EGTA 0.1 mL 0.5 mM 
ddH2O  To 100 mL  
 
 
Lysis buffer 3 (LB3) 0.2 µm filtered and stored at 4°C 
Reagents Weight or Volume Final concentration 
1M Tris-HCl pH=8.0 1 mL 10 mM 
5M NaCl 2 mL 100 mM 
0.5M EDTA 0.2 mL 1 mM 
0.5M EGTA 0.1 mL 0.1 mM 
10% NA-Deoxycholate 1 mL 0.1% 
20% N-lauroylsarcosine 2.5 mL 0.5% 
The regulatory role of Pax6 on Cell Division Cycle Associated 7 and cortical progenitor cell proliferation 
Appendix 1 Quantitative Chromatin Immuoprecipitation 202 
 
ddH2O  To 100 mL  
 
 
RIPA Stored at 4°C 
Reagents Weight or Volume Final concentration 
1M Hepes-KOH pH=7.5 2.5 mL 50 mM 
0.5M EDTA 0.1 mL 1 mM 
10% NA-Deoxycholate 3.5 mL 0.7% 
10% NP-40 5 mL 1% 
8M LiCl 3.125 mL 0.5M 




1. First Day 
1.1 Add 1 mL of cold 1x PBS was added to cortex tissues to resuspend cells to 
single ones 
1.2 Add 1x cold PBS to final 4.5 mL volume and then add one-tenth (1/10, 450 
µL) of 11% Formaldehyde solution to cell pellets and leave at RT for 15 
minutes. 
1.3 Quench formaldehyde by adding one-twentieth (1/20, 250 µL) of 2.5 M 
glycine.  
1.4 Cells are collected by centrifuge, 1350 g for 5 minutes at 4°C. 
1.5 Add 1x cold PBS and repeat Step 1.4 twice. 
1.6 Immediately freeze the cell pellets in dry ice and store at -80°C. 
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1.7 For magnetic beads preparation (Dynabeads Thermo Cat no.11203D), beads 
are washed by blocking buffer on the rotation platform at 4°C. 
1.8 Collect beads by desktop centrifuge, 3000 rpm for 5 minutes at 4°C. 
1.9 Repeat step 1.7 and collect the beads by magnetic stand. 
1.10 Add anti-Pax6 antibody (Millipore), 10 µg for each reaction and place 
on the rotation platform at 4°C. 
 
2. Second Day 
2.1 Add protease inhibitors (PI, Roche Cat no.11697498001) to LB1, 2 and 3. 
2.2 Resuspend cell pellets in 5 mL LB1-PI and then collect cells by centrifuge at 
1350 g for 5 minutes at 4°C. 
2.3 Resuspend cells pellets in in 5 mL LB2-PI and gently mix for 10 minutes at 
RT. 
2.4 Collect cells by centrifuge at 1350 g for 5 minutes at 4°C. 
2.5 Resuspend cell pellets in 3 mL LB3-PI and transfer cells to sonication tube 
(polypropylene Corning tube).  
2.6 Sonicate the cells solution for 30 seconds for 8-12 times with 30 second 
interval on ice. The sonicator machine is set at 30% amplitude. 
*Sonication repeats are depending on the cell numbers. Normally it aims to shear the 
genomic DNA to 100-600 base pair in length.  
2.7 Add 300 µL of 10% Triton X-100 to sonicated lysate and discard the debris 
by spinning at 20,000g for 10 minutes at 4°C. 
2.8 Aliquot 100 µL for whole cell extract DNA and store at -20°C. 
2.9 Collect magnetic beads from Step 1.10 by the magnetic stand. 
2.10 Wash beads with 1 mL blocking buffer and place on the rotation 
platform for 5 minutes at 4°C. 
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2.11 Collect beads by magnetic stand and resuspend beads in 100 µL of 
blocking buffer 
2.12 Add sonicated lysate to beads. 
 
3. Third Day 
3.1 Wash beads using 1 mL RIPA buffer and place on the rotation platform for 5 
minutes at 4°C. 
3.2 Collect beads by magnetic stand. 
3.3 Repeat the wash step (2.10-2.11) for total 6 times. 
3.4 Wash beads with 1 mL 50 mM NaCl-TE buffer. 
3.5 Also add equal amount of 50 mM NaCl-TE buffer (100 µL) to whole cell 
extract DNA from Step 2.8.  
3.6 Discard 50 mM NaCl-TE buffer from both beads (IP sample) and whole cell 
extract DNA by spinning at 3000 rpm for 5 minute at 4°C. From this point, IP 
and whole cell extract samples are treated the same.  
3.7 Add 100 µL of 10% Chelex/beads (Sigma Cat no C7901) to each sample and 
boil for 10 minutes. 
3.8 Allow to cool down at RT. 
3.9 Add 100 µg/mL of Proteinase K and incubate the mixture for 30 minutes at 
55°C. 
3.10 Boil for 10 minutes and collect the supernatant by spinning at 13000 
rpm for 1 minute. 
3.11 Add 100 µL of ddH2O to the beads from Step 3.10, vortex for 1 
minute and collect the supernatant as step 3.10 
3.12 Combine the supernatants from Step 3.10 and 3.11 
3.13 Purify DNA by phenol/chloroform and Phase-lock gel tube (5 prime 
Cat no. 2302800) according to the manual instructions. 
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Source: http://thebiogrid.org/202033/summary/mus-musculus/pax6.html  
 
 
 
 
 
